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ABSTRACT
This thesis describes the results obtained with 36
monoclonal antibodies (McAbs) and immunocytochemistry on a)
non-malignant lymphoid tissue [thymus (1)*, lymph node (5),
tonsil (15)]. b) 104 skin biopsies of cutaneous lymphoma
(40), contact dermatitis (14), parapsoriasis (17), chronic
inflammatory dermatosis (9), non-lymphomatous erythroderma
(3), atypical lymphocytic infiltrate (3), granulocytic
sarcoma (1), lymphocytoma (3), lymphomatoid papulosis (3),
lymphocytic infiltrate of Jessner (1) chronic lymphocytic
leukaemia (1) , myelomonocytic leukaemia (1), histiocytosis
X (3), and c) normal scalp (5).
In lymphoid tissue, determinants against T, and B cells
(and their subsets), macrophages /D cells, and K/NK cells
have a distinct topography. Immature thymic determinants
O.KT6, OKT9, OKTIO are identified in extrathymic locations
(tonsil, and/or inflammatory infiltrates as well as
lymphomas). OKT6 cross reacts with epithelial dendritic
(Langerhans') cells. J5 (common acute lymphoblastic
leukemia antigen) is absent in lymphoid tissue but present
in some cases of mycosis fungoides. Immature myeloid
markers (MylO, Myl2) are absent in lymphoid tissue. The so
called leukaemia/lymphoma markers Bel/Be2 react with
follicular epithelium (Bel) , dermal endothelium (Be2),
tonsil (Be2), benign dermatoses (Bel and Be2) as well as
most lymphomas. A mature helper T cell phenotype is usually
present in cutaneous T cell lymphoma (CTCL) and inflammatory
dermatoses. However, OKT9 and OKTIO are preferentially
expressed in CTCL versus parapsoriasis and benign
infiltrates.
Lymphomas of non-mycosis/Sezary type can be categorized
into T, B and U types. They often show aberrant
differentiation when examined with multiple markers.
Pseudolymphomas, sarcoidosis, leukaemia and
histiocytosis X show characteristic phenotypes denoting the
expansion of selected lymphohistiocytic subpopulations. The
histiocyte of histiocytosis X predictably expresses the OKT6
marker, but in addition reacts with the Leu3A (helper T
cell) antibody.
Characteristic dendritic cell markers are associated
with B (R423+) and T (OKT6+) populations in lymphoid tissue
and skin.
K/NK cells are identified in benign and malignant
infiltrates. This may have immuno-pharmacological
application.
The markers used amply illustrate the heterogeneous
nature of benign and malignant lymphoid populations.
*(n) = number of specimens tested.
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In 1968 I heard of the tragic death of a school
classmate who was struck down by acute leukaemia. He was a
gifted pupil and his death caused a shudder in the existence
of many of us who were enjoying a relatively carefree sixth
year in school. Around the same time I learned that my
father, a doctor, had developed an enlarged spleen from a
"reticulosis." He courageously continued to look after his
patients right up until his death four years later. The
loss of these two people at such an inappropriate time in
their lives repeatedly stimulated questions as to the nature
of lymphoproliferative disorders, questions so complex that
they barely seemed to be touched in standard texts.
In 1972 Professor (later Sir Alastair) Currie offered
me the opportunity of spending an additional year in
Pathology to study diseases more thoroughly than was
possible in the basic curriculum, h stimulating year was
spent with Doctor (later Professor) W. L. Ford whose
attention was focused on the Lymphocyte; during that time
(after some initial resistance) I learned that knowledge of
the normal is very important when studying the abnormal
cell. Work was being conducted on the in vivo migration
patterns of normal and malignant lymphocytes. While reading
basic science literature on cell differentiation and host
tumour interactions I became interested in the notion that
the mass of lymphoid cells in lymphomatous lymph nodes and
spleen might be more than a homogeneous proliferation of
lymphoma cells and might contain a variety of cancer cells
at various stages of development mixed with host reactive
cells. However, at that time markers to examine the
different Phenotypes of inflammatory cells were sparse. A
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chromosome marker of the transplantable lymphoma I was
studying was discovered (McMillan 1973) but this was of
limited use in providing the type of information I required.
A more ideal method would have been to study cells in tissue
section with markers tagging tumour and reactive lymphocytes
in a manner analogous to radioactive labelling studies of
lymphocyte migration. However, the number of markers at that
time was limited, even more so in human disease where Doctor
(later Professor) Angus Stuart and Doctor John Habeshaw were
beginning to apply the newly discovered E rosettes to
peripheral blood cells and lymphoid tissue to identify T
lymphocytes in a variety of pathological states. Because of
limited technology and the desire to continue medical school
and post graduate studies this idea lay dormant for 8 years.
During that time further questions arose on seeing patients
in the wards with leukaemia-lymphoma and rare disorders such
as histiocytosis x. In 1978 I entered Dermatology hoping to
combine patient care with a side interest in pathology. In
1980 I headed for the University of Oklahoma to complete
their training programs in dermatology and dermatopathology.
However, the chairman of the department, Doctor Mark
Everett, informed me that I should also work with T cells,
preferably in mycosis fungoides and parapsoriasis, since
these conditions were one of the clinical interests of the
department and, as already indicated, interested me. I was
also informed that an empty laboratory was waiting in the
pathology department. Since no one on campus had closely
related interests, he advised me to learn as much as
possible prior to studying in Oklahoma. Basic
immunocytochemical techniques were learned at the University
of Glasgow, and University of London. Alternative methods
of cell analysis (DNA cytophotometry) were also reviewed at
the University of Lieden. While in London I learned that
new reagents for T cell identification (Monoclonal
Antibodies) would be available soon and several months
20
later, while doing the experiments with an anti-T cell
serum, noticed an advertisement in an immunology journal for
such markers. Despite their expense, my chairman kindly
agreed to let me purchase some.
After an introduction to the lymphocyte, its
identification and the purpose of the work, this thesis will
describe and discuss the results obtained.
21
CHAPTER TWO
INTRODUCTION - THE LYMPHOCYTE AND ITS IDENTIFICATION
Including:
A. Early Concepts of Lymphoma
B. Discovery of T and B Lymphocytes in Animals and Humans
C. "Null" Cells and Other Subpopulations
D. The Mononuclear Phagocyte System and D Cells
E. Cell Differentiation and Lymphoma
F-. Early Application of Surface Markers and Cytochemistry
to Human Tissue
G. Monoclonal Antibodies
H. Objectives of Work Described in Thesis
22
CHAPTER TWO
INTRODUCTION - THE LYMPHOCYTE AND ITS IDENTIFICATION
A. EARLY CONCEPTS OF LYMPHOMA
The background to this work is dependent on a fusion of
modern pathological concepts of lymphoma and lymphocyte
immunology. Hodgkin's paper of gross pathology of the
lymphoid organs was published in 1832 (Hodgkin, 1832). The
use of the microscope in the 1830's led to Schwann's theory
that all animals were composed of elementary units called
cells (Schwann, 1839) and to Virchow's idea of "cellular
pathology" (Virchow, 1863). The combination of gross and
microscopic observations led to the splitting of diseases of
white cells into those with high circulating white blood
cell counts (Craigie 1845; Bennet 1845) and those with
generalized lymphadenopathy and splenomegaly but without
increased levels of circulating white blood cells
(Wunderlich, 1858) . Early on, Virchow recognized the
difficulty in separating lymph node malignancy from
hyperplasia (Virchow, 1864-1865). Initial classifications
were clinical but, later, histologic observation led to the
subdivisions of pseudoleukaemia (aleukaemic-leukaemia),
lymphosarcomatosis (lymphoma) and lymphadenoma (Hodgkin's
disease) (Wunderlich, et al., 1858). Roulet's observation
(Roulet, 1930) of reticulum cell sarcoma of lymph nodes
resulted in the division of lymphoid malignancies into the
more familiar categories of lymphosarcoma, Hodgkin's disease
and reticulum cell sarcoma (Ghon and Roman, 1916). In 1942
Gall and Mallory further emphasized the importance of
histology by dividing lymphosarcoma and reticulum cell
sarcoma into more and less differentiated categories and
added follicular lymphoma to their scheme (Gall and Mallory,
1942). Subsequently, the systems of Rappaport (Rappaport,
1966a) the British National Lymphoma Investigation (Bennett,
et ad., 1974) and Dorfman (Dorfman, 1974) appeared.
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Immunologic advances paved the way for further developments.
B. DISCOVERY OF T AND B LYMPHOCYTES IN ANIMALS AND HUMANS
In 1956 Glick described the role of the bursa of
Fabricius in the development of humoral immunity in the
chicken (Glick, et al., 1956) and subsequently the mammalian
thymus was shown to have a pivotal role in immunological
competence (Fichtelius, et ad., 1961; Miller, 1961; Good, et
ai., 1962).
Further work was conducted in the chicken because of
the simultaneous presence of thymus and bursa in this
animal, and a functional dissociation of the chicken immune
system based on differences in thymic and bursal influences
was suggested (Szenberg, 1962).
Ablative studies in laboratory animals (Warner, 1965;
Cooper, et. ad., 1966) and clinical studies in patients with
congenital thymic dysplasia or aplasia (Nezelof, et, ad.,
1964; Digeorge, 1968) demonstrated that cells derived from
the thymus, T cells, are the mediators of cellular immunity
including delayed hypersensitivity, allograft rejection, and
graft versus-host disease. Parallel studies in chickens,
rodents and hypogammaglobulinaemic children revealed that
cells responsible for antibody production, B cells, undergo
thymus independent generation in the avian bursa of
Fabricius and in mammalian foetal liver and bone marrow.
(Gitlin, et. ad., 1959; Warner, 1965; Cooper, et. ad., 1966a)
The importance of thymic and bursal influences in
pathology became clear when thymectomy and bursectomy were
found to have a suppressive effect on the development of
lymphomas in mice and chickens. (Gross, 1960; Moloney,
1960).
In 1966 Cooper and colleagues proposed that lymphoid
malignancies might be usefully classified as either thymus
system or immunoglobulin - producing system malignancies
(Cooper, 1966b). The clinical application of this theory
would however require the development of surface markers
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characteristic of the B and T systems. The demonstration of
surface immunoglobulin on rabbit lymphocytes (Sell and Gell,
1965) was followed by similar studies (Raff, et al./ 1971;
Pernis, et ,§d., 1971) in mice, chickens and rabbits. Their
bursal derivation was shown in chickens; (Rabellino and
Grey, 1972) whereas, the thymus was shown to be the source
of surface immunoglobulin negative cells (Unanue, et al..
1971). Similar approaches were used in human peripheral
blood lymphocytes in normal and pathological states (Grey,
et ad., 1971) Although human T cells lacked the theta
antigen which had been useful in mouse systems, (Raff, 1969)
the demonstration of rosetting capacity with sheep red cells
from 1970 onwards (Brain, et al., 1970; Coombs, et ad.,
1970) permitted their quantification in a variety of
conditions (Wybran and Fudenberg, 1973).
C. "NULL" CELLS AND OTHER SUBPOPULATIONS
Immunologic characterization of lymphomas was then
correlated with their histology (Braylan, et: ad., 1977;
Lukes, et ad., 1978a & b; Stein, 1978) . However,
physiological studies had also revealed a third major
division of lymphoid cells the non-T, non-B or "Null"
lymphocytes (Greenberg, et ad., 1973). This population is
composed of stem cells, killer (K) cells which kill target
cells only when the latter are coated with antibody, and
natural killer (NK) cells which are cytotoxic in the absence
of antibody (Vogler, et al.. 1979). This suggests the
presence of an additional component of potential "reactive"
cells which might be studied in lymphoproliferative
disorders.
The demonstration of T cell subpopulations with
"helper" and "suppressor" activity (Moretta, et ad., 1977)
also adds a further dimension of sophistication in the
analysis of Lymphoid populations.
D. THE MONONUCLEAR PHAGOCYTE SYSTEM AND D CELLS
The analysis of lymphoid subpopulations would, of
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course, not be complete without consideration of the
mononuclear phagocyte system (MPS).
The MPS is widely distributed throughout the body and
is derived from the bone marrow monocyte (Van Furth, et al.,
1972). The cells of this system include monoblasts,
promonocytes, monocytes, macrophages (histiocytes),
multinucleated giant cells, osteoclasts, and microglial
cells of the central nervous system.
Metchnikoff (Metchnikoff, 1892) pointed out that an
essential factor of inflammation was phagocytic activity of
microphages and macrophages. Kiyono (Kiyono, 1914)
suggested the term "histiocyte" to describe phagocytic cells
in lymph nodes, spleen and connective tissue. Aschoff
(Aschoff, 1924) proposed the term reticuloendothelial system
(RES) to cover endothelial cells and reticulum cells which
were also thought to be related to histiocytes. Putative
proliferations of this system have been labelled
"reticulosis" (Robb-Smith, 1938) and "histiocytosis"
(Rappaport, 1966b).
Although rare, the possible presence of true
histiocytic proliferations and the role of the MPS in immune
responses and cell mediated cytotoxicity suggests that the
study of an MPS component in lymphoid infiltrates would be
worthwhile. Dendritic cells (Tew et al., 1982) (D cells),
although showing little or no phagocytic activity, are
probably a subset of the MPS and require to be considered
for similar reasons.
E. DIFFERENTIATION AND LYMPHOMA
The concept of "differentiation" may also be important
in characterizing lymphoid subpopulations including
lymphomas. Failure of differentiation could result in the
accumulation of an immature counterpart of the normal cell
(differentiation block) without a significant change in
proliferation rate (McGrath, 1981). A stem cell disorder
with increased fraction of proliferating cells but
relatively normal subsequent differentiation (expansion of a
single clone) would result in increase in size of all
subsequent differentiation compartments. The amplifications
of the differentiation pathway would result in the more
differentiated compartments being larger (McGrath, 1981). T
cells normally undergo intrathymic maturation (Mathieson and
Fowlkes, 1984) and subsequently seed to peripheral organs.
A neoplasm such as mycosis fungoides which appears to begin
peripherally (although a subject of some controversy) (Ryan,
et al. . 1973) would therefore be particularly worthy of
study if differentiation markers were available. An
additional possible facet of malignancy (not mentioned in
McGrath's hypothesis) is the presence of phenotypes not
found during normal ontogeny (aberrant differentiation).
If technically feasible, then a framework incorporating
typing of lymphoma populations for T, B, macrophage, D cell,
K/NK content could be envisaged. Parallel studies of non-
malignant lymphoid populations (eg. lymphoid organs
unaffected by lymphoma and non-malignant lymphocytic
infiltrates in skin) would be useful for comparison. Any
additional information on differentiation status would be a
further bonus.
The progress in this area up until 1980 will now be
described, with special emphasis given to cutaneous
pathology.
F. EARLY APPLICATION OF SURFACE MARKERS AND CYTOCHEMISTRY
TO HUMAN TISSUE
In the early 1970's T cells, B cells and monocytes were
identified by their respective receptors for sheep
erythrocytes (T cells), C3 [B cells (Bianco, et al., 1970)
and monocytes (Huber, et al., 1968)] and Ig G (monocytes)
(Abramson, et ad., 1970). Extracted cells were studied in
cell suspensions of lymphoid tissue (Claudy, et ad., 1976)
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and skin affected by benign and malignant lymphocytic
infiltrates (Tan, et al.. 1975).
In situ studies utilizing similar technology were
performed in comparable conditions (Dukor, et £l., 1970;
Silveira, 1972; Edelson, et. ad., 1973). In situ Techniques
did not require such dense populations as extraction
methods, theoretically at least did not damage cells to the
same extent, and provided some architectural information.
Some information on lymphoid maturity could be obtained by E
rosetting with and without neuraminidase (Stingl, et, ad.,
1977) and lymphomas have been categorized into "early" and
"late" thymocyte types by this method (Yamanaka, et, ad.,
1981). The in situ E rosetting method was difficult to
perform (Brubaker and Whiteside, 1977) and could not be
adapted for ultrastructural use.
Cellular identification expanded with the development
of anti-T (Yata, et ad., 1970) and anti-B (Brochier, et ad.,
1976) cell sera. Cell subpopulations were then identified
in blood, (Brouet, et al., 1973) lymphoid tissue, (Schmitt,
et al.. 1976) and skin (Schmitt, et ad., 1976a,b; Claudy,
al., 1977; MacDonald, et al., 1978). These studies utilized
in situ or suspension methods (immunofluorescence and
immunoperoxidase) both at the light and electron microscopic
level. Each of the various approaches used had its own
advantages. The immunoperoxidase technique did not require
a specialized microscope, provided more permanent
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preparations and better visualization of tissue architecture
(Petts and Roitt, 1971) as well as being applicable at the
ultrastructural level (Schmitt, et al., 1976a/b). However
each investigator can usually list advantages of his own
favourite technique.
Enzyme cytochemical techniques have also been
successfully used to demonstrate cell types in cutaneous
lymphomas of T (Flandrin and Daniel, 1974; Sterry, et al.,
1980) and B type (Burg and Braun-Falco, 1978). Enzyme
activity, however, tends to be variable in malignant T cells
(Chu, £t al., 1981).
G. MONOCLONAL ANTIBODIES
One problem associated with the use of heteroantisera
is their inherent lack of specificity (Heyderman, 1979)
despite multiple absorptions; although, one unique marker
has been claimed to reside on Sezary cells as detected by
antisera (Khan, et al.., 1980) . An ideal method of tissue
identification of lymphoreticular cells adapted from a
recent review (McMillan, 1985) is listed in Table 1. Since
the introduction of the hybridoma technique in 1975 by
Kohler and Milstein (Kohler and Milstein, 1975) high-titre
specific monoclonal antibodies (McAbs) have been produced
against T cells (Engleman, et, al.. 1975), T cell subsets
(Kung, et al.. 1979a; Ledbetter, et. ad., 1981), immature T
cells (Kung, et al.,1980), B cells (Nadler, et al., 1981a),
monocytes (Todd, et al., 1981) and granular lymphocytes with
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TABLE 1
Tissue identification of lymphoreticular subpopulations -






4. Demonstration of lymphoreticular cells of varying
maturity and subsets of mature cells
5. Permanent record provided
6. Specific
7. Applicable to ultrastructural studies
8. Provides information on in vivo relationships
9. Produces minimal damage to cells and antigens
10. Reagents widely available
11. Easily quantifiable
12. Simultaneous demonstration ofmultiple antigens
13. Applicable to Paraffin Sections
NOTE: Prior to 1980 existing in situ immunoperoxidase technology
satisfied several conditions above (Nos. 1,2,3,5,7,8,9). The advent of
Monoclonal antibodies permitted improvements in Nos. 4, 6 and 10;
although, initially to some detriment in 3a as the original commercially
available reagents were generally more expensive than heteroantisera.
However, this was offset, to some extent, by the ability to use higher
dilutions with these reagents.
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killer-natural killer function (Abo and Balch, 1981). Many
of these reagents became commercially available in 1980-
1983 and set the stage for a new chapter in the
identification of lymphoid cells. If found to be applicable
to tissue sections these reagents, with their increased
range of detection, could be added to the existing
immunoperoxidase technology.
H. OBJECTIVES
The objectives of the work described in this thesis are
as follows:
1) To determine
a) whether Monoclonal determinants expressed on T
cells (and their subsets), B cells, K/NK cells,
monocytes/macrophages, and D cells are readily demonstrable
in non-malignant lymphoid tissue (i.e. tonsil, lymph node,
thymus) and skin.
b) whether these determinants have a recognizable
topography.
c) whether so called "immature determinants" are
truly restricted to thymus and bone marrow as indicated in
original studies of their production or if they might be
found in peripheral lymphoid organs, or normal skin.
2. To study the immune phenotype of allergic contact
dermatitis. This would serve as a prototype of reactive
inflammatory states.
3. To study the Phenotype of cutaneous T cell lymphoma
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(CTCL), i.e., Mycosis Fungoides and Sezary Syndrome, with
respect to:
a) the presence of markers associated with mature T
cells and their subsets. CTCL has previously been shown to
be a neoplasm of helper T cells by functional studies.
(Berger et ad., 1979) The latter are, however, difficult to
perform, thus limiting their use. This raises the question
whether Monoclonal subset studies might demonstrate CTCL to
consist of a phenotypically monomorphous expansion of helper
T cells. This would have important implications in
diagnostic pathology where the discrimination of benign from
malignant lymphocytic infiltrates is often difficult.
b) the presence of immature determinants. According to
the differentiation models of neoplasia already mentioned
(page 26) one might expect to find cells in CTCL expressing
immature antigens, aberrant differentiation, or
proliferation associated markers. Again this could be
diagnostically important.
c) simultaneous comparison of CTCL and prelymphomatous
disorders, eg., large plaque parapsoriasis (poikiloderma
vasculare et atrophicans). The latter group exhibits
clinical heterogeneity with approximately 10% of cases
converting to lymphoma (Everett, 1978). Similar phenotypic
heterogeneity might serve to identify cases with the
propensity for lymphoma development. Comparison with
reactive states such as allergic contact dermatitis, and
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lichen planus would be an integral part of such studies.
4) To determine whether cutaneous lymphomas of non-
Hodgkin's type might
a) be categorized by Monoclonal antibodies into T, B or
true histiocytic (monocyte - macrophage) subtypes.
b) show evidence of disturbed differentiation through
their pattern of expression of markers normally found on
mature and immature cells.
5) To examine whether characteristic phenotypic patterns or
expansions occur in other cutaneous disorders, eg., those
reputedly involving cells of the mononuclear - phagocyte
system (MPS) (Histiocytosis X, sarcoidosis), and in
particular whether these disorders involve expansions of any
recognizable MPS subset. Examination of leukaemias
involving lymphocytes/myeloid cells (chronic lymphocytic
leukaemia/myelo-monocytic leukaemia) and pseudo-lymphomas
(lymphocytoma cutis, lymphocytic infiltrate of Jessner,
Lymphomatoid papulosis) would provide further phenotypic
comparisons between malignant and benign disorders.
6) To scrutinize lymphomatous infiltrates for the presence
of putative host reactive cells such as macrophages or K/NK
cells. This might be of prognostic or therapeutic
importance.
7) To compare the reactivity of non-malignant lymphoid
tissue, benign and malignant cutaneous lymphocytic
infiltrates with reagents stated to be relatively specific
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for lymphoma cells.
This range of work was possible (and necessary) because
of the novel nature of the reagents and lack of studies
















The in situ staining technique used was a modification
of the indirect immunoperoxidase method (Heyderman, 1979)
previously used successfully with heteroantisera for the
identification of T cells in tissues. (Claudy, et: al.., 1977)
The first cutaneous study showing this was practicable with
monoclonals used lichen planus as a model (McMillan, et ad
1981a).
B. TISSUES
Punch biopsies ( 3mm or 4mm) were obtained from
clinically affected skin after 1% Xylocaine Epinephrine
(Adrenaline) anaesthesia. A minimum of 2 biopsies was taken
from each area tested, one submitted for routine
haematoxylin and eosin pathology and the other treated
separately for immunoperoxidase studies.
Surgically removed human thymus, lymph node, and tonsil
were obtained as soon as possible after excision from
patients at the Oklahoma Health Science Center and Saint
Anthony's Teaching Hospitals, Oklahoma City, Oklahoma.
The 104 skin biopsies included 5 "normal" scalp from
hair transplant patients (free of lymphocytic infiltrate but
from individuals with androgenic alopecia), 14 allergic
contact dermatitis, 24 mycosis fungoides, 3 Sezary Syndrome,
17 large plaque atrophic parapsoriasis (poikiloderma
vasculare et atrophicans), 4 lichen planus, 3 atopic
dermatitis, 2 chronic dermatitis of unspecified type, 13
non-Hodgkin's lymphomas of non-mycosis fungoides non-Sezary
type, 3 non-lymphomatous erythrodermas, 3 atypical
lymphocytic infiltrates, 1 granulocytic sarcoma, 3
lymphocytoma cutis, 3 lymphomatoid papulosis, 1 lymphocytic
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infiltrate of Jessner, 1 chronic lymphocytic leukaemia, 1
myelomonocytic leukaemia, 3 histiocytosis X. Non-malignant
lymphoid tissue consisted of 1 thymus, 5 lymph nodes, and 15
tonsils.
The clinical and pathological diagnoses were made by
Board Certified Dermatologists and Dermatopathologists at
Oklahoma University and light microscopic haematoxylin and
eosin slides were reviewed by the authour (also certified in
Dermatopathology).
Upon receipt, specimens were mounted on cork blocks with
OCT medium (AMES Company, Elkhart, Indiana). The mounted
tissue was then snap frozen in liquid nitrogen with
quenching in 2-methyl butane. Tissue was stored at minus 70
degrees centigrade in an ultra-cold freezer (Revco, West
Chester, Pennsylvania) until used.
C. IMMUNOPEROXIDASE METHOD
Cryostat sections (5 microns) were then processed as
follows:
1. Fixation
Because of variable results obtained using 3%
paraformaldehyde (McMillan, et al., 1981a; McMillan, et al.,
1981b; McMillan, et ad., 1981c) (which was previously used
with T cell heteroantisera) (Chu et al., 1979) it appeared
that the antigens detected by McAbs were more sensitive to
the deleterious effects of fixation than the markers
detected by heteroantisera. A full range of fixatives was
therefore tested on normal lymphoid tissue and skin. The
results have been published in detail elsewhere (McMillan,
et ad., 1982a). These involved testing the following for
various lengths of time and temperature: acetone,
paraformaldehyde (3%) in phosphate buffered saline (PBS),
glutaraldehyde (0.1%) in PBS, ethyl alcohol (70%) in water,
no fixative, methyl alcohol-hydrogen peroxide-hydrochloric
acid mixture. Acetone fixation (suggested by Dr. David
Mason, John Radcliffe Infirmary, Oxford England) at 4
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degrees centigrade for 15 minutes was found to be optimal.
2. Rinsing in phosphate buffered saline (PBS), pH 7.4 for
30 minutes.
3. Application of reconstituted primary antibody, at
optimal dilution in PBS at room temperature for 30 minutes.
The 36 monoclonal antibodies used, their specificities, and
sources are given in Table 2.
4. Rinsing in PBS for 30 minutes.
5. Application of secondary antibody, peroxidase-
conjugated goat antimouse IgG or IgM (Tago, Inc.,
Burlingame, California) depending on the nature of the
primary antibody; this was used at optimal dilution in PBS
at room temperature for 30 minutes. The anti-IgG
preparation is specifically formulated for use with
monoclonal reagents and consists of a mixture of affinity-
isolated antibodies directed against the four classes of
mouse IgG (Johnson RC, Tago Inc. personal communication).
6. Rinsing in PBS for 20 minutes.
7. Application of Tris HC1 buffer, pH 7.6 for 10 minutes.
8. Application of diaminobenzidine (DAB) (Graham and
Karnowsky, 1966) 10 mg per 10 ml of Tris HC1 buffer with
0.01% hydrogen peroxide for 10 minutes.
9. Rinsing in PBS for 20 minutes.
10. Progressive rinsing of slides from distilled water to
xylene.
11. Mounting in Permount (Fisher Scientific Co. Fairlawn,
NJ) .
D. ANTIBODIES
Optimal dilutions of antibody (peroxidase method steps 3
and 5) were determined by using cross titrations on sections
of human tonsil. The optimal dilutions, source, and
specificity of Monoclonal Antibodies (McAbs) used in various
studies is shown in Tables 2 and 3. The original
terminology (OKT, Leu, etc.) has been used throughout this
thesis instead of CD nomenclature (Pallesen and Plesner,
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TABLE 2
SPECIFICITIES AND SOURCES OF MONOCLONAL ANTIBODIES
AND ENZYME CYTOCHEMISTRY
ANTIBODIES SPECIFICITY
T Cell and Subsets
0KT3 (CD3) Pan T (Kung, et al, 1979).
OKT4 (CD4) HelperT (Ledbetter, et al,1981).
0KT8 (CD8) SuppressorT (Kung, et al, 1979).
Leu 1 (CD5) Pan T (Ledbetter, et al,1981).
Leu2A (CD8) SuppressorT (Ledbetter, et al,1981).
Leu3A (CD4) HelperT (Ledbetter, et al, 1 98 1).
Leu4 (CD3) Pan T (Ledbetter, et al, 198 1).
Leu5 (CD2) E receptor (Ledbetter, et al, 198 1 ).<
T11 (CD2) E receptor (Ip, et al, 1982; Greaves, et al, 1981).
OKT1 1 A (CD2) E receptor (Greaves, et al, 198 1).
T101 (CD5) Pan T, some B cell neoplasia (Royston, et al, 1980).
3A1 (CD7)
SuppressorT cells, subset of helperT cells (Cossman,
et al, 1983), K cells (Herberman and Ortaldo, 1981).
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TABLE 2 (Continued)





Immature (common) thymocytes (Kung, et al, 1980),
epidermal dendritic cells (Chapter 4).
0KT9
Immature thymocytes, T cell ALL (Kung, et al, 1980),
wide range of proliferating cell types in culture
(Greaves,et al, 1981), eg., mammary carcinoma,
teratocarcinoma. Transferrin receptor.
OKT10(CD38)
Immature thymocytes (Kung, et al, 1980), bone
marrow progenitor cells some activated T cells (Kung,




Granular lymphocytes with K/NK function (Abo and
Balch, 1981),fetal hamster olfactory epithelium,
(Ward, 1986) human neuroectodermal tumours,
(Cailland,et al, 1984) neural and neuroectodermal
cells of several species (Lipinski, et al,1983;
Schuller-Petrovic, et al, 1983).
B Cell
B1 (CD20) B cells, B cell lymphomas (Nadler, et al, 1981a).
B2 (CD21)
Subset of B cells and B cell lymphomas (Nadler, et al,
1981b).
Leu 14 (CD22) B cells, weakly with monocytes, but not macrophages.
Kappa Anti-kappa light chains.
Lambda Anti-lambda light chains
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HLADR Monocytes, macrophages, Langerhans' cells,
activated T cells, B cells (Warnke and Levy, 1980).
Monocyte/Macrophage/D Cell
OKM1 (CD11) Monocytes, macrophages, myeloid series (Breard,
et al, 1980).
M02 (CD14W) Monocytes, macrophages (Todd, et al, 1981).
LeuM1 (CD15)
Monocytes, macrophages, myeloid series (Hanjan,
et al, 1982) adenocarcinomas, (Sheibani, et al, 1986),
interdigitating reticulum cells, (Hofman, et al, 1984),
Reed-Sternberg cells, (Pinkus, et al, 1985; Hsu, et al
1986).
LeuM3 (CD14) Monocytes, macrophages (Dimitriu-Bona, et al, 1983).




Macrophages ("Histiocytes") (Yam and Li, 1971)
R423
Dendritic reticulum (follicular dendritic) cells
(Naiem, et al, 1983).
OKT6 (CD1a) Epithelial dendritic cells (Chapter 4)
Non Lineage Restricted










Common acute lymphoblastic leukaemia antigen, (Ritz,
et al, 1980), adult and fetal nonhaematopoietic tissue
(Metzgar, et al, 1981) , immature T cells (Hsu, et al,
1985), neutrophils (Cossman, et al, 1983), germinal
centre B cells, (Hsu, et al, 1 984), B cell lymphomas
and leukaemias (Hsu, et al, 1984; Cossman, et al, 1984).
Myeloblastic Leukaemia cell lines
MylO (CD34)
Kg- 1, Kg- 1 a cell lines, some ALL and ANL, myeloid
progenitor cells (Civin, et al, 1983, 1984).
My 11 (CD45R)
Kg-1, Kg-1 a cell lines, monoblastic, B-lympho-
blastoid lines, E rosette+ and E rosette- PBL,
monocytes, some ALL, ANL, CLL, CFU-C but not
CFU-E or BFU-E (Civin, et al, 1983, 1984).
My 12 Kg-1, Kg- 1 a, U-937, K-562, HEL cell lines, some ANL,CML, ALL (Civin, et al, 1983, 1984).
My 13 Kg-1, Kg-1 a cell lines blast cells from less than
10% of ANL or ALL, CLL. (Civin, 1983)
Leukaemia/Lymphoma
Bel
Leukaemic CTCL lymphocytes, lymph nodes infiltrated
by CTCL, Epstein Barr virus transformed cell lines
and some long term T cell lines.
Be2
Peripheral blood lymphocytes from 75% of CTCL
patients, Epstein Barr virus cell lines, some T cell
lines and a subpopulation of lymphocytes from 5 of 8
patients with B cell chronic lymphocytic leukaemia
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M0PC21 No known specificity.
Mouse Ascites No known specificity.
NOTES OF EXPLANATION:
1. KG-1 is a myeloblasts leukaemia cell line derived from a patient with nonlymphocytic
leukaemia (Koeffler, and Golde, 1978). The KG-la cell line arose from it as a spontaneous tissue
culture variant (Koeffler, et al., 1980). KG-la cells are phenotypically less differentiated than
KG-1 cells, and have the morphological and cytochemical features of primitive haematopoietic
blast cells. (Koeffler, et al., 1980).
2. The McAbs MY 1 0-13 have been raised against determinants on KG-la cells. None of these
antibodies react with blood granulocytes, red blood cells, or platelets from normal donors. Large
subsets of peripheral blood lymphocytes and monocytes express the Myll antigen. My10, 12, 13
antigens are not expressed on significant numbers of blood lymphocytes or monocytes. My 1 1 is found
in 25% of bone marrowcells of normal donors. My 10, 12, 13 bind only subpopulations of normal
marrow cells.
3. Sources of McAbs:
A. Orthoimmunobiology. Raritan, New Jersey, USA: 0KT3, 4, 6, 8, 9, 10, 1 1 a, and OKM 1.
B. Becton Dickinson Facs Systems Ltd., Sunnyvale, California, USA: Leul, 2A, 3A, HLADR,
LeuMI, LeuM3, Leu14, Anti-Kappa, and Anti-Lambda.
C. Coulter Ltd., Bethesda, Maryland, USA: B1, B2,T1 1, M02, and J5.
D. Hybritech, Inc., T101.
E. Barton Haynes, M.D., Dept. of Medicine, Duke University, North Carolina, USA: 3A1.
F. Toru Abo, Ph.D./Charles Balch, M.D. Departments of Microbiology and Surgery, University
of Alabama, Birmingham, Alabama, USA: HNK 1
G. David Mason, M.D., Department of Haematology, John Radcliffe Infirmary, Oxford, England: R423.
H. Curt Civin, M.D., Department of Paediatric Oncology, The John Hopkins Oncology Center,
Baltimore, Maryland, USA: MY3, MY 1 0- 1 3, M.O.P.C. 21.
I. Carole Berger, Ph.D., Department of Dermatology, Columbia College of Physicians, New York,
New York, Be 1 and Be2.
J. American type Tissue Collection, Rockvilie, Maryland: M.O.P.C. 21. Mouse myeloma protein
(culture supernatant with no known specificity, IgGI Kappa produced by the P3 x63 AG B cell line.
4. ABBREVIATIONS
ALL: acute lymphoblastic leukaemia; CLL: chronic lymphocytic leukaemia; PBL: peripheral blood
lymphocytes; BFU-E: burst forming units - erythroid; CFU-E: colony-forming units erythroid;
CFU-C colony forming units - culture; ANL, acute nonlymphocytic leukaemia.
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TABLE 3-DISTRIBUTION OF 33 MONOCLONAL DETERMINANTS IN HUMAN TONSIL
No. of tonsils Lymphoid Interfollicular Crypt Optimal dilution
Antibody tested follicles areas epithelium of primary antibody
Leuk 2D1 2 +++ +++ + 1 1 0
Leu4/5 2 + + +++ + 1 :5
T11+OKT11A 6 + +++ + 1 1 0
Leu1 1 5 + +++ + 1 20
OKT3 1 5 + +++ + 1 1 0
T1 01 6 + +++ ± 1 1 0
Leu3A 1 5 + +++ + 1 1 0
3A1 8 + +++ + 1 50
OKT4 1 5 + +++ + 1 1 0
Leu2A 1 5 + ++ + + 1 1 0
OKT8 1 5 + + + + + 1 1 0
B1 1 5 +++ + 1 1 0
B2 8 + + - 1 1 0
HNK1 (Leu7) 1 5 + + + + 1 50
HLADR 1 5 +++ + + + 1 20
OKM1 5 + + 1 1 0
M02 5 + + ± 1 1 0
MY3 5 + - 1 1 0
LeuM3 5 + + + 1 20
LeuM1 5 - + 1 20
R423 1 5 + + - 1 : 5
OKT6 1 5 - - + + 1 1 0
OKT9 1 5 +++ + 1 1 0
OKT10 1 5 + + + + 1 1 0
MY 1 0 5 - - -
MY11 5 . + + + + + 1 1 0
MY 1 2 5 - - -
MY 13 5 + - 1 1 0
J 5 8 ± - -
Be1 2 - - -
Be2 2 - + 1 50
M0PC21 5 - - -
Mouse ascites 3 - - -
++++, majority of cells stain positively; +, occasional positive cells; ++,
intermediate between + and +++; ± equivocal reaction, negative
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1987) for the sake of uniformity as this is consistent with
the authour's previous publications and the CD agreement has
come into force since most publications were written.
Because of limited funds and availability of various
reagents and or tissue during the studies outlined in this
thesis the whole range of McAbs mentioned in Table 2 was not
tested in each specimen. The McAbs utilized in each chapter
will therefore be outlined separately.
E. CONTROLS
Positive controls were carried out by testing sections
of tonsil or thymus (once the pattern of staining in this
tissue was ascertained).
Negative controls consisted of:
1. Omission of primary antibody.
2. Omission of primary and secondary antibody; i.e.,
application of DAB alone.
3. Use of an irrelevant primary antibody; eg., application
of MOPC 21 (antibody with no known specificity).
4. Use of mouse ascites as primary reagent.
5. Substitution of the second layer antibody with
peroxidase conjugated goat antirabbit IgG (Tago, Inc.).
6. The use of a battery of antibodies directed against
several specificities also served as an internal control.
An endogenous peroxidase blocker was not used as
methanol - HC1-H202 mixture was found to inhibit the
staining reaction of non-neoplastic lymphoid cells
(McMillan, et al.., 1982a). However, it was considered that
the control utilizing DAB alone would detect any endogenous
peroxidase activity in elements such as red cells.
The possibility that the sodium azide preservative
incorporated in the monoclonal reagents might significantly
inhibit the immunoperoxidase reaction (Dixon and Webb,
1964) was tested using monoclonal T101, (Table 2) which is
obtainable in vials with and without the presence of sodium
azide. A series of sections of human tonsil and skin
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(infiltrated with lichen planus) were tested using T101 as
primary antibody with and without sodium azide. The quality
and intensity of staining was marginally better in the
tissues treated with antibody plus azide.
F. QUANTIFICATION
An assessment of the proportion of histiocytic and
lymphoid cells expressing various determinants was obtained
by counterstaining of sections with hematoxylin (with or
without eosin) or methyl green. A minimum of 300
infiltrating cells (histiocytic plus lymphocytic) was
counted per specimen by the observer (E.M.).
Photomicrographs were taken with a Zeiss
photomicroscope. Positive peroxidase staining is brown in
counterstained and non-counterstained specimens. In non-
counterstained specimens with green filter interposed (to
enhance contrast) positive staining is black against a green
background. A green filter was used to permit better black
and white reproduction for journals.
G. ALPHA-NAPHTHYL ACETATE ESTERASE STAIN
Esterase cytochemical identification of histiocytes was
performed by the method of Yam and Li (1971).
Sections were placed in an incubation medium consisting
of 1.6 1 of hexazotised pararosaniline, 20 ml of 0.1 M
sodium cacodylate buffer and 0.5 ml of 1% alpha-naphthyl
acetate adjusted to pH 6.3.
The slides were incubated at 37 degrees centigrade for
60 minutes, washed in running tap water for 10 minutes and
counterstained in 1% methyl green. The counterstained
slides were then washed for one minute in distilled water,
dehydrated through graded alcohols and cleared with
synthetic medium.
Additional pertinent description of methods will be
given in each chapter.
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I. MAPPING OF DETERMINANTS FOUND ON NORMAL
LYMPHORETICULAR (T, B, K IMMATURE AND MACROPHAGE), LYMPHOMA,
AND MYELOBLASTIC LEUKAEMIA CELLS IN NON-MALIGNANT LYMPHOID
TISSUE (TONSIL, THYMUS, LYMPH NODE) AND SKIN.
A. INTRODUCTION
Prior to this study, the distribution in human tonsil of
T cells and B cells has been documented in experiments using
T cell heteroantisera (Lamelin, et. al.. 1978) and
immunoglobulin antisera (Curran and Jones, 1977). The
recent availability of monoclonal antibodies (Kohler and
Milstein, 1975) with their improved specificity and broad
range of determinants detected (including T subsets) (Kung,
et al., 1979/ Kung, et al., 1980; Ledbetter, et al., 1981)
and the dearth of studies using these reagents in "normal"
tissues suggests that studies using these reagents would be
worthwhile. The establishment of the distribution of these
determinants is important for several reasons:
1) Malignant lymphoid cells may retain sufficient
similarity to their normal non-malignant counterparts so
that their selective metastatic pattern may be similar to
normal migration pathways (McMillan, 1973; Baird, 1978).
Lymphoreticular neoplasia are unusual in that they are
derived from cells whose normal capacity includes migration
through various body compartments. Study of normal
lymphoreticular topography may, therefore, aid our
understanding of metastasis.
2) Physiologic knowledge of potential areas of interaction
of lymphocyte subpopulations, eg. T and B cells, may be
obtained.
3) Because non-tumour specific monoclonal antibodies may be
used therapeutically [eg. Leu 1 in CTCL, (Miller and Levy,
1981)] knowledge of the distribution and prevalence of the
determinants involved might facilitate the prediction of
possible side-effects of monoclonal antibody therapy. This
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is important, since knowledge of the normal tissue
distribution of various determinants is limited. The
accidental finding of the 0KT6 (immature thymocyte)
determinant on epidermal dendritic cells, (Chapter 5) in
parallel studies outlines this. McAbs have also recently
been raised to myeloblastic leukaemia cells (Civin, et. al.,
1983, 1984) Their reactivity with normal lymphoid tissue
needs to be tested for the same reasons.
4) The establishment of the regular distribution of a
particular determinant in relatively easily procured tissue,
eg. tonsil, would provide a useful control when
immunophenotyping lymphomas.
B. MATERIALS AND METHODS
The antibodies used are shown in Table 3 and their known
specificities at the time of study are shown in Table 2.
The procedure and negative controls are as outlined
elsewhere(Chapter 3). Cryostat sections of specimens of
human tonsil obtained from subjects 5 to 25 years of age
were studied. The number of tonsils tested with each
antibody is given in Table 3. Specimens of lymph node were
obtained incidentally from five adults undergoing vascular
surgery. One specimen of neonatal thymus was obtained from a
patient undergoing thoracic surgery. Five specimens of
normal skin were procured from volunteers undergoing hair
transplant surgery.
The following antibodies were tested in each lymphoid
organ:
A. Tonsil: All McAbs.
B. Lymph node: 0KT3, 0KT4, 0KT8, 0KT6.
C. Thymus: 0KT3/Leul/Tll (pan T); OKT8/Leu2A (suppressor
T); OKT4/Leu3A (helper T); 0KT6 (common thymocytes);
OKT9/OKT10 (immature thymocytes).
D. Skin: Bl, B2, Til, 0KT11A, 3A1, T101, HNK1(Leu7), 0KT9,
T10, HLADR, J5, Leu M3, Leul, Leu2A, Leu3A, 0KT3, 0KT4,
0KT8, 0KT6, LeuMl, R423, My3, MylO, Myll, Myl2, Myl3,
49
Bel, Be2, M0PC21, Mouse Ascites.
The presence of macrophages was also tested in tonsil,




The results obtained and the distribution of the
determinants are shown in Table 3 and Figure 1. The
antileukocyte antibody, Leuk.2Dl, stains the majority of
cells in lymphoid follicles and interfollicular areas.
Certain determinants, however, have a discrete localization.
The antigens detected by Til, 0KT11A, Leul, 0KT3, T101,
Leu3A, 3A1, 0KT4, Leu2A and 0KT8 have similar distributions
with most reactivity in interfollicular areas (IFAs) (Plates
1 and 2) and occasional positive staining cells in lymphoid
follicles (LFs) (Plate 3) and crypt epithelium (CE).
Positive staining with T and T subset monoclonals in L.F.s
is seen both in mantle zones (MZs) and in germinal centres
(GCs) of secondary follicles (Plate 4). Leul+, 0KT3+,
Leu3A+, 3A1+ and 0KT4+ cells sometimes occur in dense
clusters in GCs (Plate 5) or in a crescentic pattern (Plate
6) at the junction of the GC and MZ. Results with
Leu2A/OKT8 are interesting in that, although the
localization is predominantly in interfollicular areas as
with other reagents, the number of cells staining positively
is clearly fewer in number than with the other T cell
antibodies tested. The 0KT4 Leu3A (helper)/0KT8 Leu2A
(suppressor) ratio is greater than or equal to 2:1 in all
tonsils examined (Plates 7 and 8). The crescentic pattern
frequently noted with Pan T and helper T cell antibodies is
not evident with the suppressor cell reagents. It is not
known if this reflects a true difference in the topographic
distribution of helper and suppressor subsets, or whether
the absence of the crescentic pattern is merely due to the





























PanT Cell (Til, OKTlla, Leul, OKT3, T101)
THelper (OKT4, Leu3a)
T Cytotoxic/Suppressor (OKT8, Leu2a)
B Cell (Bl, B2)
Intrafonicular MPS (Mo2, My3, Myl3, R423, LeuM3, OKT9)
Crypt Epithelial MPS (OKT6)
Intcrfolliciilar MPS (Leu Ml)
K/Nk (HNK1)
Bc2 Leukaemia Lymphoma Antigen
Negative Reaction: J5 (Common Acute Lymphoblastic Leukaemia)





PLATE 1. HUMAN TONSIL. Preponderantly interfollicular
distribution of Leul+ (Mature T) lymphoid
cells. Indirect immunoperoxidase. Non
counterstained x 10. L = Lymphoid Follice
I = Interfollicular Area
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PLATE 2. HUMAN TONSIL. Leu 1+ interfollicular
lymphoid cells with preponderantly negatively
staining lymphoid follicles (L) adjacent.
Indirect imunoperoxidase. Non counterstained
x 64.
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PLATE 3. HUMAN TONSIL. Intrafollicular Leul+ lymphoid
cells (arrow). Interfollicular area (upper
quarter of field) contains numerous Leul+
cells. Indirect immunoperoxidase. Non
counterstained x 64.
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PLATE 4. HUMAN TONSIL. T11+ (E receptor antibody)
lymphoid cells in germinal centre (G) and
mantle zone (M) of secondary lymphoid
follicle. Indirect immunoperoxidase.
Counterstain haematoxylin x 100.
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PLATE 5. HUMAN TONSIL. Cluster of 3A1+ cells (arrow)
in germinal centre (G) of lymphoid follicle
which mainly stains negatively with 3A1.
Variable density of 3A1 staining suggest this
antibody may react with intrafollicular
dendritic cells in addition to lymphocytes.
Indirect immunoperoxidase. Non
counterstained. Green filter x 160.
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PLATE 6. HUMAN TONSIL. 0KT4+ cells in crescentic
pattern (arrow) at junction of germinal
centre (G) and mantle zone (M) of secondary
lymphoid follicle. Similar pattern is
obtained with Leu3A. Indirect
immunoperoxidase. Non counterstained. Green
filter x 25.
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PLATE 7. HUMAN TONSIL. Interfollicular area Leu3A
(helper T cell antibody) stains majority of
cells. Indirect immunoperoxidase. Non
counterstained x 64.
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PLATE 8. HUMAN TONSIL. Interfollicular area. Leu2A
(suppressor T cell antibody) stains minority
of cells. Cf. Plate 7. Indirect
immunoperoxidase. Non counterstained x 64.
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discernment of this pattern difficult.
Leu 2A+/OKT8+ cells are more evident in crypt
epithelium than Leu 3A+ (0KT4+ cells).
B1 and B2 reactivity is mainly within LFs (Plate 9)
with occasional positive staining in IFAs and a negative
reaction in crypt epithelium.
B1 results in membranous staining of most cells in LFs
including the MZ of secondary follicles. Variable
cytoplasmic and intercellular staining is often present in
the germinal centre (GC). B2 produces staining of GCs and
MZs with staining being more intense in the GCs.
Cytoplasmic and intercellular staining is also present in
GCs. In areas where negative staining cells permit better
contrast of the B2 positive cells, a dendritic pattern is
also observed in the GC with B2, suggesting that this
antibody may also react with dendritic reticulum (follicular
dendritic) cells.
The main localization of HNK1 cells is in LF's.
(Plates 10 and 11) In secondary LFs they are mainly
observed in the GCs but also occur in MZs.
Monoclonal HLADR stains most cells in LFs, occasional
cells in IFAs and a dendritic population in CE. The HLADR
staining in GCs and MZs in LFs is mainly peripheral,
although cytoplasmic and intercellular staining is also seen
in GCs. In the IFAs rounded staining is present, and in
some areas a dendritic staining pattern is present.
The monocyte-macrophage monoclonals produce variable
positive reactions. OKM1+ cells are occasionally observed
in LFs and IFAs. OKM1+ staining often has a dendritic
pattern in LFs. M02+ and LeuM3+ cells are found in LFs.
LeuMl+ cells are occasionally found in IFAs. R423+ cells are
confined to LFs.
Monoclonal antibody R423 produces dense staining of
the lymphoid follicles (Plate 12), and a dendritic staining
pattern is often most evident at the edge of the positively
60
PLATE 9. HUMAN TONSIL. B2+ cells within lymphoid
follicle (L). Interfollicular area (I)
stains negatively. Indirect
immunoperoxidase. Non counterstained. Green
filter x 40.
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PLATE 10. HUMAN TONSIL. HNK1 + (Killer/Natural Killer)
lymphoid cells mainly reside within lymphoid
follicle (L) (right half of field) with
interfollicular area (I) (left half of field)
staining negatively Indirect
immunoperoxidase. Non counterstained. Green
filter x 100.
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HUMAN TONSIL. HNK1+ lymphoid cells (high
power). Majority of positively staining cells
show rounded staining pattern. However, cell
left of centre exhibits dendritic staining.
Indirect immunoperoxidase. Non
counterstained. Green filter x 160.
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PLATE 12. HUMAN TONSIL. R423+ follicular dendritic cells
(left half of field). Adjacent interfollicular
area (I) (right half of field) shows predominantly
negative staining pattern. Indirect
immunoperoxidase. Non counterstained. Green
filter x 64.
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staining areas (Plate 13). Positively staining cells can
therefore be seen in counterstained specimens extending into
the MZ adjacent to GCs. Sometimes the dendritic pattern is
evident in the densely staining GCs when surrounding
negatively staining cells highlight the dendritic R423
cells.
The monocyte-macrophage monoclonals tend to produce
membranous and cytoplasmic staining. The staining observed
is most dense with optimal dilutions of LeuMl, LeuM3, and
R423, when the monocyte-histiocyte monoclonals are compared.
Monoclonal 0KT6 produces a similar reaction to HLADR
in CE (Plates 14 and 15) but does not stain follicles or
interfollicular areas.
No unequivocally positive cells are observed in any
specimen with J5. However, diffuse poorly defined staining
slightly greater than controls is often observed in LFs.
Monoclonal antibody 0KT9 stains a large number of
cells in LFs (Plate 16) and occasional cells in IFAs. Some
of the 0KT9+ cells in GCs are noted to be very large (Plate
16) and to show intense cytoplasmic staining.
OKTIO produces positively staining cells, mainly
residing within LFs. A mixture of membranous and
cytoplasmic stained cells is noted. Occasional clusters of
OKT10+ cells are also noted adjacent to crypt epithelium.
The cells mainly show intense cytoplasmic staining.
MylO and Myl2 produce a negative reaction (Table 3).
Myll positivity is observed in a large number of cells in
LFs and IFAs. My 13 stains dendritic macrophages in LFs.
Bel produces a negative reaction whereas Be2
positively staining cells occur in small clusters in the
interfollicular areas. The staining is weak.
M0PC21 and mouse ascites produce negative reactions.
LYMPH NODE (Figure 2)
The result in LFs and paracortex with 0KT3, 0KT4, 0KT8
are similar in quantity and distribution to those obtained
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HUMAN TONSIL. Dendritic nature of R423+
cells (arrow) evident at edge of lymphoid
follicle. Indirect immunoperoxidase. Non
counterstained. Green filter x 160.
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PLATE 14. HUMAN TONSIL CRYPT EPITHELIUM. OKT6+
intraepithelial dendritic cells at varous
levels through epithelium (E). Indirect
immunoperoxidase. Haematoxylin counterstain x
64.
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PLATE 15. HUMAN TONSILLAR CRYPT EPITHELIUM.
Intraepithelial dendritic OKT6+ cells.
Indirect immunoperoxidase. Non
counterstained. Green filter x 160.
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PLATE 16. HUMAN TONSIL. 0KT9 produces staining of
numerous cells in lymphoid follicle with
dense staining of follicular macrophages
(arrow). Indirect immunoperoxidase. Non
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in tonsillar LFs and IFAs. In addition,lymph node medulla
shows variable staining with 0KT3 (less than or equal to 50%
of cells), the majority of these being OKT4+.
The results with OKT6 contrast with those in tonsil
(where all cases show negative staining in the IFA for
OKT6). Positively staining cells are identified in two of
the five lymph nodes examined. They are located in
localized clusters in the interfollicular areas (Plate 17)
and also tend to produce a dendritic staining pattern.
These clusters are only occasionally found, however, the
majority of IFA producing a negative staining pattern.
No positively staining cells are identified in primary or
secondary follicles. The large number of cells staining
positively with the mature T cell antibodies, especially
with OKT3 and OKT4 which react with the majority of cells in
the IFAs, make it impossible to determine whether this small
population of OKT6 positive cells might also be expressing
these markers. A dendritic staining pattern is not noted
with any of these antibodies, however, making this less
likely.
Bel and Be2 produce negative reactions.
THYMUS
The results obtained in thymus are summarized in Table
4 and Figure 3. The antibodies are listed in order of their
preferential reactivity with more primitive ontogenetic
areas of the thymus (i.e. subcapsular region, cortex)
through to the medulla where more mature T cells are thought
to reside prior to their release into the bloodstream
(Cantor, 1976; Stutman, 1978; Weissman, 1967).
SKIN (Figure 4)
Negative reactions occur with antibodies directed
against B cells (Bl, B2), and mature T cell/ T cell subsets
(Til, OKT11A, 3A1, T101, Leul, Leu2A, Leu3A, OKT3, OKT4,
OKT8), K/NK (HNK1), two of three immature T cell (OKT9,
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HUMAN LYMPH NODE. 0KT6+ dendritic cells
occupying interfollicular area. Indirect

























































































































































































































FIGURE 3: Human Thymus. Schematic Representation Of Distribution Of T Cell
Differentiation Antigens











FIGURE 4. Reactivity of Monoclonal Antibodies on Normal Human Skin.











Negative Reaction PANT (Til, OKT11A, T101, Leul, OKT3)
T Subset (OKT4, OKT8, Leu3A, Leu2A)
K/NK (HNK1/Leu7)
Immature T (OKT9, OKTIO)
Common Acute Lymphoblastic Leukaemia (J5)
Follicular Dendritic (R423)
Myeloid Leukaemia (MY 10, MY12)
MPS (LeuMl)
Control (MOPC21)
NOTE. OKT6 and HLADR may be coexpressed on epidermal dendritic cells.
OKT6, HLADR, and LeuM3, My3, Myl3 may be coexpressed on
dermal dendritic cells
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OKTIO)/ common acute lymphoblastic leukaemia antigen (J5),
follicular dendritic reticulum cell (R423), myeloid
leukaemia (MY10, My12), monocyte-macrophage (LeuMl), and
control M0PC21. Mouse ascites produces weak diffuse
nonspecific staining of dermal collagen.
Positive reactions occur with the following: 1)
Immature T cell (0KT6); epidermal dendritic cells and
occasional dermal dendritic cells. 2) HLAD Locus (HLADR);
epidermal dendritic cells but less frequently than 0KT6;
occasional dermal dendritic cells and endothelial cells. 3)
Monocyte-macrophage (LeuM3, MY3, Myl3); weak staining dermal
dendritic cells. 4) Leukaemia-lymphoma (Bel); follicular
epithelium. 5) Leukaemia-lymphoma (Be2); dermal
endothelium.
ESTERASE STAINING
Esterase positive macrophages are identified in LFs
and IFAs of tonsil (Plate 18) and lymph node (including GCs
and MZs of secondary LF). Only occasional weak staining
cells are identified in CE of tonsil. Positive staining
macrophages are present in cortex and medulla of thymus.
Occasional positively staining macrophages are present in
the reticular dermis of normal skin.
D. Discussion:
TONSIL AND LYMPH NODE:
The results obtained with mature T cell markers and B
cell reagents indicate these populations have a distinct
topographic localization and are consistent with current
notions of T cell localization in IFAs and B cell
localization in LFs (Gutman and Weissman, 1972). The
finding of occasional T cells (0KT3+, Leul+, T101+, 0KT11A+,
T11+) within LFs is interesting because E rosetting cells
have previously been found in the neoplastic follicles of B
cell lymphomas (Jaffe, et al.. 1977), raising the
possibility that the neoplastic follicle might mirror some
of the cell/cell relationships of normal LFs. The retention
PLATE 18. HUMAN TONSIL. Esterase positive macrophages
are numerous within germinal centre (G) of
follicle with occasional positively staining
cells within mantle zone (M) and
interfollicular area (I). Alpha Naphthyl
Acetate Esterase. Methyl green counterstain x
40.
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of the capacity to form a nodular structure with some
semblance of the physiologic follicles would presumably
support this contention. T lymphocytes have previously been
described in mouse lymph node germinal centres by Gutmann
(Gutman and Weissman, 1972) and rarely in human tonsillar
LFs by Lamelin when using heteroantisera and
immunofluorescence (Lamelin, et al,., 1978) . The results
here using a battery of highly specific reagents
substantiate this phenomenon. The distribution of T subsets
mainly within IFAs parallel the results obtained with Pan T
cell reagents and indicate that helper cells are
preponderant in tonsil and lymph node IFAs. The
distribution of T subsets has not previously been reported.
The presence of T subsets and peculiar distribution of
OKT4/Leu3A (helper) cells in the crescentic pattern at GC/MZ
junction may reflect areas of potential TB cooperation.
Studies in mice (Rouse, 1982), reported at a later date,
have confirmed the presence of cells with a "helper"
phenotype in germinal centres. The crescentic pattern
frequently noted with peripheral T cell and helper T cell
antibodies is not evident with the OKT8/Leu2A (suppressor)
antibodies. It is not known if this reflects a difference
in the topographic distribution of helper and suppressor
subsets or whether the absence of the crescentic pattern is
merely due to the overall smaller number of suppressor cells
present, making discernment of this pattern difficult.
It was mentioned earlier that lymphoma cells tend to
mirror their normal counterparts in their metastatic
migration patterns. For instance, CTCL, a helper T cell
neoplasm (Berger, et al.. 1979), causes expansion of the
IFAs with spread of the disease (Long and Mihm, 1974). It
will be interesting to see if any helper or suppressor
neoplasia may occupy GCs.
Niewenhuis and Ford (Niewenhuis and Ford, 1976)
demonstrated in radiolabeling experiments that circulating
78
rat B lymphocytes initially localize in IFAs before
migrating to LFs. The presence of rare B1+ cells in human
IFAs is consistent with their findings.
An interesting contrast is the finding of occasional
intraepithelial cells staining positively with the T cell
antibodies but not with the B cell monoclonals. The
mechanism of this peculiar affinity of T cells for
epithelium is unknown (Edelson, et al., 1974; McMillan, et
al.. 1981c), but is noted in later chapters when benign and
malignant cutaneous T and B cell infiltrates are studied.
In this context, it is of interest that numerous 0KT6+
dendritic cells are present in CE. Prior to this study, the
0KT6 antigen was thought to be confined to the thymus (Rung,
et al.. 1980; Reinherz and Schlossman, 1980) and acute T
cell leukemic lymphoblasts (Reinherz, et ad., 1980). The
results here in tonsil, lymph node and in skin, indicate
that OKT6 reactive cells may be found in extrathymic
locations in non-malignant situations. OKT6 reactivity
appears to be a property of Langerhans' Cells (McMillan, et
al., 1981b; Fithian, et. al., 1981; Murphy, et al., 1981)
which have an important role in presenting antigen to T
cells (Silberberg-Sinakin, et al., 1978; Hunter, 1983). The
proximity of OKT6+ dendritic cells to exocytic T Cells
(OKT3+, Leul+, T11+, 0KT11A+, T101+) in crypt epithelium is
compatible with this role.
Cells with a suppressor phenotype (Leu2A+/OKT8+) are
more easily identified in CE than Leu3A+ helper cells. It
is unknown whether this reflects a difference in the density
of the appropriate antigens or a true difference in the
affinity of these subsets for epithelium. If the latter is
the case, then this indicates an interesting contrast
between reactive and neoplastic states because helper T cell
lymphomas are notoriously epidermotrophic (Chapter 5). A
similar epitheliotropism of cells with suppressor phenotype
(Lytl-23+) has been noted in delayed hypersensitivity
reactions in mice (Tigelaar, 1983) and skin allografts
undergoing rejection in humans (Bhan, e£. ad., 1982) .
The prevalence of Leu3A+/OKT4+ over Leu2A+/OKT8+ cells
in the IFAs of human lymph nodes and tonsils makes it
unlikely that helper-suppressor (H/S) ratios will be useful
in detecting early nodal involvement in helper T cell
neoplasia; this has been borne out by two preliminary
studies (Willemze, e£. al.. 1985; Burke, g£, al., 1986) . The
subset pattern in lymph node and tonsil contrasts with
spleen where Leu3A+ cells are predominantly in the
periarteriolar lymphocyte sheath and Leu2A+ cells are almost
restricted to the cords of Billroth in the red pulp
(VanDerValk, et al., 1984a).
The nature of the 0KT6+ cells in two of five lymph nodes
requires comment. The dendritic pattern suggests a
histiocytic subpopulation. Three histiocytic cell types
might account for 0KT6 reactivity: a) a macrophage analogous
to Nossal's follicular dendritic reticulum cell (Nossal, et,
al., 1968) b) the Langerhans' cell (McMillan, et ad., 1981b;
Fithian, et, al.. 1981; Murphy, et ad., 1981) and c) the
interdigitating reticulum cell (Veldmann, 1970; Veerman,
1974; Rausch, et al., 1977).
a) Nossal's follicular dendritic reticulum cells are
located in the corona of lymphoid follicles of mice. As no
staining was observed in primary or secondary LFs, OKT6 was
not apparently staining a subpopulation of histiocytes
analogous to Nossal's cells (CF results with R423).
b) OKT6 reactivity with cells of Langerhans' lineage (i.e.
Langerhans' cells or indeterminate cells) has been mentioned
already, and a recent study by Weiss et al. (Weiss, e£. al.,
1986) has demonstrated the Leu6+ nodal population to be
HLADR and S100 positive (Leu6 has a reactivity similar to
OKT6). Langerhans' cells have been occasionally described
in normal human lymph node (Vernon, et al.., 1973; Rausch, et
al., 1977) and especially in lymph node undergoing antigenic
challenge eg., dermatopathic lymphadenopathy (Jimbow, et
ad., 1969). It is not known if the two patients with OKT6+
nodal cells had cutaneous disease. The lymph nodes were,
however, reported as "normal" in surgical pathology and
showed no evidence of dermatopathic lymphadenopathy when re¬
examined. The number of cells staining positively with 0KT6
in lymph nodes is small, and, therefore, compatible with
their being Langerhans' cells.
The dendritic reaction obtained in tonsil with 0KT6 also
suggests that the positively reacting cells are Langerhans'
cells since Langerhans' cells have previously been described
in oral epithelium (Waterhouse and Squier, 1967) and tonsil
(Wood, et al., 1985) .
c) The third histiocytic candidate accounting for 0KT6
reactivity is the interdigitating reticulum cell which is
found in the IFA of LNs (Rausch, et ad., 1977) and may also
be involved in interactions with T lymphocytes (Veerman,
1974); Rausch, et al., 1977). This cell is closely related
morphologically to the Langerhans' cell (Rausch, et al.,
1977) and may only be differentiated ultrastructurally from
Langerhans' cells by its absence of Birbeck granules
(Rausch, et: ad., 1977). 0KT6 dendritic reactivity was only
found in the IFAs of two of five lymph nodes and in none of
the tonsils examined. 0KT6 reactivity would, therefore, be
far from a universal marker of interdigitating reticulum
cells (DRCs) in contrast to S100 which stains a large number
of dendritic cells in the T cell zones of lymph nodes (Wood,
et al.. 1985) . The acquisition of 0KT6 reactivity in T
accessory dendritic cells therefore appears to be a function
of their epithelial micro-environment (Murphy, et al..,
1986) .
The distribution of HNK1+ cells in non-neoplastic
lymphoid tissue has still to be fully characterized. HNK1+
lymphocytes are readily observed in LFs and these results
suggest that tonsil will be a useful positive control for
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phenotyping of neoplasia, even though the overall number of
HNK1+ cells in human tonsil is small. The presence of HNK1+
lymphocytes in tonsil will permit its use as a positive
control in initial attempts at studying the prevalence of
these cells in human cancer. Recently, a neoplasm of killer
cells has been described (Ferrarini, et. ad., 1983). It
remains to be seen whether killer-cell neoplasia would
initially metastasize to or preferentially expand lymphoid
follicles. It has also recently been shown that HNK1+
lymphocytes may be 0KT3+ during their ontogeny (Abo and
Balch, 1981), and it is already known that killer/natural
killer (K/NK) cells may show weak expression of the E
receptor (Herberman and Ortaldo, 1981). It is, therefore,
possible that some of the 0KT3+, T11+, 0KT11A+ cells in
lymphoid follicles might be K/NK lymphocytes, rather than
conventional T cells.
The presence of HLADR antigen on a wide range of cells
(B cells, monocytes, macrophages, Langerhans' cells, and
activated T cells) (Warnke and Levy, 1980) probably explains
the distribution observed here with positive staining in
LFs, IFAs, and CE.
The positive reaction (mainly in LFs) with OKT9 is of
particular interest. This antigen was originally produced
by immunizing mice with T-cell acute lymphocytic leukaemia
(ALL) cells (Kung, et ad., 1980) and is present in a
subcapsular thymic population (see results in Thymus) and
mitogen-activated T cells (Kung, e£ a!., 1980). The
presence of OKT9 on a wide variety of replicating cell
types, including T cell ALL (Kung, et. ad., 1980) and
cutaneous T-cell lymphoma (Chapter 5) suggests that
monoclonal OKT9 may be useful in immunotherapy. The OKT9
antibody labels the transferrin receptor (Greaves, e£. ad.,
1981). The results here, however, suggest that this antigen
is probably expressed by a large number of cells in normal
reactive tissue and suggest significant side effects if OKT9
is used in this manner. The large number of LFs staining
here with 0KT9 indicates the probable expression of 0KT9 on
cells of B lineage and some macrophages. Reaction of 0KT9
with tingible body macrophages has also been reported by Hsu
et al (Hsu and Jaffe, 1984a).
The monoclonal determinant OKTIO has been found in
immature thymocytes (Kung, et aJL., 1980), (see results in
Thymus) bone marrow progenitor cells, some activated T
cells, and T-cell ALL. (Kung, et al^., 1980) The exact nature
of the OKT10+ cells observed here in tonsil remains to be
seen. A similar mixture of membranous and cytoplasmic
staining in lymphoid follicles has been noted by other
groups (Bhan, et al., 1981a; Hsu and Jaffe, 1984a). The
results, therefore, confirm that this antigen has a broader
distribution than confinement to immature thymocytes and T-
cell ALL. The same provisos concerning McAb therapy with
CKT10, therefore, stand as with OKT9.
Occasional cells in LFs react positively with the
monocyte antibodies (OKM1, My3, Myl3, M02, LeuM3). The
staining tends to be variable, however. Similar
distributions in tonsil for OKM1 (VanDerValk, et ad., 1984a;
Knowles, et. ad., 1984) and LeuM3 (Hofman, et ai., 1984;
Wood, et. al.., 1985) have recently been noted. Whether
tonsils will prove to be the most satisfactory control
tissue in phenotyping lymphomas for monocyte or myeloid
differentiation antigens remains to be seen. LeuMl+ cells
are uncommon and tend to be found at random throughout IFAs.
A contrasting distribution of LeuMl+ cells (IFAs) versus
OKM1+ cells (LFs, IFAs, medullary sinuses) has also been
recorded by Hofman, et al. (Hofman, et al.. 1984) The
findings with the monocyte-macrophage antibodies, therefore,
suggest the presence of monocyte-macrophage subpopulations
occupying different microenvironments in vivo (CF
distribution of OKM1, LeuM3, M02, and LeuMl in Table 3).
Alternatively, these antigens may be restricted to varying
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stages of monocyte maturation in a manner analogous to the
patterns of immunoglobulin expression seen on B cells during
their stages of differentiation.
As expected, the R423 monoclonal produces positive
staining of dendritic cells in LFs but not in IFAs or CE.
The distribution of R423+ cells, therefore, contrasts
sharply with the 0KT6+ dendritic population, which is
confined to CE. These results are consistent with previous
notions of different subpopulations of dendritic ("D-cell")
subpopulations in normal lymphoid tissue (Tew, et. ad.,
1982). The dendritic reticulum (follicular dendritic) cell
is thought to be involved in antigenic capture for B cells
(Mandel, et ad., 1980). The 0KT6 antigen is found on
Langerhans' cells, which are involved in antigenic
processing of T-cell-mediated immune reactions (Silberberg,
et al., 1978).
An equivocal or negative reaction is obtained with J5 in
all specimens. This antibody detects the common acute
lymphoblastic Leukaemia antigen (CALLA) (Ritz, et ad.,
1980), which is present on non-T, non-B (null) cell
leukaemias. The distribution of the J5 antigen, therefore,
contrasts with the other "immature" markers OKT9 and OKTIO,
which, although present in some leukaemias, have also been
shown here to be readily demonstrable in tonsil. J5
reactivity may be more prevalent in lymphoid tissue than
these results suggest, however, because Hsu, et al., (Hsu
and Jaffe, 1984a) using a more sensitive technique, recorded
hazy diffuse staining in germinal centre cells and some
cells in MZs and T cell zones.
The My antibodies produce contrasting results. MylO and
Myl2 produce a negative reaction, which suggests that the
antigens detected by these reagents are not prevalent in
nonneoplastic lymphoid tissue. Further investigation of the
distribution of these determinants in normal tissues would
be worthwhile, because they may be relatively specific for
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malignant cells. My 11 stains a large number of cells in LFs
and IFAs. This is consistent with the presence of the
respective antigen on peripheral blood lymphocytes (PBLs)
positive and negative for E rosettes. My3 and 13 react with
intrafollicular macrophages.
The leukaemia-lymphoma antibodies Bel, Be2 produce
negative staining in lymph nodes but in tonsil Be2 produces
positive staining in the interfollicular area (Bel reaction
negative). Tonsil was not included in the original
screening studies of these antibodies. (Berger, Morrison,
Chu, et ad., 1982) The results indicate that reactive
lymphoid tissue may express the Be2 antigen in a small
proportion of cells. The Epstein Barr virus status of the
donors of the tonsils concerned is unknown.
M0PC21 does not have any known specificity and produced
a negative reaction in the tonsils examined. This antibody
will probably be very useful as a negative control in
immunophenotyping of the lymphoreticular system.
THYMUS (TABLE 4, FIGURE 3)
The results in thymus are consistent with Reinherz's
scheme of intrathymic differentiation (Table 5) with gradual
acquisition of some antigens and loss of others as
thymocytes mature and migrate from deep cortex to medulla.
The 0KT9, OKTIO, and 0KT6 antigens are readily demonstrated
in thymic cortex (Plates 19 and 20) but not in thymic
medulla where the cell phenotype OKT3+, Leul+,
Leu3A+/Leu2A+, OKT6-, OKT9-, OKTIO- is similar to that of
resting mature peripheral T cells found in peripheral blood
(Kung, et ad., 1980) and the T cell zones of peripheral
lymphoid tissue (Table 4).
The finding of Leu3A/OKT4 and Leu2A/OKT8 staining of the
majority of cortical thymocytes implies the presence of
cortical thymocytes simultaneously expressing "helper" and
"suppressor" antigens. This situation again contrasts with
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TABLE 5
Scheme of Intrathymic Differentiation in Humans
Adapted from Reinherz et al. (Reinherz, Schlossman, 1980)










Thy 5 and Thy 6
Stage III Thy 7 Thy 8
Mature
Thymocyte OKT10+ OKT10+





Mature OKT1 + OKT1 +
Peripheral OKT3+ OKT3+




PLATE 19. HUMAN THYMUS. Common thymocyte antibody OKT6
stains majority of thymocytes in thymic
cortex (C) whereas medulla (M) shows weak
staining. Thymic macrophages are evident by




PLATE 20. HUMAN THYMUS. High power. Thymic cortex (C)
stains positively with OKT6 whereas medulla
(M) only shows occasionally weakly staining
cells. Indirect immunoperoxidase. Non
counterstained x 64.
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circulating peripheral blood T cells which are generally
either Leu3A+/OKT4+ (helper) or Leu2A+/OKT8+ (suppressor).
The significance of cells bearing these immature or
double markers in malignant T cell lymphoma will be
discussed later (Chapter 5).
The presence of rare dendritic forms expressing the 0KT6
marker in thymic cortex is worth further investigation.
Cells containing Birbeck granules have been previously noted
in ultrastructural studies of human thymus (Hoshino, al..
1970). Consideration of the antigen handling function of
Langerhans' cells for T cells in cell mediated immune
reactions (Silberberg, et. ad., 1975) makes it tempting to
speculate that Langerhans' cells may be involved in some
type of information transfer integral to intrathymic T cell
development. The presence of Langerhans' cells within the
thymus and the presence of the 0KT6 determinant on
Langerhans' cells and immature T cells also suggests the
possibility of a more direct developmental link between
Langerhans' cells and T cells. This notion is not
inconsistent with evidence that epidermal Langerhans' cells
are derived from bone marrow derived monocytes (Katz, et.
ad., 1979). Presumably a common bone marrow derived stem
cell might migrate to the thymus and skin and differentiate
into OKT6+ Birbeck granule-(indeterminate)/Birbeck granule+
(Langerhans') cells. The latter, under the inductive
influence of the thymus might influence the development of
or actually differentiate into T cells.
In contrast to the rare OKT6+ dendritic cells
demonstrated here an Ia+ epithelial reticular network is
relatively easily demonstrated in human thymus (Janossy, et
al., 1980) and there is evidence for a role of these
dendritic cells and macrophages in T-cell development
(Wekerle, et ad., 1973; Beller and Unanue, 1978).
Concurrent studies of tonsil (Bhan, et ad., 1981a;
Hofman, et ad., 1983a; Si, et al., 1983; Feller, et. al.,
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1983; Hsu and Jaffe, 1984a and b; Wood, et al., 1985), lymph
node (Poppema, et ad., 1981), and thymus (Bhan, et al.,
1980; Hsu and Jaffe, 1985) in other laboratories have
produced similar findings to those outlined here.
A paper has recently appeared (VanDenOord, et. ad., 1985)
indicating a similar paucity of reactivity of
interdigitating reticulum cells with OKT6 but demonstrating
an increase of OKT6+ cells in dermatopathic lymphadenitis.
The distribution of cell subsets in human spleen (Stuart and
Warford, 1983; Timens and Poppema, 1985) has also been
reported. The main differences from the pattern in lymph
node and tonsil were those already described for Leu3A/Leu2A
(page 80) and the reactivity of OKT8 with splenic sinusoids.
(Stuart and Warford, 1983)
SKIN
The negative reaction with B cell and mature T
cell/subset McAbs is expected and confirms the specificity
of these reagents for lymphoid cells, which tend to be
infrequent passengers through normal skin.
The negative staining with immaturity antigens OKT9,
OKTIO contrasts with tonsil where OKT9, OKTIO positivity is
recorded on lymphocytes (OKT9, OKTIO) and macrophages
(OKT9). This indicates the utility of screening new McAbs
with multiple organs. The common thymocyte antibody OKT6
produces surprising cross reactivity with epidermal
dendritic cells. Prior to these studies, and those in
Chapter 5, OKT6 was thought to be specific for common
thymocytes (Kung, et. ad., 1980). These studies were among
the first to demonstrate such crossreactivity. Simultaneous
studies in independent laboratories have shown the OKT6
positive epidermal dendritic cells to be la (HLADR) positive
(Fithian, et ad., 1981) and to contain Birbeck granules
(Murphy et, ad., 1981) indicating their Langerhans' cell
nature.
The reactivity of epidermal and dermal dendritic and
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endothelial cells with HLADR confirms previous findings.
(Rowden, 1977) Epidermal HLADR+ cells are less frequent
than 0KT6+ cells and this has been noted by other workers
(Harrist, et al.. 1983a).
The positive reaction of dermal macrophages with My3,
Myl3, LeuM3 (negative epidermal dendritic reaction) and
preponderant localization of 0KT6 reactivity to epithelium
is reminiscent of tonsil and again suggests the existence of
subsets of MPS cells or preferential expression of certain
antigens on MPS cells during their lifespan.
The negative reaction with R423 in contrast to the above
MPS McAbs is consistent with confinement of this marker to
follicular dendritic cells (FDC). Results in Chapters 6 and
7 indicate, however, that R423+ FDC may be found in the skin
in certain pathological states where B cell migration is
disturbed.
The negative reaction with leukaemia associated antigens
J5, MylO, Myl2 along with similar results in tonsil suggest
a limited distribution of these antigens in non-malignant
tissue and that further testing would be useful to
characterize their specificities and any cross reactivities
with normal tissue components.
The reactivity of Bel with follicular epithelium and Be2
with endothelial cells again broadens the spectrum of
reactivity of these McAbs beyond lymphomas and malignant
cell lines. As demonstrated in Chapters 5 and 7 these two
antigens may also be expressed on reactive lymphoid cells.
II. POSITIVE PATCH TESTS IN ALLERGIC CONTACT
DERMATITIS
A. INTRODUCTION
The requirement for comparison between reactive and
malignant states; the theory that mycosis fungoides (one
type of cutaneous lymphoma) is due to a persistent antigenic
91
stimulus; and the morphologic similarities between "mycosis"
cells and transformed lymphocytes suggests that a study of
contact dermatitis would be worthwhile. Additional
information concerning the immunopathology of contact
dermatitis might also be obtained.
The characteristics of immune infiltrating cells in
allergic contact dermatitis are studied using McAbs directed
against mature T cells, T cell subsets, immature
differentiation antigens, Killer (K) and Natural Killer (NK)
cells, B cells, Langerhans' cells and common acute
lymphoblastic leukemia antigen (CALLA).
B. MATERIALS AND METHODS
Thirteen positive patch tests from 8 patients with
allergic contact dermatitis and 1 lesional biopsy of poison
ivy were studied. The "positively reacting" substances were
rosin, paraphenylene diamine (PPD) mix, isopropyl-n-phenyl
paraphenylene diamine (IPPD), fragrance, furasizone,
mercapto mix, (N-Cyclohexy 1-2-benzothiazole sulfenamide
2,2-Benzothiazyl Disulfide, 4-morpholinyl-2-Benzothiazyl
Disulfide), ammoniated mercury, merthiolate (2 cases),
chromate, nickel (2 cases), and neomycin. Patch tests were
read at 48 hours, and 3 mm punch biopsies taken of positive
patches. The McAbs used include Leul, Til, Leu2A, Leu3A,
Bl, HLADR, 0KT6, 0KT9, OKTIO, HNK1, J5, R423, Bel and Be2;
their source and specificity is outlined in Chapter 3 Table
2.
C. RESULTS (Figure 5)
Light microscopy of haematoxylin eosin stained sections
show features of allergic contact dermatitis with epidermal
spongiotic oedema, exocytosis (mainly lymphocytic), and
mlcrovesicle formation. Epidermal changes are focal and
spotty horizontally and vertically. The dermis exhibits
variable oedema with a papillary, subpapillary and
perivascular lymphohistiocytic infiltrate.
In cases examined, >50% of the infiltrating cells in
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(Leu2A)
+ O PANT (Leul, Til)
0 HLADR Positive Keratinocyte
Note that certain markers may be coexpressed e.g. HLADR, OKT6 on
dendritic cells, HLADR and PAN T or T subset markers on T cells. These are
shown separately in schematic diagram in a manner analogous to single













dermis and epidermis react with Leul (Pan T) and Til (E
receptor). The majority of these cells are Leu3A+ (helper),
the helper/suppressor ratio varying from 2:1 to 10:1, larger
numbers of helper cells being observed in denser
infiltrates. The HLADR antibody produces patchy positive
membranous staining of epidermal keratinocytes. A more
intense level of positive staining with HLADR is also noted
in (1) epidermal dendritic cells: (2) cells surrounding and
within spongiotic microvesicles (Plate 21, 22); these
consist of rounded and dendritic forms; (3) dermal cells;
isolated HLADR+ dendritic cells are observed throughout the
dermis (Plate 23) (especially in the papillary and
superficial reticular dermis). HLADR+ dendritic cells are
also interspersed throughout the perivascular mononuclear
cell infiltrates. HLADR positivity with a confluent pattern
is also observed throughout the perivascular mononuclear
cell infiltrates indicating that the majority of the Leul+
and T11+ cells are also HLADR+ (although the density of
antigenic staining is less than in the HLADR+ dendritic
cells). The confluent HLADR positivity of perivascular
cells tends to vary in intensity both within the same
specimen and among different biopsy specimens.
The OKT6 antibody reacts with epidermal dendritic cells,
cells within microvesicles (Plate 24), and dendritic cells
lying free and interspersed throughout the dermal
mononuclear infliltrates. The OKT6+ dendritic cells account
for 5-10% of the infiltrating dermal cells.
Only occasional cells (<1%) react with McAB B1 (B cell).
HNK1+ lymphocytes are only seen in 1 case, forming less
than 1% of the cell population and occurring in the dermis
and epidermis (including spongiotic microvesicles).
A negative reaction is obtained with OKT9 (immature)
OKTIO (immature) J5 (CALLA) and R423 (Follicular dendritic
cell antibodies. Bel produces a positive reaction in 1 of 4
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PLATE 21. ALLERGIC CONTACT DERMATITIS. HLADR+ cells
around and within spongiotic microvesicles
(S) HLADR+ cells in upper dermis (D) and
lower epidermis (E) subjacent to lowest
vesicle mainly show dendritic morphology
whereas HLADR+ cells within vesicle (arrow)
display more rounded morphology. Indirect
immunoperoxidase. Non counterstained x 40.
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PLATE 22. ALLERGIC CONTACT DERMATITIS. Densely
staining mainly rounded HLADR+ cells adjacent
to and within spongiotic microvesicle (S).
Indirect immunoperoxidase. Non counterstained
x 100.
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PLATE 23. ALLERGIC CONTACT DERMATITIS. High power of
dendritic staining HLADR+ cells in dermis (D)
and epidermis (E). Indirect immunoperoxidase.
Non counterstained. Green filter x 160.
97
PLATE 24. ALLERGIC CONTACT DERMATITIS. Epidermal OKT6+
cells on inner edge and adjacent to
spongiotic microvesicle (S). Indirect
immunoperoxidase. Non counterstained. Green
filter x 160.
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positive patch (Nickel) tests (10% of infiltrating lymphoid
cells). Be2 reaction is negative in 3 of 3 cases tested.
Positive controls (tonsil, cutaneous lymphoma, including
one J5 positive specimen) are positive. All negative
controls (Mouse ascites as primary antibody, omission of
primary antibody, substitution of goat antirabbit Ig G for
goat antimouse Ig G, and DAB alone) are negative. The use
of multiple primary antibodies of different known
specificities also serves as an internal control.
D. DISCUSSION
This study shows the majority of infiltrating
lymphocytes in allergic contact dermatitis to have a T11+,
Leul+, Leu3A+ phenotype. As far as mature T cell markers are
concerned, the phenotype is similar to that of cutaneous T
cell lymphoma (CTCL) and many cases of benign dermatoses
(Chapter 5). The results suggest that the effector cells in
allergic contact dermatitis have the phenotype of mature T
helper cells. This is compatible with one study of cell-
mediated immunity (PPD intradermal skin testing) where the
infiltrating cells have been shown to have an OKT3+, OKT4 +
helper phenotype (Klareskog, ejt al., 1982) and other studies
of contact dermatitis (Haynes, et ad., 1982a; Scheynius, et
al., 1983; Ralfkiaer and Wantzin, 1984). The infiltrating
cells in various forms of inflammatory myopathy have also
been shown to have a similar Leul+, Leu3A+ phenotype
(Feeback, 1982). The demonstration of a Leul+, Leu3A+
phenotype in the infiltrating cells of irritant contact
reactions (Scheynius, et al.. 1983; Gawkrodger, et. al..
1986) suggests that Leu3A positivity probably cannot be used
to differentiate the allergic from the irritant model.
The staining pattern obtained with HLADR antibody in
epidermis is compatible with the presence of HLADR antigen
on Langerhans' cells and epidermal cells (Rowden, 1977).
Similar findings have been reported by Gawkrodger, et al.
(1986). Major histocompatibility complex (MHC) antigens are
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divided into two groups, class I and class II. Class I
antigens, human lymphocyte antigens (HLA)-A, B, and C are
expressed on all adult nucleated cells. Class II antigens,
the HLA-D series are mainly expressed on immune-competent
cells; eg., B cells, activated T cells, macrophages,
Langerhans' cells, endothelial cells. Normal epidermal class
II positive cells include Langerhans' cells (Rowden, et al..
1.977; Klareskog, e£. al.. 1977) and occasional keratinocytes
especially those of acrosyringeal epithelium (Murphy, £t
al.. 1983; Carr, et al., 1986). The functional significance
of keratinocyte class II expression is unknown. Several
authours have suggested that HLADR expression may allow
keratinocytes to act as antigen-presenting cells (Lampert,
et ad., 1981; Suitters, et ad., 1982; Tjernlund and
Scheynius, 1986). The HLADR expression is probably mediated
by gamma-interferon (Scheynius, et. ad., 1986) released from
immune competent cells (Lampert, 1981; Nickoloff, et. ad.,
1985).
It is uncertain how many of the rounded HLADR+ cells
within spongiotic microvesicles are Langerhans' cells or
activated T cells. The confluent staining pattern produced
by HLADR on the infiltrating dermal T cell population
suggests that many of the cells have the phenotype of
activated Tcells (Evans, et ad., 1978). Some of the dermal
HLADR reactivity is undoubtedly contributed by Langerhans'
cells. The preponderantly negative reactions with
monoclonal antibody B1 indicates that HLADR positivity is
not mainly due to B cells.
0KT6+ dendritic cells are noted throughout the
epidermis including spongiotic microvesicles. They are also
noted apparently lying free within the dermis and throughout
the dermal mononuclear infiltrates (which consist
preponderantly of mature Leult, T11+ T cells) in a manner
similar to other T cell infiltrates. The pattern of 0KT6
reactivity indicates that HLADR reactivity observed is not
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due solely to positively staining Langerhans' cells,
substantiating that HLADR reactivity also resides on the T
cell population. Although studies of this kind do not give
direct information on cell function, the close approximation
of 0KT6+ cells to T cells provides evidence that Langerhans'
cells may play an important role in contact dermatitis in
humans. There is certainly good animal evidence that these
cells function in the handling and presentation of antigen
to T cells (Silberberg-Sinakin, et al., 1978), and
lymphocytes have been noted in close apposition to
Langerhans' cells in contact dermatitis in animals (Poulter,
1983). The role of antigen presenting cells in delayed-
type hypersensitivity has recently been reviewed (Poulter,
1983). The 0KT6+ dermal cells may account in part for the
0KT3- histiocytes found adjacent to lymphocytes in contact
allergic reactions (Panfilis, et al., 1983).
The positive reaction with 0KT6 contrasts with the
negative reaction with another dendritic cell marker R423.
The reaction obtained with monoclonal antibodies B1 and R423
is consistent with current concepts of the relative
importance of B cells (and their accessory cells) in humoral
immunity and T cells in cell-mediated immunity (Weissman, et
ad., 1978). However, biopsies of patch tests taken at a
later stage in allergic contact reactions may show a
significant B cell component with the formation of germinal
centres containing follicular dendritic cells (Ralfkiaer and
Wantzin, 1984). The explanation for this may lie in the
role of B cells in immunologic memory (Ralfkiaer and
Wantizin, 1984) .
Only rare cells in epidermis and dermis are noted to
react with the monoclonal antibody HNK1 and only in one
case. HNK1+ reactive cells are apparently uncommon in ACD
since one other study (Ralfkiaer and Wantzin, 1984) failed
to demonstrate them in any cases examined. K and NK cells
are believed to have an important function in immunity of
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animals against tumours and viruses. (Herberman and
Ortaldo, 1981) Their importance in humans is less clear
(Herberman and Ortaldo, 1981). Although several types of
cells are involved in cellular cytotoxicity (Herberman and
Ortaldo, 1981), this study indicates that the damage in
contact dermatitis is probably mediated via classical T
lymphocytes rather than K or NK cells, which apparently have
properties of both monocytes (0KM1+) and T cells (weak E
rosette positivity)(Herberman and Ortaldo, 1981).
These results are also compatible with animal evidence
that contact sensitivity and cellular cytotoxicity are
mediated by different lymphocyte subclasses (Dennert and
Hatlen, 1975; Huber, et. ad., 1976) as only occasional cells
produce a positive reaction with the cytotoxic suppressor
cell antibody Leu2A. It must be emphasized that reactions
were studied only at 48 hours and that sequential testing
may reveal variation in the distribution and quantity of
various subpopulations (Gawkrodger, et. ad., 1986). For
instance cells with a suppressor phenotype may be more
common in later stages of developing or resolving
(spontaneous or iatrogenic) lesions.
The negative reaction obtained with 0KT9 and OKTIO is
of great interest. Haynes, et al. (Haynes, et al., 1982a)
also found a negative reaction for the transferrin receptor
in allergic contact dermatitis when using a different McAb,
5E9. Both these antigens may be expressed by a proportion
of the infiltrating cells in CTCL (McMillan, 1985) Chapter
5). This may be due to immaturity or "dedifferentiation"
from neoplastic transformation (Chapter 5). Since both the
0KT9 and OKTIO determinants may be expressed by a proportion
of T cells undergoing antigen-induced activation in vitro
(Kung, et al.. 1980) a positive reaction in contact
dermatitis with these antibodies was expected. It is
possible that antigen-induced transformation in vivo differs
from neoplastic transformation of CTCL. This is probably a
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quantitative difference rather than an absolute difference
in expression of the 0KT9 and OKTIO antigens since 0KT9
antigen was demonstrated on some lymphoid cells in one other
study of allergic contact dermatitis, although a negative
reaction was obtained with OKTIO as in this study (Ralfkiaer
and Wantzin, 1984). The differences observed in various
studies may reflect the sensitivity of the techniques used,
and possibly a more sensitive technique such as the avidin-
biotin method would produce 0KT9 and OKTIO positivity. Most
of the blastic transformation of T lymphocytes in contact
sensitivity appears to occur in the local draining lymph
node (Dahl, 1981) and so it is possible that OKT9 and OKTIO
reactivity might be found in nodes draining affected areas.
It is, of course, also possible that 0KT9 and OKTIO
reactivity might be more prevalent at other stages in the
contact reaction. Despite these anatomic and technical
considerations, the results are compatible with the
suggestion that "immature" markers may be preferentially
expressed in lymphomas (Chapter 5,6). Comparitive studies
of 0KT9, OKTIO reactivity in CTCL and lymphomatoid contact
dermatitis (Orbaneja, et al.. 1976) would obviously be of
interest.
The result obtained with 0KT6 is also of interest in
the context of cutaneous T cell lymphoma (CTCL) where an
0KT6+ dendritic subpopulation is present throughout the
helper T cell infiltrates (Chapter 5). Contact allergens
(Fischmann, et. ad., 1979; Cohen, et ad., 1980) and antigen
persistence (Tan, et ad., 1974) have been implicated in the
pathogenesis of CTCL. The similarity of phenotypes noted
here, namely Leul+, T11+, Leu3a+ with interspersed OKT6+
cells is consistent with this hypothesis and a similar
phenotype has also been shown in prelymphomatous states
(Chapter 5).
The negative reaction with J5 which detects common
acute lymphoblastic leukaemia antigen (CALLA) provides
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additional data on the spectrum of reactivity of this
marker. A negative reaction was also found in non-malignant
lymphoid tissue (this chapter). CALLA is presently known to
be expressed on acute lymphoblastic leukemia (ALL) cells
(Metzgar, et al., 1981) some lymphomas, (Metzgar, et al.,
1981) including CTCL (Chapter 5) and some non-malignant
tissues (Metzgar, et al., 1981).
Reactivity of the leukaemia-lymphoma antibodies Bel,
Be2 was not readily demonstrated (Bel positive in 10% of
cells in 1 of 4 cases, Be2 negative 3 of 3 cases.) However,
similar reservations are required as with the immaturity
markers OKT9 and OKTIO (Pages 102-103). In addition, the
number of cases tested is small. Reactivity of these markers
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LARGE PLAQUE PARAPSORIASIS AND CUTANEOUS T CELL
LYMPHOMA (MYCOSIS FUNGOIDES/SEZARY SYNDROM)
A. INTRODUCTION
The known transition of a percentage of cases of large
plaque (atrophic) parapsoriasis (LPAP) and poikiloderma
vasculare et atrophicans into clinicaly evident mycosis
fungoides (MF) (Plate 25) (Samman, 1972; Everett, 1978)
suggests a relationship between the two conditions. Mycosis
fungoides (MF) (Alibert, 1835)/Sezary syndrome SS (Sezary
and Bouvrain, 1938) (SS), form part of the spectrum of
cutaneous T cell lymphomas (CTCL) (Lutzner, et ad., 1975)
They are considered neoplastic on the basis of the
accumulation of mononuclear cells which is initially most
evident in skin (and blood in SS), but which may eventually
occur in several organs (Rappaport and Thomas, 1974) and may
ultimately be associated with a fatal outcome. Many of the
cells constituting these infiltrates have been shown to have
abnormal nuclear morphology (Lutzner, et ad., 1971) and
chromosome content by conventional (Whang-Peng, et ad.,
1982) and cytophotometric (Van Vloten, et. ad., 1974)
methods. However, more physiological analogies may also be
drawn in considering the biology of this condition, as cells
resembling mycosis cells have been described when normal
lymphocytes are "activated" or "transformed" in vitro by
phytohaemagglutinin (Yeckley, et ad., 1975). Langerhans'
cell lymphocyte apposition (Rowden and Lewis, 1976) has also
been noted in a manner analogous to delayed
hypersensitivity.
The T cell nature of mycosis fungoides has been
established by E rosetting techniques (Edelson, et al.,
1973), cytochemical (Sterry, et ad., 1980; Chu, et al.,
1981), and immunocytochemical methods (Brouet, et ad.,
1973) .
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PLATE 25. MYCOSIS FUNGOIDES. PLAQUE STAGE.
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The predominantly T cell nature of the lymphocytes
composing the infiltrates of LPAP was initially determined
by the author in pilot studies [using heteroantiserum and
peroxidase anti-peroxidase in conjunction with light
microscopy (McMillan, et al., 1982b) and immuno-electron
microscopy. (McMillan, et al.., 1981c)]. These experiments
will not be outlined further, but filled a gap in
parapsoriasis studies when compared with the wealth of data
already obtained in MF. It was considered that testing of
LPAP and MF infiltrates with McAbs might identify
subpopulations in infiltrates currently labelled under the
inclusive term of "T cell". In vitro functional studies
have already demonstrated "helper" activity of cells
extracted from tissues involved by MF (Berger, et al., 1979)
or Sezary Syndrome (SS) (Broder, et ad., 1976)
Histologically the infiltrates of MF are polymorphous (Lever
and Schaumburg Lever, 1983). This, therefore, raises the
question of whether the lymphoid component is heterogenous
or a monoclonal population of cells expressing "helper"
markers.
One study of lymphoblastic leukaemia has shown that
utilization of markers expressed at different stages of
thymocyte maturation might permit an assessment of the
differentiation status of a T cell tumour (Reinherz, et ad.,
1980). Similar scrutiny of CTCL from this perspective had
not been performed before the experiments described below
were performed.
The T cell nature of mycosis fungoides and Sezary
Syndrome, the prominent position of the T cell in
speculation and experimental work on tumour immunity, and
the similarities between mycosis cells and transformed
lymphocytes have all hampered any search for possible host
reactive lymphocytes in the cutaneous T cell lymphomas.
However, evidence exists that cells other than classic T
cells may be significantly involved in host surveillance.
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For instance, athymic nude or neonataly thymectomized mice
do not have an especially high incidence of spontaneous or
carcinogen-induced tumours (Herberman and Ortaldo, 1981).
Natural killer (NK) cells are lymphocytes from normal non¬
immune donors with the capacity to rapidly lyse tumour
cells, virally infected cells, or certain undifferentiated
normal cell types in vivo and in vitro (Roder and Pross,
1981). Animal work suggests that NK cells partly fill this
gap in tumour surveillance (Herberman and Ortaldo, 1981) .
The role of NK cells in spontaneously occurring human
tumours is less clear. Indirect evidence for such a role
could initially be obtained by the demonstration that NK
cells accumulate at the site of human tumour development.
This subject has recently been reviewed (Roder and Pross,
1981). The available animal evidence suggests that lymhomas
would be an ideal subject for initial study. Studies of
this kind have been hampered by the lack of a relatively
specific immunologic marker for K/NK cells which could be
utilized for their in situ identification. Certain McAbs
react with K/NK cells, but their cross-reactivity with other
lymphoid or myeloid cells impairs their usefulness.
Recently a McAb, HNK1 (Leu7) has been produced against human
granular lymphocytes with K/NK function (Abo and Balch,
1981). This suggests that studies to detect host immune
cells in situ might be feasible.
B. MATERIALS AND METHODS
Twenty-seven cases of CTCL (24 MF, 3 SS), seventeen
cases of LPAP (poikilodermatous) , and nine cases of chronic
benign dermatosis (CBD) (4 lichen planus, LP; 3 atopic
dermatitis, AD; and 2 chronic dermatitis of unspecified
type) were studied using the method outlined in materials
and methods (Chapter 3).
In MF, SS, and LPAP diagnosis was based on clinical
criteria and histopathologic evaluation of multiple skin
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biopsies (McDonald, 1982; McMillan and Everett, 1982a)
(confirmed by authour). Serial sections were examined in
all cases classified as LPAP. The MF patients demonstrated
similar histopathologic changes (with the exception of one
case); i.e., epidermotropic lymphoid infiltrates showing
single cell exocytosis and/or Pautrier microabscesses (Plate
26) and consisting of a mixture of small and medium-sized
lymphocytes and numerous atypical lymphoid cells with
hyperchromatic convoluted nuclei. None of the MF patients
had extracutaneous disease at the time of the initial
diagnosis as judged by routine staging procedures including
chest x-ray, lymphangiography, blood and bone marrow
examination, liver biopsy and lymph node biopsy. Thus,
other types of T cell leukaemia/lymphoma (eg. T cell chronic
lymphocytic leukaemia, node based peripheral T zone
lymphoma) with secondary cutaneous infiltrates are excluded.
The one patient with different clinico-pathological
features presented with rapid development of large cell
lymphoma (LCL) of non-epidermotropic type and poikiloderma
after a 2 year history of pruritus. Initial biopsies over
the first 2 years showed a superficial perivascular
lymphocytic infiltrate. Convoluted or MF cells were
conspicuous by their absence in the lymphoma which
ultimately developed, despite multiple biopsies from various
sites and at various times.
The McAbs used included 0KT3/Leul; OKT4/Leu3A;
OKT8/Leu2A; 0KT6; 0KT9; OKTIO; B1/B2; J5; HNK1; LeuMl;
LeuM3; R423 and Bel/Be2. The spectrum of reactivity of
these antibodies is given in Chapter 3. This battery of
McAbs detects mature T cells and subsets (0KT3/Leul,
OKT4/Leu3A, OKT8/Leu2a), immature thymocytes (0KT6, 0KT9,
OKTIO), B cells (Bl, B2) other subpopulations such as
killer/natural killer cells (HNK1), and
monocytes/macrophages (LeuMl, LeuM3). The use of J5 permits
comparison with common acute lymphoblastic leukaemia. The
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PLATE 26. MYCOSIS FUNGOIDES. Epidermal Pautrier
microabscesses. Haematoxylin and eosin x 160.
Ill
use of LeuMl further defines the T cell neoplasm since some
activated T cells exhibit LeuMl positivity (Hanjan, et al.,
1982). The McAbs Bel and Be2 are purported to be relatively
specific for malignant cells and may be of diagnostic use in
peripheral blood studies of CTCL (Berger, et al., 1982).
Their utility on tissue sections requires to be determined.
C. RESULTS
The results are summarized in Table 6.
1. MATURE PAN T MARKERS (Leul/0KT3).
In 20 Of 23 MF the phenotype of exocytic and dermal
cells is that of a mature T cell (Leul+, OKT3+; >50-80% of
cells). In 3 cases, all tumour stage, (numbers 2, 12, 15)
Leul/OKT3 stains <50% of cells and in one plaque stage
(number 5) although Leul/OKT3 stains >50% of the total
population sheets of negatively staining tumour cells are
noted (Plate 27) (which do however stain with OKT9). An
OKT3+, Leul+ phenotype is also noted in SS (60-80% of
cells), LPAP (60-90% of cells) (Plate 28, 29) and BCD (65—
90% of cells).
Four cases of MF show staining of the majority of cells
in Pautrier microabscesses with Leul/OKT3.
2. SUBSET MARKERS (Leu2A/OKT8).
A helper phenotype is demonstrated in 27/27 CTCL (24
MF; 3 SS) (Plate 30), 14/17 LPAP (cases 4, 15, 17 are
exceptions), and 7/9 BCD. There is considerable overlap in
H/S ratio among CTCL, LPAP, and BCD, (Tables 6 and 7) (see
also results in contact dermatitis). Single exocytic Leu3A+
and Leu2A+ cells (Plate 31) are noted in CTCL, LPAP and BCD.
The Pautrier microabscesses in MF show a large number of
Leu3A+/OKT4+ cells (Plate 32) but are Leu2A/OKT8- (Plate
31). Leu2A+/OKT8+ cells in MF are found scattered diffusely
throughout the dermal infiltrates and occasionally at the
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TABLE 6-PROPORTION OF CELLS BEARING MONOCLONAL
DETERMINANTS IN CUTANEOUS T CELL LYMPHOMA
LARGE PLAQUE PARAPSORIASIS AND BENIGN CHRONIC DERMATOSES
Mycosis Fungoides (MF)
Case H/S Stage OKT6 J 5 OKT9 OKT10 B1/B2 M1/M3
1 5:1 P 15% Nt ± Nt 0% Nt
2 3:1 T 5% Nt 30% 1 0% Nt Nt
3 4:1 P 1 0% 1 0% 1 0% 0% 0% 2:1
4 3:1 P 1 0% 0% 20% 0% 0% Nt
5 5:1 P 20% 0% 40% 20% 0% 1 :3
6 5:1 ... P 1 0% Nt 1 0% 20% 0% 2:1
7 4:1 P 20% Nt 10% 0% 0% Nt
8 2.5:1 P 20% Nt 30% Nt Nt Nt
9 4:1 P 1 0% Nt 30% 0% 0% Nt
1 0 3:1 P 1 0% 0% 1 0% ± Nt 2:1
1 1 5:1 P 1 0% 0% 20% Nt Nt 3:1
1 2 3:1 T ± 0% 1 0% ± 0% Nt
13a 3:1 P 1 0% 0% ± 1 0% 0% 1:2
13b 3:1 T Nt Nt 30% Nt 0% 0:2
1 4 3:1 P 20% Nt 20% 0% 0% 1:1
1 5 2:1 T + Nt ± 0% 0% 1:1
1 6 4:1 P ± 40% + 0% 1 0%(B1) 0:1
1 7 2:1 P ± Nt Nt Nt Nt Nt
1 8 2:1 P Nt Nt Nt Nt Nt Nt
1 9 2:1 P Nt Nt Nt Nt Nt Nt
20 4:1 T 10% 1 0% 30% 20% Nt 2:1
21 3:1 P 1 0% Nt 1 0% 1 0% Nt Nt
22 3:1 P 1 0% Nt 30% Nt Nt 1 :2
23 4:1 P 1 0% Nt 40% Nt 0% 0:1
24 3:1 P Nt Nt 1 0% Nt Nt Nt
Range 2:1-5:1 0-20% 0-40% 0-40% 0-20% 0-1 0% 0:1 -1 :3
No. Pos/No.tested 24/24 H:S>1 1 7/21 3/9 1 8/21 6/15 1/13 10/13 M1
13/13 M3
Sezary Syndrome (SS)
1 1.5:1 10% Nt + 1 0% Nt Nt
2 4:1 1 0% Nt 1 0% 0% 0% Nt
3 4:1 1 0% Nt 40% 0% 0% Nt
Range 1.5:1 -4:1 1 0% Nt 0-40% 0-1 0% 0% Nt




TABLE 6 Cont. - Large Plaque Atrophic Parapsoriasis (LPAP)
Case H/S OKT6 J 5 OKT9 OKT10 B1/B2 M1/M3
1 2:1 30% Nt 1 0% 0% Nt Nt
2 4:1 30% Nt 0% 0% Nt Nt
3 3:1 Nt Nt 0% 0% Nt Nt
4 1:2 Nt Nt 0% 0% Nt Nt
5 3:1 20% Nt 0% 0% Nt Nt
6 2:1 + Nt 0% 0% Nt Nt
7 2:1 1 0% Nt 0% 0% Nt Nt
8 4:1 1 0% Nt 0% 0% 0% Nt
9 10:1 30% Nt 0% 0% Nt Nt
1 0 3:1 ± Nt 0% Nt Nt Nt
1 1 2:1 30% Nt 0% 0% 0% Nt
1 2 2:1 20% Nt 0% 0% 10% (B1) 1 :3
1 3 2:1 1 0% Nt ± 0% 0% Nt
1 4 1.5:1 1 0% Nt <10% Nt 0% 2:3
1 5 1 :1 1 0% Nt 0% 0% 0% Nt
1 6 3:1 1 0% Nt 0% o% 0% Nt
1 7 1:1 20% Nt 0% Nt 0% Nt
Range 1 :2-1 0::1 0-30% Nt 0-1 0% 0% 0-1 0% 1:3-2:3
No. Pos/No. tested 14 H/S>1 1 2/1 4 Nt 2/1 7 0/14 1 / 8 2/2 M1
H/S<1 2/2 M3
Controls
LP 1 4:1 ± Nt Nt Nt Nt Nt
LP 2 4:1 ± Nt Nt Nt Nt Nt
LP 3 1:1 20% Nt ± 0% Nt 0:1
LP 4 2:1 1 0% Nt 1 0% Nt 0% 2:1
AD 5 2:1 1 0% Nt 0% Nt Nt 1 :2
AD 6 2:1 1 0% Nt 0% Nt Nt 1:1
AD 7 1 :1 1 0% Nt 0% Nt Nt 1:1
CD 8 3:1 1 0% Nt Nt Nt Nt Nt
CD 9 3:1 Nt Nt Nt Nt Nt Nt
Range H/S<1 -4:1 0-20% Nt 0-1 0% 0% 0% 2:1-0:1
No. Pos/No. tested H/S>1 IN 7/9 6/8 Nt 1 / 5 0/1 0/1 4/5 M1
5/5 M3
Key: Nt = Not Tested
± = Equivocal Reaction
1 1 4
PLATE 27. MYCOSIS FUNGOIDES. Mature T cell marker,
0KT3, stains numerous cells left 1/3 of field
whereas majority of neoplastic population




LARGE PLAQUE PARAPSORIASIS. Exocytic Leul+ T
cells. Indirect immunoperoxidase. Non
counterstained. Green filter x 100.
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PLATE 29. LARGE PLAQUE PARAPSORIASIS. Dermal Leul+ T
cell population. Indirect immunoperoxidase.
Non counterstained. Green filter x 100.
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PLATE 30. MYCOSIS FUNGOIDES. Dermal Leu3A+ (T helper)
cells. Epidermis (E). Dermis (D). Indirect






ELATE 31. MYCOSIS FUNGOIDES. Isolated epidermal Leu2A+
(T suppressor) cell (arrow). Pautrier
microabscess (P) stains negatively with
Leu2A, in contrast to Leu3A (Plate 32).
Indirect Immunoperoxidase. Non
counterstained. Green filter x 160.
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MYCOSIS FUNGOIDES. Leu3A+ (helper T) cells
within Pautrier microabscesses (P). Reaction
with Leu2A (T suppressor) antibody negative.
Indirect immunoperoxidase. Non
counterstained. Green filter x 160.
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periphery of infiltrates in the reticular dermis.
Leu3A+/OKT4+ cells in contrast occur in sheets and clusters.
In 2 cases of MF exocytic cells are 0KT3+, Leul+ but
Leu3A-/Leu2A-. In 2 cases of parapsoriasis where exocytic
cells are plentiful these are almost entirely Leu2A+/OKT8+.
3. 0KT6.
0KT6 is found to react with epidermal dendritic cells
in all specimens examined. (Plate 33). 0KT6 dendritic cells
form a prominent component of Pautrier microabscesses in MF
(Plate 34). Dermal 0KT6 reactivity (Plate 35) is noted in
17/21 MF, (equivocal in 4), 3/3 SS, 13/15 LPAP (2
equivocal), 6/8 BCD (2 LP equivocal). This result contrasts
with the negative results obtained with another dendritic
cell antibody R423, which is associated with B cell zones of
lymphoid tissue (Chapter 4), benign (Chapter 7), and
malignant (Chapter 6) cutaneous B cell infiltrates.
4 . J5.
J5 positive lymphoid cells are identified in 3/9 MF.
J5 reactivity is not tested in the other conditions
mentioned.
5. 0KT9.
0KT9 reactivity is observed in 18/21 MF, (10-40% of
cells), 2/3 SS, i.e., 20/24 CTCL; but only 2/17 LPAP (<10%
of cells), and 1/5 BCD (10% of cells in LP). See also
contact dermatitis results (Chapter 4) for contrast with
CTCL. (13 positive patch tests OKT9 negative).
In MF OKT9 reactive cells are intraepidermal (Plate
36), found at the dermo-epidermal junction and intradermal
in location. In the latter situation they are found singly
and in clusters (Plate 37).
6. OKTIO.
OKT10 positive dermal cells (Plate 38) are identified
in 6/15 MF (10%-20% of cells), 1/3 SS (10% of cells), i.e.,
7/18 CTCL; 0/15 LPAP, 0/1 LP. See also results in contact
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PLATE 33. MYCOSIS FUNGOIDES. 0KT6+ epidermal and
dermal dendritic cells. Epidermis (E). Dermis
(D). Indirect immunoperoxidase. Haematoxylin
counterstain x 100.
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PLATE 34. MYCOSIS FUNGOIDES. 0KT6+ dendritic cells
within Pautrier microabscesses (P). Indirect
immunoperoxidase. Haematoxylin counterstain x
160.
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PLATE 35. MYCOSIS FUNGOIDES. Dermal 0KT6+ dendritic
population. Right of centre the 0KT6+ cells
appear to form a chain. Surrounding lymphoid
cells stain negatively. Epidermis (E).
Dermis (D). Indirect immunoperoxidase.
Haematoxylin counterstain x 40.
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PLATE 36. MYCOSIS FUNGOIDES. Pautrier microabscesses
(P) contain numerous 0KT9+ (immature
T/transferrin receptor+) cells whereas tumour
population in subjacent papillary dermis (D)
contains only rare positively staining cells.
Indirect immunoperoxidase. Non




PLATE 37. MYCOSIS FUNGOIDES. Dermal 0KT9+ population.
Negatively staining sheets of tumour cells




PLATE 38. MYCOSIS FUNGOIDES. OKT10+ (immature
thymocyte) dermal cells (arrows). Epidermis
(E). Dermis (D). Indirect immunoperoxidase.
Haematoxylin counterstain x 64.
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dermatitis (Chapter 4) for contrast with CTCL. (13 positive
patch tests OKTIO negative.)
OKTIO positive cells are not identified in the
epidermis.
7. B1/B2.
B cells are identified by reactivity with B1 in 1/14 MF
(10% of cells), 0/2 SS, 1/8 LPAP, and 0/1 BCD. See also
contact dermatitis, Chapter 4. B1+ cells are dermal in
location. No B1+ cells are identified in the epidermis,
which contrasts with the mature T cell and subset marker
pattern.
No immature B cells (B2+) are identified. This
contrasts with results in B cell lymphomas, Chapter 6.
8.. LeuMl/M3; Esterase Positive Macrophages.
A monocyte/macrophage component (LeuMl+ and/or LeuM3+)
is identified (Plate 39) in 13/13 MF, 2/2 LPAP, and 5/5 BCD.
These do not exceed 15% of the cell population in any case.
Large esterase positive cells are identified in 21/21 CTCL
(18/18 MF, 3/3 SS; 5-15% of cells), 9/9 LPAP (5-15% of
cells), 2/3 LP (5-10% of cells).
9. HNK1+ CELLS (Not Shown in Table.)
HNK1+ lymphocytes (Plate 40) are identified in 8/18 MF
(<l%-5% of cells), 3/3 SS (<1% of cells), 2/9 LPAP (<1% of
cells), 2/3 LP (<1% of cells), 0/3 AD. HNK1+ cells are
usually dermal in location, occupying the papillary and
upper reticular dermis. Epidermal exocytic HNK1+ cells are
also observed in epidermotropic infiltrates; eg., 4 of 11
CTCL. In one case of MF HNK1+ lymphocytes are seen adjacent
to Pautrier microabscesses. Otherwise, they are found
scattered in small numbers throughout the epidermis with no
apparent clustering effect. However, they are seen in
occasional juxtaposition to exocytic T lymphocytes. In the
positively staining cases of lichen planus HNK1+ lymphocytes
are located at the dermo-epidermal junction as well as
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PLATE 39. MYCOSIS FUNGOIDES. LeuMl+ dermal cells.
Indirect Immunoperoxidase. Non
counterstained. Green filter x 160.
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PLATE 40. SEZARY SYNDROME. HNK1+ (K/NK) dermal
lymphoid cells. Epidermis (E). Dermis (D).
Indirect immunoperoxidase. Non
counterstained. Green filter x 100.
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within the epidermis, and in the lichenoid infiltrates of
the papillary and the upper reticular dermis. Examination
of counterstained sections of positively staining cases show
that the HNK1+ lymphocytes are not intravascular but are
located in the interstitium of the dermis, at the dermo-
epidermal junction or between epidermal keratinocytes.
10. R423.
A negative reaction is obtained with R423 in 14/14 MF,
1/1 SS, 8/8 LPAP, 2/2 Lichen planus, 4/4 chronic dermatitis.
11. Bel/Be2 (Not Shown in Table).
Bel reactivity is found in 9/11 MF (10-80% of cells),
3/3 SS (5-60% of cells), 1/5 LPAP (10% of cells), 1/5 AD
(70% of cells), 1/3 LP (15% of cells).
Be2 reactivity is found in 6/10 MF (10-60% of cells),
3/3 SS (30-70% of cells), 1/5 LPAP (25% of cells) 1/5 AD
(40% of cells, weak staining), 2/3 lichen planus (20-40% of
cells (Plate 41).
D. DISCUSSION.
1. Mature Pan T and Subset Markers
The results indicate that the majority of cases of CTCL
exhibit a mature helper phenotype but with a proportion of
cells present bearing cytotoxic/suppressor markers. This is
in contrast to cases of T cell ALL, the majority of cases
being OKT3-, OKT4-, OKT8- (immature) in one study.
(Reinherz, et aJL., 1980) A similar mature phenotype of CTCL
has been demonstrated by other groups from 1981 onwards
(McMillan, et ad., 1981d; Kung, et ad., 1981; Laroche and
Bach, 1981; Haynes, et ad., 1981; McMillan et, al; 1982c;
Holden, et al., 1982a; Knowles and Halper, 1982; Haynes, et
ad., 1982a; Schmitt, et. al., 1982; Thomas, et ad., 1982;
Wood, et al., 1982; Thivolet, et ad., 1982; Mackie and
Turbitt, 1982; Hashimoto and Iwahara, 1983; Beuchner, et
al., 1983; Sheibani, et. al., 1983; Hofman, e£. ad., 1983b;
Willemze, et al.. 1983a and b; Chu, et al., 1984; Ralfkiaer,
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LICHEN PLANUS. Be2+ dermal lymphoid
population. Be2 is purportedly relatively
specific for lymphoma cells. Indirect
immunoperoxidase. Non counterstained. Green
filter x 160.
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et al.. 1985a and b; Nasu, et ad., 1985; Abel, et al.. 1985;
Wood, et ad., 1986; Vonderheid, et. al.. 1987) . This result
of membrane phenotyping therefore appears to be in agreement
with in vitro functional studies. (Broder, gt al.., 1976;
Berger, e£. al., 1979). Despite this apparent agreement
between membrane phenotyping and functional studies in MF it
should not automatically be assumed that a phenotype typical
of a particular subset implies the same functional activity.
For instance, in chronic lymphocytic leukemia (T cell type)
cells have been identified which have a "suppressor"
phenotype immunologically (Leu2A+) but "helper" function
(Siegel, et al., 1981) .
This then raises the question of the significance of
the cells in MF infiltrates reacting positively with
"suppressor" antibodies. Whether similar results would be
obtained in skin with pre-existing subset markers (Gupta, et
ad., 1978) is unknown. The nature of the cells reacting
positively with suppressor antibodies is open to
speculation. In the majority of cases studied here, the
number of cells reacting positively with "helper" and
"suppressor" antibodies suggests that these reactivities can
be accounted for bv separate suboooulations of cells. In 4
cases, however, the number of Leu3A+/OKT4+ cells appears
similar to that of Leul+/0KT3+ cells suggesting that the
subset markers (Leu3A+/OKT4+ plusLeu2A+/OKT8+) exceed the
Luel+/0KT3+ component unless some cells are expressing both
markers simultaneously. One group has suggested that a
subgroup of CTCL does indeed express OKT4/OKT8
simultaneously and that this may be of diagnostic use (Chu,
et ad., 1984). Their suggestion is based on the observation
that "helper" and "suppressor" numbers exceed the quantity
of cells detected by pan T cell markers. This could arise
from malignant dedifferentiation or by a more physiologic
process. Simultaneous expression of markers normally found
on separate subpopulations has been described previously on
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non-malignant lymphocytes when conventional T and B cell
markers were used (Dickler, et ad., 1974), and a similar
phenomenon may occur with the cell surface markers detected
by "helper" and "suppressor" subset antibodies (Bach and
Bach, 1981)
This situation does need further clarification as a
proportion of macrophages may express Leu3A/OKT4 antigenic
determinants (Wood, al.. 1983a), and presumably these
cells, which are 0KT3-/Leul-, could account for some of the
"subset" numbers exceeding the pan T cell population.
Leul-, Leu3A+, Leu2A- malignant lymphocytes could also
contribute to this phenomenon.
This area is further complicated by the demonstration
in vitro (Pichler, et. ad., 1978) that "suppressor" cells may
change to "helper" cells. Whether lymphocytes may change
their surface markers after migration into the skin is
presently unknown.
One study utilizing the more direct approach of double
labelling immunofluorescence has failed to demonstrate
Leu3A+/Leu2A+ cells in MF (Ralfkiaer, et. ad., 1985a)
None of the rare cases of MF with a purely suppressor
ohenotyoe (Thomas, et, al., 1982) were noted in this study.
However, one point worthy of consideration is whether the
"suppressor" cells identified here immunologically may
express "helper" function as in T CLL or whether they exert
"suppressor" function and may even exert a controlling
effect on the transformation and multiplication of the
"helper" cells. "Suppressor" lymphocyte activity has
certainly been demonstrated in some patients with Sezary
Syndrome (Kansu and Hauptman, 1979). One study (Vonderheid,
et ad., 1987) indicates that Leu2A+ "suppressor" cells do
not correlate with responses to treatment in pretumour MF.
The authours concluded that T suppressor cells play little
biologic role in the natural history of CTCL. Data should
be obtained from other groups before definitive conclusions
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are reached.
The architectural pattern of "helper" and "suppressor"
cells is similar to that formed in other studies (Willemze,
et al.. 1983a; Chu, et a_l., 1984) of CTCL. No case with
alignment of 0KT8+ cells at the dermo-epidermal junction
(separated from 0KT4 + dermal lymphocytes), as described by
Thomas et al. (Thomas, et ad., 1982), is noted. Exocytosis
of Leu3A+ cells is more evident in MF when compared to
parapsoriasis where exocytic cells tend to be Leu2A+.
Further studies will be required to determine whether
cases of LPAP undergo a change of H/S ratio with progression
of MF. The overlap of H/S ratios observed between CTCL,
LPAP and CBD (Tables 6 and 7) indicates that simple
assessment of H/S ratios in the skin would be of limited
diagnostic help in MF, and this is in agreement with one
other study (Willemze, et ad., 1983a).
A loss or deficiency of mature cell markers is noted
here, both in focal areas and throughout the cell
population. This is more evident in tumour stage MF and
aberrant phenotypes have been noted in advanced stages of
the disease elsewhere (McMillan, et. ad., 1982c; Holden, et.
ad., 1982b; Knowles and Halper, 1982; Haynes, et, ad., 1982a;
Schmitt, et ad., 1982; Wood, et al,., 1982; Willemze, et ad.,
1983a; Ralfkiaer, et aJL., 1985a; Nasu, et al.. 1985; Abel,
et ad., 1985; Wood, et ad., 1986). One study suggests this
change may actually be noted at an early stage and be of
diagnostic use (Chu, et_ al., 1984), but the latter point is
presently controversial (Ralfkiaer, et ad., 1985a).
The mature phenotype of 20 of 23 cases of MF is
compatible with a stem cell disorder (Chapter 2) which still
results in more differentiated compartments being larger.
However, the 3 tumour stage cases with <50% of cells
staining with mature markers and 1 plaque stage with sheets
of tumour cells staining negatively with the same reagents






















































































































































































































































































































































































































































































































































































































































































































































































































































in some cases of MF. The 2 cases of MF showing Leul+ 0KT3+
Leu3A- 0KT4- Leu2A- 0KT8- exocytic cells (phenotype not
found during normal intrathymic differentiation, Table 5)
imply that aberrant differentiation may also be a
concomitant of this disease. The theories of stem cell
disorder (single clone expansion) versus differentiation
block have been proposed in a mutually exclusive manner to
relate malignancies to normal cellular differentiation
(McGrath, 1981) . The above observations suggest this
viewpoint requires modification as all 3 mechanisms of
disturbed differentiation outlined in Chapter 2
(differentiation block, stem cell disorder, and aberrant
differentiation) may occur in one disease.
2. 0KT6.
The finding of 0KT6 reactivity with epidermal dendritic
cells in the first cases of LPAP and MF studied (McMillan,
et ad., 1981b; McMillan, et al.. 1982d) was somewhat
surprising (Plates 42, 43) as this antibody was initially
used in an attempt to detect immature thymocytes. (Also see
reactivity of 0KT6 with dendritic cells in normal skin and
crypt epithelium of reactive tonsil, Chapter 4.) This
finding was first communicated in 1981 (McMillan, et al..
1981b) and double labelling immunofluorescence (Fithian, et
al., 1981) and single labelling EM (Murphy, et ad.,
1981) studies in two independent laboratories being
conducted at the same time confirmed this 0KT6 reactivity
resided in Langerhans' cells.
0KT6+ cells form a variable proportion of the
infiltrates of CTCL, LPAP, and CBD examined. Similar
findings have been documented elsewhere (McMillan, et. ad.,
1981b; McMillan, et. ad., 1981d; McMillan, et ad., 1982d;
Thomas, et. ad., 1982; Wood, et ad., 1982; Hofman, et al. ,
1983b; Chu, et ad., 1984; Ralfkiaer, et ad., 1985a; Wood, et
ad., 1986). (The findings of 0KT6 reactivity in a variety
of T cell infiltrates contrast with monoclonal antibody
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PLATE 42. LARGE PLAQUE PARAPSORIASIS. OKT6+ dendritic
cells in epidermis (E) and dermis (D).
Surrounding lymphoid cells stain negatively.
Indirect immunoperoxidase. Non counterstained
x 64.
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PLATE 43. LARGE PLAQUE PARAPSORIASIS. One of the first
cases to show cross reactivity of common
thymocyte antibody 0KT6 with epidermal
dendritic cells. Epidermis (E). Dermis (D).
Indirect immnoperoxidase. Non counterstained
x 160.
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R423, another dendritic cell antibody, which produced a
negative reaction in all specimens examined.)
0KT6 reactive cells could, therefore, occur in MF for
either of two reasons. First the lymphomatous nature of
this condition suggests that immature T cells might be
present (McMillan, et al.. 1981d). The 0KT6 marker is
expressed on T cells at an intermediate stage of intrathymic
differentiation (Reinherz, et al., 1980/ Kung, et al., 1980)
located in thymic cortex (Bhan, £t al., 1980; McMillan, et
al., 1982a) (Chapter 4) and a subset of human T cell
lymphoblastic lymphoma has been shown to have an OKT6
positive, cortical thymic phenotype (Bernard, et al., 1981).
Secondly, cells with the ultrastructural morphology of
Langerhans' cells have been described in close apposition to
lymphocytes in the cutaneous infiltrates of MF (Rowden, et
al., 1979) and hypotheses have been advanced concerning the
role of Langerhans' cells and helper T cells in the
induction of MF (Cohen, et al., 1980). At least some dermal
OKT6 positive cells in CTCL contain Birbeck granules and
are, therefore, Langerhans' cells (Holden, et. al., 1982c).
The Langerhans' cell might be involved in a reactive process
against a persistent antigenic stimulus (Tan, et. ad., 1974))
or may be transformed by a retrovirus (VanDerLoo et ad.,
1979). In experimental lymphomas histiocytes may induce
proliferation of surrounding lymphocytes (Ponzio, et ad.,
1977). Research is currently underway to determine whether
morphologic differences exist between the OKT6 positive
cells in benign and malignant infiltrates. The possibility
that the OKT6 positive cells in the cutaneous infiltrates of
CTCL are immature T cells rather than Langerhans' cells has
not been substantiated. However, the circulating OKT6
positive cells in CTCL do appear to be lymphoid rather than
histiocytic (Chu, 1983) .
3. J5.
The presence of J5 reactivity in a proportion of CTCL
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cells (40% in 1 case) is of interest. The number of cases
assessed is too small to gain any notion of the frequency of
this phenomenon, and no benign infiltrates were tested for
comparison. However, the equivocal or negative results
obtained in tonsillar tissue (Chapter4) indicate the rarity
of expression of this antigen in normal lymphoid tissue.
The results obtained here in CTCL indicate that this antigen
is not restricted to common acute lymphoblastic leukemia
cells and neutrophils but may be found in other
malignancies. It's presence has also been identified in
lymphoblastic lymphoma (Ritz, et ad., 1981). Future
comparisons with benign dermatoses are obviously required.
4. OKT9.
The results obtained with OKT9 indicate that a
difference exists between CTCL, LPAP, CBD and ACD in their
expression of this determinant (20/24 CTCL; 10-40% of cells:
2/17 LPAP; <10% of cells; CBD 1/6 cases <10% of cells; 0/14
ACD) (Chapter 4). Preferential expression of the
transferrin receptor in CTCL has been shown in earlier parts
of this project (McMillan, et, ad., 1982e; McMillan, et ad.,
1983a) on smaller numbers of patients and similar findings
have subsequently been published from other laboratories
(Haynes, et. ad., 1982a; Ralfkiaer, et. ad., 1985a) . However,
the overlap with benign infiltrates and the demonstration by
one other group of significant numbers of OKT9 reactive
cells in allergic contact dermatitis (Ralfkiaer, et ad.,
1984a) suggests that any diagnostic application would
require clinicopathologic correlations. The demonstration
of OKT9 reactivity in benign infiltrates (1/5, LP; 10% of
cells) is not surprising since some lectin stimulated T
cells may be OKT9 positive (Greaves, et. al., 1981).
In order to further characterize the OKT9 positive
cells in CTCL more information is required concerning the
expression of this marker in non-malignant states. For
instance, when mature T cells (OKT3+) (Reinherz, et al.,
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1979) become activated do they all retain 0KT3 positivity
(0KT3+, 0KT9+) or do they dedifferentiate losing the OKT3
marker (OKT3-/OKT9+)? Likewise what is the phenotype of the
0KT9 reactive cells in CTCL? Are they OKT3-/OKT9+ or
OKT3+/OKT9+ or are both types of cells present? The
presence of sheets of cells in 2 cases of CTCL (1 tumour; 1
plaque) which were 0KT3-, Leul- but 0KT9+ indicates the
presence of the former phenotype (OKT3-/OKT9+) which is
normally found on immature thymocytes (Chapter 4). Studies
of cutaneous lymphoma of non MF/ non SS type mentioned later
(Chapter 6) indicate the latter phenotype (OKT3+/OKT9+) may
at least occur in CTCL of non MF type. Phenotypic
Comparisons of CTCL cells and activated lymphocytes are all
the more intriguing in view of the ultrastructural
similarities between CTCL cells and activated lymphocytes
(Yeckley, et al.. 1975).
Apart from antigenic stimulation of mature 0KT3+, Leul+
T cells or malignant dedifferentiation, 0KT9 reactivity may
also be present in CTCL simply as a function of
lymphoproliferation. The 0KT9 determinant is neither T cell
nor tumour specific and is found on a wide range of
proliferating cell types, eg., fast cycling fraction in T
cell ALL, dividing cells in foetal thymus, foetal liver,
normal adult bone marrow, and malignant cell lines of
teratocarcinoma, mammary carcinoma, and neuroblastoma
(Greaves, et, al.. 1981) .
The demonstration that the 0KT9 determinant recognizes
a. transferrin receptor (Sutherland, et ad., 1981) raises an
additional perspective. DeSousa et al. have provided
evidence that disturbed lymphocyte traffic (ecotaxopathy)
secondary to upsets in iron metabolism may be involved in
the pathogenesis of Hodgkin's disease (DeSousa, et al.,
1978) and Rowden et al. (Rowden, et. al., 1981) have
suggested similar possibilities should be considered in
mycosis fungoides. It has previously been suggested that
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abnormal lymphocyte traffic might be involved in producing
the lymphoid accumulation in MF (Tan, et al., 1974).
Further studies of iron metabolism, eg. ferritin,
transferrin, and lactoferrin would obviously be of interest.
5. OKT1Q.
The OKTIO McAb was originally found to react with
prothymocytes and some T cell ALL (Reinherz, et. ad., 1980) .
In this study differences are found when CTCL (7/18
positive; 10-20% of cells) is compared with LPAP (0/14) and
ACD (0/14) (Chapter 4). The results expand our earlier
results in a smaller number of cases (McMillan, et al.,
1983b; McMillan, et al., 1984). Chu et al. have also
demonstrated OKTIO positive cells in CTCL (92% of cases; 1-
20% of cells) with negative results in a variety of benign
dermatoses (Chu, e£. al., 1984). Again, although not specific
for lymphoma or immature T cells this antibody should be
tested in further examples of lymphocytic infiltrate in view
of its preferential expression in CTCL.
6. B1/B2.
The monoclonal antibody B1 reacts with a small number
of cells in the conditions examined (1/15 CTCL; 1/8 LPAP;
0/1 LP). See also contact dermatitis Chapter 4. Negative
results are obtained with B2 which detects immature B cells.
These results taken in conjunction with those using pan T
cell markers confirm the T cell nature of CTCL, LPAP, and
LP. Of the large number of recent McAB studies examining
CTCL (McMillan, et ad., 1981d; Kung, gt ad., 1981; Laroche
and Bach, 1981; Haynes, et, al., 1981; McMillan, et ad.,
1982c; Holden, et. ad., 1982a; Holden, et ad., 1982b; Knowles
and Halper, 1982; Haynes, et ad., 1982a; Haynes, et ad.,
1982b; Schmitt, et ad., 1982; Thomas, et ad., 1982; Wood, et
al., 1982; Thivolet, et al., 1982; Mackie and Turbitt, 1982;
Hashimoto and Iwahara, 1983; Beuchner, et al., 1983;
Sheibani, et al.. 1983; Hofman, et ad., 1983b; Willemze, et
al., 1983a; Willemze, et ad., 1983b; Chu, et al., 1984;
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Abel, £1.., 1985/ Ralfkiaer, £!.•/ 1985a; Ralfkiaer, s£.
al., 1985b; Nasu, £t al.., 1985; Wood, et al.., 1986) few
have included simultaneous testing with B cell antibodies.
Three studies which did, however, have also found B cell
content to be insignificant (Sheibani, e£. ill., 1983;
Willemze, et ad., 1983a; Nasu, et al.. 1985). The results,
therefore, contrast with those in pseudolymphomas (Chapter
7), and cutaneous lymphomas of non MF/SS origin (Chapter 6).
7-. LeuMl/LeuM3; Esterase Positive Macrophages
The results obtained with the macrophage antibodies
LeuMl/LeuM3 and esterase cytochemistry indicate further
heterogeneity of CTCL infiltrates. Since LeuMl reactivity
may reside on some activated T cells it is possible that
some of the LeuMl reactive cells are lymphoid rather than
histiocytic. However, no case with a LeuMl preponderant
phenotype is observed. The numbers of LeuMl+/LeuM3+ cells
is similar to the estimate of macrophage content in CTCL
using non-specific esterase (this chapter) or other
macrophage McAbs (Wood, et al., 1982). Further information
is required on functional aspects of LeuMl+/LeuM3+ cells
before inferences can be made as to their possible roles in
CTCL and benign lymphoid infiltrates. It is, therefore,
likely that the situation contrasts with Hodgkin's disease
where LeuMl positivity is a conspicuous feature in
Hodgkin/Reed Sternberg cells (Hsu and Jaffe, 1984c).
8. HNK1+ Lvmohocvtes
The results indicate that HNK1+ lymphocytes may be
found in human lymphomatous lesions. It is uncertain
whether this phenomenon is due to migration of the HNK1+
lymphocytes into the tumour or due to trapping of HNK1+
cells undergoing physiologic migration through the affected
area. As mentioned later (Chapter 6) this may account in
part for the presence of HNK1+ lymphocytes in one category
of cutaneous lymphoma. The numbers of HNK1+ lymphocytes
present are small, however, HNK1+ lymphocytes usually
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forming <1% of the population in CTCL. It is unlikely that
blood contamination of the frozen sections accounts for this
positivity as examination of 30 sections from 5 scalp
biopsies (healthy donors) (Chapter 4) did not reveal HNK1+
lymphocytes. Although it cannot be ruled out that the HNK1+
lymphocytes are tumour cells, this seems unlikely, as no
tumour with a preponderant HNK1+ phenotype was observed.
Since a subpopulation of HNK1+ cells are OKT3+ and most
cases of CTCL have an OKT3+ phenotype, it could be argued
that aberrant differentiation in the T cell tumour might
result in a fraction of tumour cells with an OKT3+ HNK1+
phenotype. This question could be resolved by immuno-
electron microscopy.
An HNK1+ phenotype does not necessarily imply that
these cells are functioning optimally in terms of their
migrational or cytolytic capabilities. Decreased NK
function has previously been described in human lymphomas
(Tursz, et. ad., 1982) including CTCL (Kragballe, et ad.,
1983).
The presence of HNK1+ lymphocytes in small numbers in
benign dermatoses; eg., lichen planus 2 of 3 cases, <1% of
cells (this chapter), allergic contact dermatitis 1 of 7
cases, <1% of cells (Chapter 4), indicates that HNK1+
lymphocytes are not restricted to malignant lymphoid
populations. The small number of HNK1+ lymphocytes observed
in these conditions makes it unlikely that they are the main
instigators of the spongiotic and hydropic injury seen in
these diseases. However, the finding of HNK1+ lymphocytes at
the dermo-epidermal junction in lichen planus suggests that
they may play a role in the formation of apoptosis and
hydropic degeneration seen in this disorder. It is unknown
whether the HNK1+ lymphocytes identified in 2 of 9 cases of
LPAP (a potentially premalignant disorder) might be
eliminating or controlling transformed lymphocytes.
The possibility that HNK1+ lymphocytes are present in
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cutaneous lymphomas of non MF/SS type will be examined in
the next chapter.
9. R423+ Dendritic Cells
Absence of R423+ dendritic cells contrasts with the
consistent finding of 0KT6+ dendritic cells in CTCL and
benign T cell infiltrates. R423+ dendritic cells are,
however, later demonstrated in cutaneous B cell lymphoma and
pseudolymphoma (Chapters 6 and 7).
10. Bel/Be2.
The Bel/Be2 antigens are frequently present in
cutaneous infiltrates of CTCL (Bel, 12/14 cases; Be2, 9/13
cases). The presence of Bel/Be2 positive cells in benign
dermatoses such as lichen planus (Bel, 1/3 cases; Be2, 2/3
cases) and atopic dermatitis (Bel, 1/5 cases; Be2, 1/5
cases) (occasionally also in contact dermatitis, Chapter 4)
indicates these reagents are not however specific for
lymphoma when used on tissue sections. Reactivity of these
reagents with further cutaneous disorders will be discussed
in later chapters.
Salient features of recent studies of CTCL carried out
by others using McAbs are outlined in Table 7, and are
contrasted with the findings reported in this chapter (top
line). There is considerable agreement between the results
of various workers. The spectrum of reactivity of the
immature markers OKT9, OKTIO, and leukaemia-lymphoma
antibodies Bel, Be2 with benign dermatoses, LPAP and CTCL is
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FIGURE 6: Reactivity of monoclonal Antibodies OKT9, OKT10, Be1, Be2 with
Benign Dermatoses, Large Plaque Parapsoriasis and Cutaneous T Cell
Lymphoma.















FIGURE 7: Schematic Representation ofComparitive Surface Antigen Expression
of Cutaneous T Cell Lymphoma, Large Plaque Parapsoriasis, and
Benign Dermatoses.
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CHAPTER SIX
CUTANEOUS LYMPHOMAS OF NON-MYCOSIS/SEZARY TYPE
A. INTRODUCTION
The involvement of skin by non-Hodgkin's lymphomas
(NHL) of non MF/SS type has been described by several
workers. (Bluefarb, 1959; Kim, et. ad., 1962; Ribero, 1972;
Long, et al.. 1976; Saxe, et jad., 1977; Burke, et ad., 1981)
The immunological typing of leukaemia lymphoma may have
prognostic and therapeutic significance (Chapter 8).
Contrary to the tenets of the Lukes-Collins
classification (Lukes and Collins, 1974) there is growing
evidence that morphologic criteria alone are poor predictors
of lineage. (Jaffe, et ad., 1982; Bain, 1983) For
instance, a) large cleaved follicle center B cell lymphomas
may be confused with multilobated or convoluted T cell
lymphomas; (Palutke, et. ad., 1980) b) small convoluted B
cell lymphomas have recently been described and these can be
confused with CTCL (Palutke, et al., 1980) c) Although
morphologic criteria exist for differentiating B cell from T
cell immunoblastic sarcomas (Levine, £t £d., 1981) the
failure rate in such predictions is high.
Existing methods of lymphoma typing have resulted in a
high proportion of unclassifiable cases because of
expression of insufficient (Lukes, et. ad., 1978a and b)
(NULL) or dual (Habeshaw and Stuart, 1975) markers. The
ultimate role of immunologic characterization will,
therefore, depend on more accurate methods of analysis.
Cutaneous lymphomas of non MF/SS type have been
previously studied utilizing enzyme cytochemistry and
heteroantisera although such studies are sparse. (Burg and
Braun-Falco, 1978; Willemze, et. ad., 1982a; VanDerValk, et
ad., 1984b) A surprisingly high incidence of true
histiocytic neoplasia has been reported by one group.
(Willemze, et al.. 1982a)
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B. MATERIALS AND METHODS
The methods are as outlined in Chapter 3. Thirteen
patients with cutaneous lymphoma are included in the study.
These are classified (Table 8) as primary (P) if no evidence
of concurrent disease was detected at the time of oncologic
screening, concurrent (C) if cutaneous involvement was a
presenting feature but systemic involvement was found on
screening, and secondary (S) if cutaneous involvement
developed subsequent to the diagnosis of NHL elsewhere.
Lymphomas are classified according to the method of
Rappaport. (Rappaport, 1966a) The histologic criteria for
the diagnosis of cutaneous lymphoma have been described.
(Evans, et al.. 1979; Burke, et al., 1981) The panel of
monoclonal antibodies used and their specificities are
described under methods (Chapter 3). In addition to the
macrophage/monocyte antibodies non specific esterase is used
to detect histiocytes as this method has previously been
found useful in determining the origin of "histiocytic"
neoplasia (Burg and Braun-Falco, 1978; Willemze, et al.,
1982a; VanDerValk, et. al., 1984b). Because of loss of T
cell markers in certain cases of CTCL (Chapter 6) a wide
battery of reagents is used eg., 4 pan T cell markers (Leul,
0KT3, Leu4, Til). A leukocyte marker, (Pizzolo, et. ad.,
1980) 2D1, is also employed to differentiate lymphoma from
epithelial neoplasia and sarcomas in potentially "null"
cases.
C. RESULTS
The results are summarized in Table 8.
With the monoclonal antibody panel used the 13
cutaneous lymphomas could be categorized into T cell (8
cases, Nos. 2,3,5,7,10,11,12,13) B cell (3 cases, Nos.
4,6,9) and unclassifiable or U cell (2 cases Nos. 1 and 8).
When grouped by histologic type the distribution is as
follows:










































































































































































































































































































































































































































































































































































































































































































































b) Nodular Mixed Lymphocytic Histiocytic: 1 case, 1
B cell.
c) Diffuse Lymphocytic Well Differentiated: 3 cases,
3 T cell.
d) Diffuse Mixed Lymphocytic Histiocytic: 1 case, 1
T cell.
e) Diffuse Histiocytic (Nodal): 1 case, 1 T cell.
Testing with 2D1 (13 cases) and HLA (5 cases) is
uniformly positive.
Phenotyoe of Individual Cases
The rationale behind assignment of phenotype to
individual cases will now be described.
Case 1. The negative reaction with pan T (Leul, 0KT3,
Leu4/5) and B markers (Bl, B2, Leul4, Kappa, Lambda) makes
this case unclassifiable (U type). A positive reaction with
Leu3A and 0KT9 (Plate 44) would be compatible with a
macrophage tumour or T cell tumour showing aberrant
differentiation. Support for the former possibility could
not be obtained with LeuMl/M3 which stain a minority of
infiltrating cells. Weak staining of tumour cells with
mature T cell marker 0KT3 suggests this tumour is probably T
cell derived with loss of mature surface antigens.
Case 2. (Plates 45, 46, 47) Reactivity of the majority of
tumour cells with pan T (Leul, 0KT3) and negative reaction
with B markers permits designation as a T cell neoplasm.
Leu3A and 3A1 positivity (Plate 47) in the presence of a
Leul+, 0KT3+ reaction indicates a helper T cell phenotype.
Despite the positive reaction in the majority of cells with
Leul, and OKT3, a minority of cells stain with E receptor
antibody Til suggesting aberrant differentiation.
Case 3. T cell identity is indicated by reactivity with
Leu4/5 and negative reaction with B markers. However, Leul
(pan T) stains a minority of cells (aberrant
differentiation).
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LARGE CELL LYMPHOMA. (Phenotyically
unclassifiable) 0KT9+ cells. Weak staining
with 0KT3 suggests this tumour is T cell
derived. Indirect immunoperoxidase. Non
counterstained. Green filter x 64.
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t
PLATE 45. LARGE CELL LYMPHOMA. T cell type. Cutaneous
ulcerated plaques on back, right flank and
right axilla.
164
PLATE 46. LARGE CELL LYMPHOMA. T cell type.
Predominantly non epidermotropic infiltrate.
Epidermis (E). Dermis (D). Haematoxylin and
Eosin x 40.
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PLATE 47. LARGE CELL LYMPHOMA. T cell type. 3A1+ (T
cell, T subset) dermal tumour cells. Similar
staining observed with Leul (mature T) and
Leu3A (helper T) but not with Til (E
receptor), indicating aberrant
differentiation. Indirect immunoperoxidase.
Non counterstained. Green filter x 160.
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Case 4. This tumour is assigned a B cell phenotype on the
basis of reactivity with B1 and B2. A minority of small
lymphocytes infiltrating the tumour are Leul+, 0KT3+, Leu2A+
suppressor T cells.
Case 5. The Leul+, 0KT3-, B1-, B2- phenotype implies a T
cell tumour with associated loss of the 0KT3 marker
(aberrant differentiation).
Case 6. Bl, Leul4 (pan B) positivity in the majority of
cells and reactivity in a minority of cells with Pan T McAbs
(Leul, 0KT3) indicates a B cell identity. Testing with
Kappa/Lambda reagents shows an almost pure population of
Kappat cells, (monoclonality).
Case 7. A Leul+, 0KT3+, Leu3A+, B1-, B2- helper T cell
phenotype is present.
Case 8. A Leu3A+ phenotype was present as in case 1 with
similar possibilities of T cell tumour with aberrant
differentiation or macrophage (true histiocytic) neoplasm.
The latter possibility cannot be established with non¬
specific esterase as a minority of cells show diffuse
cytoplasmic positive staining. The presence of Leul, 0KT3
positivity in a component of infiltrating cells suggests the
possibility of varying degrees of differentiation within a
thymic derived (T cell) neoplasm.
Case 9. The majority of large cells within the lymphoid
follicles of this nodular lymphoma are B cells (Plate 48)
(B1+, Leul4+, HLADR+) with a minority of admixed B2+ cells.
B2 shows both rounded and dendritic staining pattern. R423+
dendritic cells are concentrated within lymphoid follicles
(Plate 49). Leul+, 0KT3+, Leu4/5+, T11+ T cells are present
within and between adjacent LFs with Leu3A+ (helper)
outnumbering Leu2A+ (suppressor) cells in both locations.
Where mantle zone architecture is retained the majority of
lymphocytes are Kappat B cells (Kappa:Lambda, 2:1) with an
admixture of Leul+, 0KT3+, Leu4/5+, T11+ T cells. However,
within the neoplastic germinal centre and within
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NODULAR LYMPHOMA. Follicular Leul4+ B cells.
Indirect immunoperoxidase. Non
counterstained. Green filter x 160.
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PLATE 49A. NODULAR LYMPHOMA. Tumour nodule (N) contains
large number of R423+ follicular dendritic
cells, similar to lymphoid follicles of non-
malignant lymphoid tissue (tonsil). Indirect
immunoperoxidase. Non counterstained. Green
filter x 64.
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PLATE 49B. NODULAR LYMPHOMA. R423+ follicular dendritic
cells interspersed throughout tumour nodules.
Indirect immunoperoxidase. Non counterstained
x 100.
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nodules where good mantle zone preservation is not evident
the Kappa/Lambda ratio is higher (4:1). In some areas the
tumour nodule reaction is weak or negative with Kappa and
Lambda reagents. Esterase positive macrophages are frequent
within tumour nodules and occasionally found between them.
The macrophage antibodies produce contrasting staining with
LeuM3+, My3+ cells virtually confined to lymphoid follicles
and LeuMl+ cells (Plate 50) present solely within the
interfollicular areas.
A weak staining pattern of the tumour nodules is
frequently observed with Leul. This can, however, be easily
discerned from the intense Leul+ staining found in
infiltrating small T lymphocytes.
A hazy equivocal or negative staining pattern is
obtained with J5.
HNK1+ lymphocytes (Plates 51, 52) tend to be most
evident between tumour nodules in contrast to their
intrafollicular location in non-malignant lymphoid tissue
(Chapter 4).
Reactivity with anti-transferrin receptor antibody OKT9
is often evident within the neoplastic nodules.
Cases 10. 11. 12. On the basis of reactivity of the
majority of infiltrating cells with T cell McAbs and
negative reaction with B cell McAbs these three diffuse well
differentiated lymphocytic proliferation are assigned a T
cell phenotype.
Case 13. As discussed in Chapter 8, the cutaneous histology
of this case is malignant from a morphologic standpoint.
The clinical course and microscopy are consistent with
lymphomatoid papulosis type A. The cutaneous biopsies of
this case were labelled by Doctor Costan Berard as cutaneous
lymphoma mixed lymphocytic-histiocytic type prior to the
development of nodal lymphoma. Irrespective of the
microscopic semantics involved the phenotype of the
cutaneous infiltrates is that of a Leul-, Leu4/5+,
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NODULAR LYMPHOMA. LeuMl+ macrophages located
between tumour nodules (N) in a manner
reminiscent of that found in non-malignant
lymphoid tissue (tonsil). Indirect
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PLATE 51. NODULAR LYMPHOMA. Band Of HNK1+ lymphocytes
between tumour nodules (N) contrasts with
normal follicular distribution of HNK1+
lymphoid cells in non-malignant lymphoid




PLATE 52. NODULAR LYMPHOMA. High power view of HNK1+
lymphoid eels in dermal infiltrate. Indirect
Immunoperoxidase. Haematoxylin counterstain x
160.
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Leu3A+, HLADR+ helper T cell expressing aberrant
differentiation (Leul-) and the transferrin receptor
(0KT9+). The phenotype of the large atypical histiocytic
Reed-Sternberg like cells has been described in Chapter 7.
The nodal infiltrate (more fully described in Chapter 7) can
only be assigned T cell status after testing with Leu4/5.
Again the differentiation status is aberrant with lack of
expression of Leul (pan T) and subset markers (Leu2A/Leu3A).
D. DISCUSSION
1) Lineage Assignment
The majority of lymphomas studied (8/13) are of the
diffuse histiocytic (Rappaport)/large cell (International
Working Formulation, 1982) category.
A preponderance of large cell types (44%) in cutaneous
lymphoma has previously been noted (Burke, et ad., 1981)
Ultrastructural studies of lymphocyte transformation
indicate that lymphocytes may acquire morphological
characteristics similar to histiocytes. (Andre-Schwartz,
1964; Wiener, et. al.. 1967) The "histiocytic" cases in this
study are characterized into T (50%), B (25%) and U Cell
(25%) .
a) True Histiocytic Markers
Although B cell tumours form 3/13 lymphomas studied (2
histiocytic/LCL, 1 nodular mixed lymphocytic histiocytic) no
tumours consisting predominantly of the other two components
of the follicular compartment (macrophages and follicular
dendritic cells, Chapter 4) are identified by the
macrophage/D cell markers, NSE, LeuMl/M3, or R423. The
components of nodular MLH lymphoma will be discussed later.
The results, therefore, contrast with those of Willemze
et al. who found 66% of cutaneous large cell lymphomas to be
true histiocytic, when using enzyme cytochemistry (NSE) and
heteroantisera to lysozyme as histiocytic markers.
(Willemze, et al., 1982a) An independent study by Wood et
al. using McAbs directed against T cells, B cells, and
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macrophages produced similar results to those outlined here
with LCL comprising 71% of cutaneous lymphomas, 47% of these
being T cell, 40% B cell and 13% U cell. (Wood, gt al..
1983b).
Investigations of nodal LCL have generally shown a
preponderance of B cell with few T cell or true histiocytic
types. (Warnke, et. ad., 1980; Knowles, et. ad., 1982) It may
be argued that the prevalence in this study of T cell
tumours compared with previous studies of nodal lymphoma may
reflect a generalized affinity of T cells for the skin.
b) Dual Marker Expression
No cases exhibit dual expression of T and B markers, a
phenomenon previously demonstrated in leukemia lymphoma with
a different series of surface markers. (Chapel and Ling,
1977)
c) Additional Histiocyte markers (LeuMl; OKT6, Leu3A)
Although LeuMl reactivity may be found on activated T
cells (Hanjan, et ad., 1982) no cases are found here with
expansion of a LeuMl+ neoplastic population as may be found
in Hodgkin's disease where the R-S cells are LeuMl+, OKT9+.
(Straughen and Dimitriu-Bona, 1986) (Hsu, et. al., 1986)
Likewise no cases demonstrate the OKT6+, HLADR+, Leu3A+
phenotype characteristic of Histiocytosis X (Chapter 7).
A similar lack of a LeuMl+ phenotype in nodal LCL and
peripheral T cell lymphoma has been described by Hsu et al.
(Hsu and Jaffe, 1984c)
d) Non-Soecificitv of HLADR, OKT9
An HLADR+ (Ia+) phenotype is present in 4:4 specimens
tested. The HLADR antigens are useful in determining the B
or T cell origin of normal peripheral blood lymphocytes as
the majority of peripheral blood and tonsillar B cells
(Chapter 4) express HLADR. (Winchester, et. al.., 1976)
Since HLADR antigens are found on only a small
proportion of human peripheral blood T cells (Fu, et al.,
1978) and certain activated T cells, (Evans, et. ad., 1978)
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(unlike the mouse where Ia+ T cell subsets have been well
characterized), it has been suggested that HLADR antigens
may form a useful marker of B cell derived tumours.
(Halper, et jil., 1980) The finding of HLADR positivity in 2
T cell lymphomas (cases 2 and 13) and the frequency of T
cell tumours in cutaneous lymphoma of non MF/SS type
suggests HLADR alone will be of limited use in establishing
neoplastic lineage.
Likewise, although the OKT9 antigen was originally
described on immature T cells and thymocytes it is found
here to be present on T and B cell tumours. Knowles, et al.
(Knowles, et ad., 1982) also found OKT9 to be of minimal
value in assigning lineage.
The non-specificity of HLADR and OKT9 in lineage
assignment is compatible with the findings in non-malignant
lymphoid tissue in Chapter 4.
e) Requirement for Multiple McAbs
The combination of T cell and B cell markers permits
the identification of T cell or B cell lymphoma in 11 of 13
cases tested. Difficulties caused by overlap of monoclonal
markers, as may occur in CLL, (Royston, et ad., 1980) were
not encountered. However, these experiments establish a
clear requirement for multiple T cell monoclonals when
attempting accurate lineage analysis. For instance, cases 3
and 13 were considered U cell prior to the availability of
the T cell markers, Leu4/5.
2) Comparison with Normal T Cell Differentiation (Aberrant
Phenotypes)
Seven of eight cases of T cell lymphoma show phenotypes
not found on normal mature peripheral T cells (Table 9).
Some of the differences observed (eg. OKT9, HLADR
expression) may be representative of cellular activation
(analogous to stimulation of normal lymphocytes by antigen
or phytohemagglutinin (PHA)) or may be a function of active
proliferation (eg. OKT9+). Loss of markers could represent
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TABLE 9
ABERRANT PHENOTYPES IN CUTANEOUS
NON-HODGKIN'S LYMPHOMA OF
NON-MYCOSIS SEZARYTYPE
Phenotypic Loss* Phenotypic Gain






13 (Skin) Leu1 OKT9 HLADR
Lymph Node Leu1 Leu2A/Leu3A OKT9 HLADR
*Since each case was not tested with the full range of
markers these cases probably represent an underestimate of
the range of phenotypic abnormalities in this group of
patients with cutaneous lymphoma.
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immaturity (reversal of or lack of differentiation) or
actual aberrant differentiation with the presence of
phenotypes not known to occur during normal thymic
differentiation. For instance, case 2 (0KT3+, Leul+,
Leu3A+, 0KT9+) does not fit with any known category of
intrathymic differentiation (Reinherz and Schlossman, 1980)
but may be similar to that of the physiologically
transformed helper T cell in vitro. (Kung, et ad., 1980)
However, an OKT3+, Leul+, Leu3A+, OKT9+ phenotype is not
common in acute allergic contact dermatitis (Chapter 4) . If
cases one and eight are also T cell then these also
represent unusual phenotypes. Case 11 (Leul+, Leu2A-,
Leu3A-) does not fit with any presently known category of
physiological lymphocyte transformation or intrathymic
differentiation. Knowles at al. (Knowles, et al., 1982) in
concurrent studies using OKT subset McAbs have described
similar phenotypes in systemic NHL eg. Leul+, OKT8-, OKT4-
(similar to case 11: Leul+, Leu2A-, Leu3A-); Leul-, OKT3-,
OKT8-, OKT4+ (similar to cases 1 and 8). Both categories in
their study expressed strong helper function in vitro
confirming their T cell nature. Bach et al. (Bach, et al.,
1981) described two cases with phenotypes similar to case 11
(OKT4-), which were functionally helper T. Interestingly
enough McAbs directed at non-competing epitopes of OKT4
(OKT4A, OKT4B, OKT4C, OKT4D, OKT4E) did react with the OKT4-
cells.
Wood, et al., (Wood, et al.. 1983b) using the Leu
series of reagents found two cases with phenotypes similar
to cases 1 and 8 (Leul-, Leu2A-, Leu3A+) and categorized
these as T cell despite negative reactions in the majority
of cells with a battery of pan T reagents. Their approach
to lineage assignment was, therefore, more liberal than the
one here but their overall results showed a similar




None of the cases studied showed cerebriform morphology
as in the case described by Kim and Winkelmann. (Kim, et
al., 1962) Despite this, interspersed 0KT6+ dendritic cells
are observed in 5 of 8 T cell lymphomas in a manner similar
to that found in MF and SS (Chapter 5). No case expresses a
preponderantly 0KT6+ phenotype as may be seen in cutaneous
multilobated T cell lymphoma (VanDerPutte, et. ad., 1982a) or
Histiocytosis X (Chapter 7). The 3 B cell and 2 U cell
lymphomas are notably devoid of an 0KT6 reactive component.
4) Comparison with Other T Cell Lymphomas and Leukaemias
The results of this study of cutaneous lymphoma of non
MF/SS type, therefore, contrast with those in acute T cell
ALL, (Reinherz, et ad., 1980) lymphoblastic lymphoma,
(Bernard, et al.., 1981) and MF/SS (Chapter 5) where the
majority of cases can be classified respectively into early,
common and late thymocyte types.
As in MF/SS (Chapter 5) no cases with a Leu2A+
suppressor phenotype are identified. In contrast Leu3A+
preponderance is observed in 5 of the 8 T cell lymphomas. A
majority of Leu3A+ cases was also noted by Wood et al.
(Wood, et al., 1983b) and in this respect the NHL's are
similar to MF/SS (Chapter 5). Only one case (#10) ,
however, has an overall phenotype (Leul+, Leu3A+) identical
to the majority of MF/SS, and in this case OKT6+ dermal
cells are totally absent unlike the situation normally found
in the latter group of conditions.
5) E Receptor Antibody (Til)
Loss of Til (E receptor antibody) in >50% of cells with
retention of OKT3, as in case 2, is reminiscent of the E
receptor negative OKT3+ cases of T cell ALL reported by
Sondel (Sondel, et ad., 1981). However, E rosetting
capacity and Til reactivity cannot be equated since cases of
lymphoma have been described which fail to form E rosettes
(E-) but react with Til (T11+) (Knowles, et £d., 1982).
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One similar case which was Leul+, Leu4+ (OKT3+) Leu5-
(T11-) occurred in Wood's series (Wood, et &±_., 1983) . The
latter study utilized a very similar battery of McAbs to the
ones in this study but exact comparisons are difficult since
the Stanford group did not simultaneously utilize any
potential markers of immaturity such as 0KT9.
6) Leul Specificity
The presence of Leul (0KT1) reactivity in CLL (Royston,
et al.. 1980) (generally thought to be a B cell neoplasm in
view of its E- SIg+, B1+ phenotype) and low grade NHL's
(ie., small lymphocytic, mantle zone, some follicle centre
cell derived lymphomas) (Knowles, et. ad., 1982; Cossman,
al.. 1984) suggests Leul/TlOl/OKTl should be used alone with
caution as markers of T cell lymphoma without simultaneous
use of pan B reagents such as Bl. Of the three B cell
lymphomas in this particular study, (cases 4, 6, and 9) only
case 9 (nodular mixed lymphocytic histiocytic) shows weak
Leul expression of some tumour cells. This was easily
differentiated from the intense staining observed in
infiltrating T cells.
7) J5
Of the seven cases tested with J5 (5T, IB, 1U) no
positively staining cases are observed. This antigen which
is present on some foetal and newborn thymocytes and
occasionally in CTCL (Chapter 5), may be found on cutaneous
lymphoblastic lymphomas of pre B type (Bernard, et al.,
1982). Testing of further cases will be required to
determine its true prevalence in cutaneous lymphoma.
Although it may be expressed by the neoplastic cells of
follicular centre B cell lymphomas (Ritz, et ad., 1981) the
reaction with J5 in case 9 is negative, as in non-neoplastic
lymphoid follicles (Chapter 4). However, as discussed in
Chapter 4, highly sensitive techniques such as the avidin-
biotin peroxidase method may pick up low levels of
expression of this antigen not detected by the indirect
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immunoperoxidase technique.
8) B Cell Markers
B cell lymphomas are detected here by their general
reactivity with McAbs Leul4, Bl, B2, anti-Kappa/Lambda and
general lack of reactivity with T cell McAbs.
a) Leul4
Leul4 was provided prior to its commercial release so
that data on lymphoma reactivity with this antibody are
sparse. Leul4 reacts with B cells and has weak reactivity
with monocytes but not macrophages. Leul4 is positive in
one nodular mixed lymphocytic histiocytic (B1+) lymphoma and
one diffuse large cell (B1+) lymphoma. The remaining
cutaneous B cell lymphoma (CBCL) case was not tested. A
negative reaction is obtained in the two T cell and one
Leu3A+ U cell lymphoma examined.
Positive reactions have also been obtained with this
marker in pseudo-lymphomas of B cell type (Spiegler Fendt
Sarcoid) but not in lymphomatoid papulosis, a T cell pseudo-
lymphoma (Chapter 7).
b) Kappa/Lambda Ratio and Difficulties in
Implementing the Concept of Monoclonalitv
The anti-Kappa/Lambda reagents show a Kappa/Lambda
ratio of >5:1 in case 6 (diffuse large cell) and 4:1 in case
9 (nodular mixed lymphocytic histiocytic). The Kappa/Lambda
ratio in the latter is lowered to some extent by the
presence of polyclonal mantle populations around some
lymphoid follicles where the K/L ratio approaches the more
normal ratio of 2:1.
Studies of lymphoma clonality are based on the fact
that: 1) Individual lymphoid cells are restricted in their
potential for immunoglobulin (Ig) expression and that these
restrictions are maintained within their progeny (Nisonoff,
et aJL., 1975) . 2) A malignant tumour is thought to
represent the proliferation of a clone of cells arising from
a single transformed cell (Friedman and Fialkow, 1976).
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Evidence for this concept has come from karyotype analysis
(McMillan, 1973/ Moore, et, ad., 1974) isoenzyme patterns
(Lyon, 1972), and immunoglobulin expression (Preud'Homme and
Seligmann, 1972) .
Monoclonality of B cell neoplasia may be inferred from
their uniform restriction to a single light chain type
(Gearhart, et ad., 1985) and the demonstration that heavy
chain production is not restricted clonally (Levy, et al..
1977) has resulted in light chain ratios being used as the
major criterion for monoclonality.
The actual criteria used for monoclonality vary. Some
investigators insist that the tumour population must stain
exclusively for one light and or heavy chain (Sarage, et.
ad., 1981), some insist on a K/L ratio of >5:1; (Starzl et,
al.. 1984) whereas, others regard a K/L ratio of >3:1;
(Levy, et. al., 1983) as "monoclonal". By the first set of
criteria neither case 6 nor case 9 would have been
monoclonal, by the second set case 6 would be monoclonal,
and by the third set both would be monoclonal.
Case 9 exemplifies 2 technical difficulties which can
obscure a monoclonal pattern, namely the presence of
presumptive non-neoplastic polyclonal lymphocytes (mantle
zone in this particular example) and non-marking neoplastic
lymphocytes which can dilute the neoplastic SIg bearing
population. The former has also been noted by Harris et al.
(Harris, et al., 1984) and the latter by Warnke et al.
(Warnke and Levy, 1978) . In fact Taylor (Taylor, 1976)
reported that few if any follicular-lymphoma cells stained
for Kappa or Lambda. This latter finding may, however, have
been complicated by alterations of Ig from fixation (Warnke,
et al., 1978) .
It should also be emphasized that monoclonality does
not equate with the seemingly autonomous proliferation
usually associated with malignancy as lymphomas showing
monoclonal patterns in transplant patients have reversed on
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discontinuing immunosuppression (Starzl, et ad., 1984) and
monoclonal K/L ratios have been described in apparently
benign lymphoid hyperplasia (Levy, et al.. 1983) (although
follow-up was limited to less than 1 year in many cases).
The application of K/L markers to cutaneous lymphocytic
infiltrates has been infrequent. The reagents used in this
study are among the first anti-K/L McAbs produced. The
results obtained in cases 6 and 9 indicate they will be
useful in future studies of CBCL.
c) B1/B2 Expression and Comparison With Normal B Cell
Differentiation
Anti-Kappa/Lambda reagents probably cannot be used
alone for the identification of CBCL since a proportion of
NHL are Ig negative (Froland and Natvig, 1970). In this
respect the results with B1 and B2 are of interest.
Human B cells have previously been identified by heavy
chain isotypes of immunoglobulin (Froland and Natvig, 1970) ,
HLAD related la-like antigens (Humphreys, et ad., 1975),
receptors for Fc portion of Ig G (Huber, et al., 1969),
receptors for the C3 component of complement (Bianco, et
ad., 1970), and for murine and monkey erythrocytes
(Pellegrino, et al., 1975).
Many of these markers are limited by their lack of
specificity for B lymphocytes. For instance, complement
receptors do not always distinguish between T and B
lymphocytes since normal T cells (Bankhurst, et. al., 1978)
activated T cells and occasional cases of T cell leukemia
(Toben and Smith, 1977) and lymphoma (Pinkus, et ad., 1979)
may have them.
B1/B2 are distinct from previously described B cell
surface markers including SIg, la-like antigens, Fc and C3
receptors. B1 (Stashenko, et. ad., 1980; Nadler, et. al.,
1981a) is present on >95% of B cells in peripheral blood and
lymphoid organs. B1 is expressed on virtually all tumours
of B cell origin with the exception of myeloma. (Nadler, et.
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al., 1981a) It is also present on a proportion of non-T,
non-B acute lymphatic leukemia of "pre-B" type (Nadler, et.
al., 1981a). B2 has a similar cellular distribution but in
contrast to B1 is only weakly expressed on peripheral blood
B cells (Nadler, et al., 1981b). B2 shows more heterogeneous
expression on B cell malignancies, being present on 90% of
CLL, 50% of diffuse and nodular poorly differentiated
lymphomas, and 10% of acute lymphatic leukemia cells but is
absent in Burkitt lymphoma, Waldenstrom macroglobulinemia,
and myeloma (Anderson, 1984).
B1 spans most stages of B cell differentiation being
detected before the development of cytoplasmic mu-chains
(mu+ pre-B cells) and is lost at the secretory stage of B
cell differentiation (Stashenko, et al., 1981). The B2
antigen expresses distinct binding sites for C3d component
of complement (Ida, et. ad., 1983). B2 appears on the cell
surface after the cytoplasmic mu pre-B stage (Nadler, e£,
al., 1984), and is lost earlier than B1 at a time when
surface IgD is no longer detectable (Stashenko, et ad.,
1981). A small population of B cells stains with B2 and
lacks B1 (B1-, B2+) (Anderson, et ad., 1985). During B cell
activation phenotypic alterations of the B cell surface
occur including loss of B2, B1 and IgD with acquisition of
SIgG and T10 (Stashenko, et al., 1981) .
Tumours which are thought to correspond to an "early"
stage of B cell differentiation, eg., B CLL, are B1+ B2+
whereas those corresponding to later stages of
differentiation or transformed B cells (Waldenstrom's
macroglobulinemia, plasma cell myeloma, large cell
lymphomas) are B1+ B2- (Nadler, et, ad., 1981b).
A hypothetical model of normal B cell differentiation
and that of the malignant B cell, adapted from a recent
publication (Anderson, et. ad., 1984), is shown in Table 10.
Using these criteria Case 6 (diffuse histiocytic/large cell;



























































































































differentiation than Case 4 (diffuse histiocytic/large cell;
B1+ B2+) and Case 9 (nodular mixed lymphocytic histiocytic;
B1+ B2+-). Case 4 is unusual in its B2+ phenotype as
diffuse LCLs, which are thought to correspond to the
transformed B cell are generally B2- (Anderson, et: al..
1985). However, occasional cases are B2+ (Nadler, et al.,
1981b; Friedman, et ad., 1985) and presumably belong to a
"less mature" subgroup by phenotypic criteria. However, the
precise clinical significance of the expression or absence
of B2 in histologically defined B cell tumours is presently
unknown.
The weak expression of Leul (0KT1) in case 9 suggests
that at least a proportion of the lymphoma cells in this
case were of a less mature B cell category than cases 4 and
6 i.e., similar to B-CLL (Anderson, et ad., 1984).
The lack of overlap between B1/B2 and T cell markers
(Table 8) i.e., lack of "double marker" expression does
suggest B1 (and to a lesser extent B2) will be useful in
differentiating B cell from T cell derived tumours.
9) Follicular (Nodular) Lymphoma
The results in case 9 are of particular interest as
there are few reports to date of McAb phenotyping of
cutaneous nodular (follicular) lymphoma.
Early observations suggested that lymphomas with a
follicular pattern are related to and possibly derived from
normal lymphoid follicles (Brill, et ad., 1925; Symmers,
1927) .
The term "nodular" later replaced the term "follicular"
in describing these tumours as Rappaport (Rappaport, et ad.,
1956) argued that the follicular pattern did not prove a
relationship to normal follicles but might merely reflect a
cohesive tendency of the cells. However, light microscopic,
(Lukes and Collins, 1974) electron microscopic (Levine and
Dorfman, 1975), and immunologic studies (Jaffe, et ad.,
1974) have provided further evidence for the relationship
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between nodular lymphomas and normal lymphoid follicles
(LFs) and the term "follicular" has regained acceptance.
Despite the presence of pseudonodular patterns in T cell
lymphoma (Ioachim and Finkbeiner, 1980) and negative
staining patterns for SIg in some cases of follicular
lymphoma (Garcia, et ad., 1986) it is, therefore, generally
accepted that nodular lymphomas are B cell derived tumours.
Testing of case 9 shows many similarities between the
lymphoma follicles and non-malignant lymphoid tissue
(Chapter 4) strengthening this concept. This is illustrated
in Table 11.
The main differentiating features in follicular
lymphoma are: 1) The presence of Bel+, Be2+, GC cells,
monoclonal K/L ratio, weak Leul GC expression and lack of
Myl3+ GC cells in LFs. 2) Tendency to Leu2A+ (suppressor)
preponderance, large numbers of HNK1 + lymphocytes, and
occasional "spillage" of B1+ and R423+ cells in IFAs.
Follicular dendritic reticulum cells (DRC) are
identified in case 9 with McAb R423. These are absent in
the other lymphomas (including 2 diffuse B cell) examined.
In 1927 Maximow described a non-lymphoid population of
embryonic non-phagocytic reticulum cells (Maximow, 1927)
("embryonale nicht speichernde Retikulumzellem") which are
present in cortical follicles. Later, electron microscopic
studies (Swartzendruber, 1965) and immunologic studies
(Nossal, et ad., 1968) indicated these cells are restricted
to cortical follicles.
R423+ cells may also be found in the LFs of benign
cutaneous B cell infiltrates (Chapter 7). The B cell
monoclonal antibody B2 may also be reacting with DRC in case
9 as in normal lymphoid tissue (Chapter 4). (The B2+ cells
in case 4 are presumably B cells as a negative reaction is
obtained with R423.)
Some diffuse B cell lymphomas (centrocytic by Kiel
classification) may also contain R423+ DRCs (Stein, e£. ad.,
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1982; Naiem, et jad., 1983).
Electron microscopic studies in the early 1970's by
Kojima (Kojima, et ad./ 1973) and Levine (Levine and
Dorfman, 1975) demonstrated the presence of DRCs in nodular
lymphoma. Levine et al. (Levine and Dorfman, 1975)
suggested that they merely represented residual markers of
pre-existing germinal centres. Kojima et al. (Kojima, et
al.. 1973) on the other hand regarded DRCs as lymphoid cell
precursors and nodular lymphomas as dendritic cell
neoplasms.
Radioautographic studies certainly do not support the
concept of DRCs as lymphoid precursors (Everett and Caffrey,
1967). However, the demonstration of R423+ DRCs in extra-
nodal lymphoma in case 9 suggests these cells may be
intimately involved in the formation of the lymphoid
follicles and possibly in the migration of the neoplastic
process. DRCs certainly appear in neonatal rat lymph node
cortex prior to the development of recognizable primary
follicles and germinal centres (Nossal and Ada, 1971) . The
lack of demonstrable antibody and complement on the DRC of
neoplastic follicles (Stein, et al., 1982), however,
suggests that such a "B cell trap" in neoplastic and
possibly normal follicles is unlike antigen trapping and
probably antibody and C3 independent (Stein, et ad., 1982).
Testing in case 9 with the anti-CALLA reagent J5 is
negative when used in a concentration similar to that used
originally in determining its distribution in normal tissues
(Ritz, et al.. 1980; Metzgar, et ad., 1981) and CTCL
(Chapter 5) with the indirect immunoperoxidase technique.
The presence of CALLA has been shown to correlate with a
follicular architecture (Garcia, et ad., 1986). The
negative reaction in case 9 indicates that CALLA in high
concentration is not a sine qua non of follicular
architecture in cutaneous lymphomas.
The significance of weak Leul expression in some of the
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lymphoma cells in case 9 is unknown. A similar phenomenon
has been noted in nodal follicular lymphomas by some groups
(Knowles, et al.. 1982; Burns, et al., 1983) but not by
others (Harris, et al.., 1984) . Among B cell neoplasia the
Leul (Tl) antigen is formed most commonly on B-CLL (Royston,
et al., 1980). Its expression on B cell lymphomas may
represent aberrant antigen expression by neoplastic B cells
or derivation from an uncommon Leul (Tl) positive normal B
cell (Caligaris-Cappio, et al., 1982).
Ree et al. (Ree and Leone, 1978) demonstrated a
positive correlation between the prominence of
perifollicular lymphocyte rims which consist predominantly
of non-neoplastic B-lymphocytes (Harris and Data, 1982), and
survival in nodular lymphoma. Colby et al. (Colby, et ad.,
1980) on the other hand could not confirm this but found
such a correlation between survival and degree of nodularity
(Colby, et. ad., 1980) . The presence of Leul + , OKT3+ and
HNK1+ lymphocytes in the interfollicular areas of case 9
suggests that similar studies of these associated putative
immune cells would be of interest.
10) Common Leukocyte Antigen 2D1
The monoclonal antibody 2D1 may have application in
differentiating lymphomas from epithelial malignancies and
sarcomas (Pizzolo, et ad., 1980). All 13 lymphomas are
positive suggesting this reagent might be useful in "null"
cases where marker expression is insufficient for even broad
inferences to be made as to the neoplastic cell sub-type.
However, further information is required concerning the
sensitivity of this marker as 2 of 20 lymphoid malignancies
in Pizzolo's original study were 2D1 negative (Pizzolo, et
al., 1980).
11) Class I and II HLA Expression
Five of five cases tested (Numbers 2,3,4,9,10) are
class 1 HLA+. This contrasts with one study of three
diffuse histiocytic lymphomas which were HLA- (Woda, et. ad.,
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1981). Four of four cases tested are Class II HLADR+ (Ia+).
This contrasts with MF which generally shows an HLADR-
phenotype (Wood, et ad., 1982) .
12) Myeloid Antibodies
The results obtained with the myeloid antibodies
indicate the frequent presence of macrophage subpopulations
bearing the My3 and Myl3 determinants as in non-malignant
lymphoid tissue (Chapter 4). The Myll+ phenotype in 4 of 5
cases (Numbers 2,3,4,9) fits with the broad spectrum of
reactivity of this antibody which reacts with E+ and E- PBL.
The negative reaction in 5 of 5 cases with MY10 and
Myl2 parallels the results with these reagents in non-
malignant lymphoid tissue and is consistent with their
restricted specificity for immature myeloid cells.
13) Macrophages (Esterase, LeuMl, LeuM3)
Esterase positive macrophages are identified in 5 of 5
T cell, 2 of 2 B cell, and 1 of 1 "U" cell lymphomas.
Macrophages are also readily identified in T, B and U cell
lymphomas with the use of the LeuMl/LeuM3 McAbs, although
these show varying degrees of positivity. The degree of
overlap between LeuMl, LeuM3, and esterase positive cells is
unknown.
The differing distributions of LeuMl and LeuM3
positivity in non-malignant lymphoid tissue (Chapter 4) and
follicular B cell lymphoma (Table 11) and disparate reaction
in case 6 (LeuMl-, LeuM3+) (Table 8) suggests the presence
of discrete LeuMl+, LeuM3+ subpopulations.
On che basis of light and electron-microscopic studies
in 7 diffuse T cell lymphomas Palutke et al. described
numerous admixed macrophages as a characteristic feature of
T cell lymphomas of large cell type (Palutke, et al., 1980).
The results here indicate that macrophages are frequently
found in lymphomas of T, B and U types and their presence
per se is not an accurate predictor of neoplastic cell
lineage.
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TABLE 11-COMPARISON OF IMMUNO-ARCHITECTURAL PATTERN IN FOLLICULAR
LYMPHOMA (FL) AND NON-MALIGNANT LYMPHOID TISSUE (NMLT)
A. GERMINAL CENTRES FL NMLT
1. B1+ phenotype + +
2. B2+ cells rounded pattern + +
3. B2+ dendritic pattern extending into MZ + +
4. Ia+ (HLADR+) phenotype + +
5. OKT9+ cells (transferrin receptor) + +
3. OKT10+ cells (occasional) + +
7. CALLA+ (J5+) phenotype
3. OKT6+ cells
3. Esterase+ macrophages + +
10. M1+ cells
11. M3+ cells + +
12. R423+ follicular dendritic cells + +
13. T cells (OKT3+ T11+) + +
14. Leu3A+ helper T cells (H>S) + +
15. Leu2A+ suppressor T cells + +
16. Be1+ cells +
17. Be2+ cells « +
18. Polyclonal K/L ratio - +
19. Polyclonal mantle zone (variable) + +
>0. HNK1+ lymphocytes + +
>1. Weak expression of Leu1 on B cells (variable) +
12. My3+ dendritic cells + +
?3. HLA+ phenotype + +
?4. 2D1+ (human leukocyte antigen) phenotype + +
?5. My10+ cells
>6. My11+ phenotype + +
17. My12+ cells
!8. My13+ cells - +
5. INTERFOLLICUU\R AREAS
. Preponderance of T cells (OKT3+ T11+ Leu1+) + +
!. Preponderance of Helper T cells (Leu3A) - +
l. "Spillage" of B1+ cells from LFs +
•. B2+ cells
I. Ia+ cells + +
i. OKT9+ cells + +
'. CALLA+ J5+ cells
!. OKT6+ cells (in tonsil)
(in occasional Lymph nodes) +
i. Esterase* macrophages + +
0. M1+ cells + +
1. M3+ cells
2. R423+ cells (rare + cells in FL)
3. HNK1+ lymphocytes +
4. OKT6+ cells in adjacent epithelium + +
(FL + [resident epidermal cells])
(NMLT + [tonsillar crypt epithelium)
5. Exocytic T cells in adjacent epithelium +_
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14) Bel and Be2 (Table 8)
Bel and Be2 reactivity (5/11 and 6/11 cases
respectively), are not confined to any particular histologic
or phenotypic category of tumour. The results indicate in
addition that only a proportion of lymphomas react with
these reagents.
15) HNK1
HNK1+ lymphocytes are identified in 6/12 tumours (range
<1%-10% of cells). They are not confined to any lineage,
being present in 3 T, 2 B, and 1 U cell, and are present in
all histologic categories. The results, therefore, confirm
that HNK1 + lymphocytes may be found in situ in human
lymphomatous lesions.
The lymphomas are non-epidermotropic and exocytic HNK1 +
lymphocytes are absent from positively staining specimens.
HNK1 + lymphocytes are distributed apparently at random
throughout the superficial and mid-reticular dermal
infiltrates. No clustering of HNK1+ lymphocytes is
observed. In the nodular CBCL HNK1 + lymphocytes are
distributed mainly between the pseudofollicles and within
areas showing a diffuse pattern of proliferation.
The largest number of HNK1+ lymphocytes are observed in
the case of nodular CBCL (10% of infiltrating cells). This
may reflect the normal propensity of these cells for
lymphoid follicles (Chapter 4). However, the contrast in
distribution observed between nodular CBCL and tonsillar
lymphoid follicles (Table 11) suggests that this explanation
is overly simplistic. The distribution of the HNK1 +
lymphocytes in the follicular lymphoma (Plate 51) is,
therefore, also compatible with a host-tumour interaction.
16) Unclassifiable (U Cell) Types
Although inferences can be made concerning lineage in
"U cell" lymphomas (cases 1 and 8) cases of NHL have been
reported which are totally devoid of any lineage related
markers, reacting only with la (Wood, et al.. 1983b), OKTIO,
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(Aisenberg and Wilkes, 1980; Aisenberg, <g£. jil., 1983) or
OKT9 and OKTIO (Aisenberg, £l., 1983). Batteries of
McAbs may, therefore, not be a panacea in neoplastic cell
categorization and may require complementary functional
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MISCELLANEOUS CUTANEOUS LYMPHOHISTIOCYTIC INFILTRATES
A. INTRODUCTION
No study of immunological markers in lymphoma would be
complete without a comparable study of a) cutaneous
pseudolymphomas, eg., lymphocytoma cutis (From, 1979),
lymphomatoid papulosis (Macaulay, 1968), lymphocytic
infiltrate of Jessner (From, 1979), b) benign infiltrates
with a marked histiocytic component (eg. sarcoidosis), c)
histiocytic malignancy (eg. histiocytosis X), and d)
leukaemia cutis.
A variety of the above disorders are, therefore,
included.
B. MATERIALS AND METHODS
The following disorders are studied:
Lymphocytoma cutis (3 cases), lymphomatoid papulosis
type B (Willemze, el; ad., 1982b) (1 case), lymphomatoid
papulosis type A (Willemze, et al., 1982b) (2 cases),
lymphocytic infiltrate of Jessner (LIJ, 1 case), sarcoidosis
(1 case), histiocytosis X (3 cases), chronic lymphocytic
leukaemia (CLL, 1 case) and myelomonocytic leukaemia
(Naegeli Type) (MML, 1 case). The lymph node of 1 case of
lymphomatoid papulosis type A which eventuated in nodal
diffuse histiocytic (large cell immunoblastic polymorphous)
lymphoma is also studied and compared with the cutaneous
phenotypic pattern.
The reagents used include Leul, Leu2A, Leu3A, 0KT6,
0KT9, OKTIO, Leul4, Bl, B2, HLADR, R423, LeuMl, LeuM3, HNK1,
Anti-Kappa, Anti-Lambda, Anti-Leuk 2D1, Multiclone T,
Leu4/5, and non-specific esterase.
In Histiocytosis X, J5, MY10 and Myll are also tested
in the first 2 cases. Because of limited amounts of tissue,
Case 3 is only tested with OKT6, LeuMl, LeuM3 and HNK1.
C. RESULTS
1'. Lymphocvtoma Cutis (From, 1979) (cutaneous lymphoid
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hyperplasia, Spiegler-Fendt sarcoid, Type 4 cutaneous
lymphocytic infiltrate).
The 3 cases examined show clusters of Bl/B2/Leul4
positive B cells (Plate 53) surrounded by Leul+ T cells
showing a mixture of Leu3A+, Leu2A+ cells (H/S ratio 1:1 to
3:1). The B cell clusters are HLADR positive and contain
interspersed R423 positive dendritic cells (Plates 54, 55).
LeuM3+ macrophages are present within the lymphoid follicles
in 3 cases and LeuMl+ cells are found scattered throughout
the infiltrates in 2/3 cases. 0KT9 positive cells are
prevalent in LF of 2/2 cases tested. Esterase positive
macrophages are present within LF (Plate 56) and in an
extrafollicular location. Leul+, Leu2A+, Leu3A+ cells are
present within LFs and in a perifollicular location,
although, a crescentic Leu3A pattern as seen in tonsillar
secondary LFs is not seen. Epidermal dendritic 0KT6
positive cells are present in all 3 cases, apparently in a
normal distribution. Exocytic Leul+ cells are absent. The
epidermal 0KT6/Leul pattern, therefore, fits with the non-
epidermotropic pattern found in this group of disorders and
contrasts with that found in acute allergic contact
dermatitis (Chapter 4). Dermal dendritic 0KT6 positive
cells are found in only 1 of 3 cases and these are in a
perifollicular location, similar to lymph node (Chapter 4).
The Kappa/lambda ratio, measured in 2 cases, is 1:1 and 4:1.
HNK1+ lymphocytes are present in 1/2 cases. These are
in a follicular location as in non-malignant lymphoid tissue
(tonsil).
2. Lvmohomatoid Papulosis (Type 6 cutaneous lymphocytic
infiltrate. (From, 1979)
Because of the diverse patterns observed, these cases
will be described separately.
Case 1. Lvmohomatoid papulosis type B. (Willemze, et. al..
1982b)
The majority of large atypical cells (LAC) are Leul+,
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PLATE 53. LYMPHOCYTOMA CUTIS (Spiegler Fendt Sarcoid,
Cutaneous lymphoid Hyperplasia). Lymphoid
follicle contains large number of Leul4+ B
cells. Indirect immunoperoxidase. Non
counterstained. Green filter x 100.
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PLATE 54. LYMPHOCYTOMA CUTIS. Lymphoid follicle (L)
contains large number of R423+ cells forming
a dendritic meshwork. Surrounding dermal T
cell infiltrate (T) stains negatively.
Indirect immunoperoxidase. Non
counterstained. Green filter x 100.
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PLATE 55. LYMPHOCYTOMA CUTIS. High power view of R423+
dendritic cells interspersed throughout
follicular B cells. Indirect
immunoperoxidase. Non counterstained. Green
filter x 160.
200
PLATE 56. LYMPHOCYTOMA CUTIS. Esterase positive
macrophages (arrows) among follicular
lymphoid cells, similar to non malignant
lymphoid tissue Alpha Naphthyl Acetate
Esterase. Methyl green counterstain. Green
filter x 100.
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Leu3A+. Throughout the lymphoid population helper
preponderance is present (H/S. 3:1). Dermal 0KT6 dendritic
cells are interspersed throughout. (Approximately 10% of
infiltrating cells). Large cells with diffuse cytoplasmic
esterase activity form approximately 10% of the population.
LeuMl and/or LeuM3 positive macrophages are found scattered
throughout (LeuMl/LeuM3, 3:1). HNK1+ lymphocytes form less
than 1% of the infiltrating cells. A negative reaction is
obtained with OKT9, Bl, B2, R423.
Case 2. Lvmphomatoid Papulosis type A. (Willemze, e£. al..
1982b)
The majority of LAC are Leul- and show variable
strengths of diffuse cytoplasmic esterase (Plate 57) and
Leu3A positivity. These cells are strongly HLADR positive.
This immunochemical pattern is also present in the Reed-
Sternberg (RS) like cells (Plate 57) so typically seen in
this subgroup. The lymphoid component is Leul+ and exhibits
variable HS ratios. (H/S 1:1 in an 8 day old papule and H/S
1:3 in an 8 week old papule). HNK1+ lymphocytes form 10% of
the lymphoid population in the 8 week old lesion. A
negative reaction is obtained with OKT9, OKTIO, B1/B2, and
R423.
Case 3. Lvmphomatoid papulosis tvoe A.
A mixture of patterns is seen in the large cell
component with Leul+, Leu3A+ cells preponderant in early
biopsies (H/S, 3:1), with an admixture of Leul- cells with
diffuse-cytoplasmic esterase and variable cytoplasmic Leu3A
positivity. OKT6 positive cells form approximately 10% of
the infiltrate. HNK1+ cells form <1% of the total
infiltrating cells. Large clusters of cells reacting only
with OKT9 are also present, reminiscent of the pattern seen
in CTCL (Chapter 5).
In later biopsies approximately 80% of the cellular
population reacts with OKT9 and HLADR (Plate 58) alone, with
large clusters of OKT6 positive cells (Plate 59).
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PLATE 57. LYMPHOMATOID PAPULOSIS TYPE A. Binucleate
Reed Sternberg-like cell centre of field
(arrow) exhibits diffuse cytoplasmic esterase
activity. Alpha Naphthyl Acetate Esterase.
Methyl green counterstain x 160.
203
PLATE 58. LYMPHOMATOID PAPULOSIS TYPE A. HLADR+ dermal
infiltrate. Dendritic cells (arrow) within
epidermis (E) are also HLADR+. Indirect
immnoperoxidase. Haematoxylin counterstain x
100.
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PLATE 59. LYMPHOMATOID PAPULOSIS TYPE A. Cluster of
OKT6+ dermal cells. This pattern is
apparently uncommon in type A lesions.
Indirect immunoperoxidase. Non
counterstained. Green filter x 100.
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A negative reaction is obtained throughout with OKTIO,
B1/B2, and R423.
LeuMl and/or LeuM3 positive macrophages are
occasionally found (<10% of infiltrate, LeuMl/LeuM3, 1:2).
After four years of recurring self healing cutaneous
papules, plaques, and nodules this patient developed a nodal
lymphoma. The pathology will be discussed later.
Phenotyping of the nodal infiltrate shows the neoplastic
population to be Leul-, Leu3A-, OKT6-, OKT9+, B1-, B2-,
2D1+, HLADR+, R423-, LeuM3-, HNK1-, NSE-, multiclone T+
(Leu4/5+). Clusters of large LeuMl+ cells are also present
(<10% of infiltrating cells.)
3. LYMPHOCYTIC INFILTRATE OF JESSNER (Type 3 cutaneous
lymphocytic infiltrate) (From, 1979).
Testing shows a dermal Leul+ population (H/S 4:1).
Occasional OKT10+ cells are observed (10% of the
population). Although epidermal OKT6+ cells are present,
there is a complete absence of dermal OKT6+ cells. HLADR
positivity is present throughout the lymphoid population. A
negative reaction is obtained with B1/B2, R423 and HNK1.
4. SARCOIDOSIS
The epithelioid histiocytes of sarcoidosis are
esterase+, LeuM3+, LeuMl-, OKT6-, OKT9+ (Plates 60, 61).
Associated lymphoid cells are Leul+, Leu3A+ (H/S > 5:1) with
Leu3A+ lymphocytes scattered throughout the granulomas and
Leu2A+ cells tending to be found at the periphery. HNK1+
lymphocytes are absent.
5. HISTIOCYTOSIS X
The results in Histiocytosis X are summarized in Table
12. The HX tumour cells are OKT6+, HLADR+ with variable
Leu3A positivity (Plates 62, 63, 64, 65) .
6. CHRONIC LYMPHOCYTIC LEUKAEMIA
The leukaemic infiltrate is not tested with a full
range of T+B markers. However, the infiltrating cells are
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SARCOIDOSIS. Epitheloid histiocytes are
esterase positive. Alpha Naphthyl Acetate
Esterase. Methyl green counterstain. Green
filter x 40.
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PLATE 61. SARCOIDOSIS. Epithelioid histiocytes of
sarcoidal granulomas (S) are LeuM3+.
Scattered LeuM3+ histiocytes (arrow) are also
present between the granulomas. Indirect































































































































































































































































PLATE 62. HISTIOCYTOSIS X (SKIN). 0KT6+ histiocytes in
upper dermis/ at dermo-epidermal junction and
infiltrating epidermis. Epidermis (E).
Dermis (D). Indirect immunoperoxidase.
Haematoxylin counterstain x 64.
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HISTIOCYTOSIS X (SKIN). Morphology of 0KT6+
cells varies. In this tumour the
histiocytosis cells are dendritic. Indirect
immunoperoxidase. Non counterstained x 64.
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HISTIOCYTOSIS X. (PERIORBITAL TUMOUR).
Although many 0KT6+ tumour cells are
dendritic, the morphology is clearly more
rounded than in tumour in Plate 63. Indirect
immunoperoxidase. Non counterstained. Green
filter x 64.
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HISTIOCYTOSIS X (LYMPH NODE). Tumour cells
are Leu3A+. This antigen (normally T helper)
is more readily identified on histiocytosis X
cells than normal Langerhans' cells.
Indirect immunoperoxidase. Non-
counterstained. Green filter x 100.
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Leul+ (Plate 66) (H/S 2:1). An unusual feature in CLL is an
absence of 0KT6 positive epidermal dendritic cells above the
infiltrated area of skin.
7. MYELOMONOCYTIC LEUKAEMIA (Plates 67, 68)
The leukaemic infiltrate is LeuMl+, 0KT9+. A
proportion of the infiltrating cells are LeuM3+
(LeuMl/LeuM3, 4:1). A negative reaction occurs with Leul,
Leu2A Leu3A, 0KT6, B1/B2, NSE, R423, and HNK1.
The results are summarized in Table 13.
D. DISCUSSION
1. LYMPHOCYTOMA CUTIS (TABLE 13)
The B cell nature of lymphocytoma cutis has previously
been shown in immunological (Braun-Falco and Burg, 1975) and
ultrastructural (Schmoeckel, et. ad., 1977) studies.
The clustering of B1+/B2+ cells with interspersed R423
(follicular dendritic) cells and LeuM3+ NSE+ macrophages
intermixed with and surrounded by Leul+, Leu2A+/Leu3A+ T
lymphocytes (Figure 8) is remarkably similar to the
situation found in lymphoid follicles of nodal (Figure 2)
and tonsillar tissue (Figure 1). The presence of
perifollicular 0KT6+ dendritic cells in 1 case is also
similar to that occasionally found in nodal tissue (Chapter
4). Although 0KT6+ dendritic cells are rare in the
perifollicular regions of tonsil (Chapter 4) analogies can
also be drawn between that organ and skin affected by
lymphocytoma cutis when one considers the presence of LFs
adjacent to 0KT6+ dendritic cells in crypt epithelium of
tonsil (Figure 1)(Chapter 4) and the presence of resident
0KT6+ LC in overlying epidermis in lymphocytoma cutis
(Figure 8).
The role of skin as a lymphoid organ has been
previously postulated (Fichtelius, et. al.., 1970) and the
term Skin Associated Lymphoid Tissue (SALT) (Streilein,
1978) has been coined. Various antigens have been
incriminated in lymphocytoma cutis, including viruses
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PLATE 66. CHRONIC LYMPHOCYTIC LEUKAEMIA. Leul+
perivascular dermal infiltrate. Indirect
immunoperoxidase. Non counterstained. Green
filter x 160.
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PLATE 67. MYELOMONOCYTIC LEUKAEMIA. Cutaneous papules
and plaques.
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PLATE 68. MYELOMONOCYTIC LEUKAEMIA (SKIN). Leukaemic
infiltrate, which occupies full thickness of
reticular dermis apart from Grenz zone (G),
is LeuMl+. Epidermis (E). Indirect
immunoperoxidase. Non counterstained. Green
filter x 10.
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TABLE 13-MONOCLONAL ANTIBODY PATTERNS IN MISCELLANEOUS
DERMAL LYMPHOHISTIOCYTIC INFILTRATES
CASE NO. DIAGNOSIS Leu 1 Leu2A Leu3A OKT6 OKT9 OKT10 Leu1 4/B1 B2 NSE
1 Lymphocytoma + + + - + + Nt +++ +++ ++
2 Lymphocytoma +++ + +++ + + + + Nt +++ ++ + +
Perifoll Perifoll L.F.
3 Lymphocytoma + + + + + + Nt Nt +++ +++ Nt
4 Lymphomatoid PAP (B) +++ + +++ + - Nt - - + +
5 Lymphomatoid PAP (A) ++++ +++ + ± - - - - +++
(++) (++)
6 Lymphomatoid PAP (A) +++ + +++ + to +++ +++ - - - +++
7 Nodal Lymphoma - - . - ++++ Nt - - -
8 Jessner's Infiltrate ++++ + +-+++ - Nt + - - Nt
9 Sarcoidosis + + + +++ - + + Nt - - +++
1 0 Histiocytosis X - - ++ ++++ + - - - ++
1 1 Histiocytosis X - - + + ++++ + - - - ++
1 2 Histiocytosis X Nt Nt Nt ++++ Nt Nt Nt Nt ++
1 3 CLL +++ + + + Nt Nt Nt Nt Nt
1 4 MML - - - - +++ Nt - - -
CASE NO. DIAGNOSIS HLADR R423 M1 M3 HNK1
1 Lymphocytoma +++ + + + + -
2 Lymphocytoma Nt +++ Nt ++ +
L.F.
3 Lymphocytoma + + + + ++ Nt
4 Lymphomatoid PAP (B) + - ++ + +
5 Lymphomatoid PAP (A) +++ - Nt Nt +
6 Lymphomatoid PAP (A) +++ - + + +
7 Nodal Lymphoma ++++ - + - -
8 Jessner's Infiltrate + - Nt Nt -
9 Sarcoidosis Nt - - +++ -
1 0 Histiocytosis X +++ - - - -
1 1 Histiocytosis X +++ - - - -
12 Histiocytosis X Nt Nt - - -
1 3 CLL Nt - - - Nt
1 4 MML Nt ++++ + -
Note: a) Staining pattern in case 5 at 8 days is shown in parentheses ().
b) Staining pattern in Histiocytosis X refers to cells with Histiocytic morphology only.
Key: ++++ = positive staining in > 75% of cells
+++= positive staining in 50-75% of cells
++= positive staining of 25-50% of cells
+ = positive staining of 0-25% of cells
+ = equivocal staining pattern
Nt = not tested
Perifoll = staining pattern in perifollicular region
L.F. = staining pattern in lymphoid follicles
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FIGURE 8. Lymphocytoma Cutis.
Schematic Representation Of Immunophenotypic Pattern
KEY yC Epidermal OKT6 Dendritic Population (Presumptive Normal
Residents)
OKT6 + Interfollicular Cells
® B Cell. B1 +; Variable B2 Positive
Follicular Dendritic Macrophage ( R423 + LeuM3 +Esterase+ )
O T Helper. (Leu3A+)
O T Cytotoxic Suppressor (Leu2A+)
LeuMl+ Interfollicular Cell
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(Sanchez, et ad., 1981) drugs (Bernstein, gt, al.,
1974);(Adams, 1981), insect bites (Allen, 1949) and tattoos
(Zinberg, et. ad., 1982). The immunoarchitectural pattern
demonstrated here certainly indicates that a dermal lymph
node or tonsil equivalent may form under the correct
stimulus. The presence of significant numbers of B cells
with similar Kappa/Lambda ratios to those observed here, and
follicular dendritic cells has been shown in one other study
involving cases which showed a diffuse pattern of
infiltration (Ralfkiaer, et, ad., 1984b) and one study
involving follicular and diffuse infiltrates (Wirt, et al.,
1985).
The mechanism of LF and germinal centre formation may
be similar to that in normal lymphoid tissue. In this
respect the presence of T cells and follicular dendritic
cells is of interest as current evidence indicates that both
these cell types (Klaus, et al., 1980) play a key role in GC
formation. The follicular dendritic cell appears to be an
uncommon visitor to the cutaneous microenvironment as
testing of a variety of cutaneous lymphohistiocytic
infiltrates (Table 14) shows that R423+ dendritic cells
(unlike lymph node or tonsil) are rarely found in skin
except in the presence of B cell infiltrates. This
observation fits with their role in antigen trapping
(Mandel, et ad., 1980) when B memory cells are being
generated. Experiments in germ free mice also indicate that
antigen is normally required for GC formation (Hanna, §t
ad., 1969). Studies of antigen-antibody complexes and C3
receptors similar to those performed in follicular lymphoma
(Stein, et. ad., 1982) are required to further examine the
similarities between the GC's in lymphocytoma and normal
GC's. This would confirm involvement of an antigen
dependent process in lymphocytoma as the etiologies outlined
above would indicate.







































































































































































its migratory capability has previously been debated
(Mandel/ et al.« 1980). The presence of R423 + FDC in
lymphocytoma (this chapter) and cutaneous follicular
lymphoma (Chapter 6) provides strong evidence that this cell
does have the capacity to migrate into extranodal sites and
fits with observations of a circulating precursor of the FDC
detected by monoclonal antibody KiM4 (Reichert et al.,
1983). This cell may, therefore, play a fundamental role in
the initiation of the cutaneous infiltrates in this
disorder. Germinal centre B cells in contrast lack homing
receptors (Reichert, et al.., 1983) necessary for the normal
recirculation of lymphocytes between blood and/or lymph and
tissues (Ford, 1979). The FDC may, therefore, facilitate
the establishment of GC B cells in skin.
The B2 antigen has recently been shown to be the C3d
receptor (Gerdes and Stein, 1982) and this receptor is
strongly expressed by FDC. (Ida, et al., 1983) The B2+
cells observed may, therefore consist of a mixture of FDC
and B cells.
The Kappa/Lambda ratio of 4:1 in 1 case would be
regarded as monoclonal by at least one group of
investigators with considerable experience in this area
(Chapter 6). This is pertinent as cases diagnosed as
lymphocytoma cutis may eventuate in lymphoma (Shelley and
Wood, 1976) .
The absence of HNK1+ lymphocytes in 1/2 cases tested is
interesting. This contrasts with the uniform presence of
HNK1+ lymphocytes in the lymphoid follicles of tonsil
(Chapter 4).
2. LYMPHQMATQID PAPULOSIS
The phenotype of Case 1 is similar to that described in
other cases of lymphomatoid papulosis type B (Burg, et al.,
1981; Willemze, et al., 1983b) and is in agreement with
previous labellings of this disorder as a T cell
pseudolymphoma (Burg, e£ ad., 1981).
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This subgroup is believed to be related to CTCL
(.Willemze, £t ad., 1982b) and the Leul+, Leu3A+ phenotype is
certainly similar. However, unlike many cases of CTCL
(Chapter 5) significant numbers of 0KT9 reactive cells are
not observed in this case. 0KT9 reactivity has been
observed in a few cases of lymphomatoid papulosis in other
studies (Ralfkiaer, et al,., 1985c). When making comparisons
with CTCL it should be mentioned that the division of Ly.
pap. into subgroups A and B (Willemze, et £1., 1982b) is
relatively recent and that although it is logical to assume
that CTCL development would develop from cases of type B
with their cerebriform morphology rather than subgroup A
with its preponderance of Reed-Sternberg like cells
prospective or retrospective studies substantiating this are
awaited.
The immunochemical pattern found in Case 2 suggests a
histiocytic origin for the LAC, including RS like cells, and
is in agreement with other studies of Ly. pap. type A
(Black, et al., 1972; Beckstead, et aJL., 1982; Tokura, et.
al., 1986). Willemze has suggested this pattern is similar
to that of indeterminate cells or interdigitating reticulum
cells (Willemze, et ad., 1983b). A similar pattern has been
observed in Hodgkin's disease (Kadin, et al.., 1985). The
cytochemical similarity between the Reed Sternberg cells of
Hodgkin's disease and interdigitating reticulum cells has
also been emphasized (Kadin, et al.., 1985) . One recent
study with McAb BerH2 (Cerroni, et ad., 1989) also indicates
phenotypic differences between the LAC in Ly.Pap types A and
B and similarity between the LAC in Ly.Pap type A and Reed
Sternberg cells of Hodgkin's disease.
The presence of 0KT6+ cells in Ly. Pap type B and their
relative absence in type A has been noted previously
(Willemze, et al., 1983b). This association is interesting
in view of the proven T cell nature of type B lesions and
more dubious nature of the LACs in type A.
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Until larger numbers of cases of Ly. Pap. type A are
studied and a wider range of T cell reagents used the
question of the lineage of the LAC in type A lesions remains
open. Other studies using different markers have suggested
that a proportion of the LAC in Ly. Pap. type A are in fact
Leul- T cells exhibiting aberrant differentiation
(Ralfkiaer, et al.. 1985). This finding is not inconsistent
with their R-S like morphology as T cells undergoing blastic
transformation in vitro may develop morphologic features
similar to R-S cells. In addition, R-S cells in Hodgkin's
disease may occasionally express T cell markers (Kadin,
1985) .
The findings in case 3 are of particular interest
because of the unusual phenotypic pattern present in the
cutaneous infiltrates and the subsequent development of
nodal lymphoma. The presence of significant numbers of
0KT6+ cells (Plate 59) is atypical of Ly. Pap. type A
(Willemze, et. 1983b). The presence of clusters of
cells reacting only with 0KT9 (in early biopsies) and
ultimately of 0KT9 reactivity alone in 80% of the cutaneous
infiltrates is similar to patterns observed in cutaneous
lymphoma (Chapters 6, 7).
Although the clinical course and cutaneous pathology
are both typical of Ly. Pap. type A (history and slides
reviewed by Dr. Willemze) one other experienced pathologist
(Dr. Costan Berard) considered the cutaneous lesions to be
those of malignant lymphoma, mixed lymphocytic - histiocytic
(Rappaport) or diffuse, mixed small and large cell type
(working formulation). This emphasises the clinico-
pathological nature of the diagnosis of Ly. Pap. and
difficulty in predicting malignant behaviour in a disease
which is often histologically "malignant". Irrespective of
the "true" histologic diagnosis, the final outcome and
phenotype results suggest that some cases of lymphomatoid
papulosis eventually exhibiting malignant behaviour may
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demonstrate phenotypes characteristic of lymphoma ab initio.
The nodal histology and immunology are also worth
discussing. Five expert lymphoma pathologists in Europe and
the United States were asked for their opinion on the lymph
node pathology of this patient. The diagnoses given were
Hodgkin's disease mixed cellularity with focal lymphocyte
depletion (1 European, 3 United States) and malignant
lymphoma, large cell immunoblastic polymorphous type
(Working formulation)/diffuse histiocytic type (Rappaport)
(1 United States). The immunophenotyping demonstrates
expression of certain T cell markers on the tumour (Leu4/5)
but absence of Leul which is normally a pan T marker. The
results, therefore, indicate the tumour is of T cell lineage
but that it demonstrates aberrant differentiation.
It has recently been suggested that some cases
diagnosed as Hodgkin's disease developing in lymphomatoid
papulosis are really T immunoblastic sarcomas (Wood, et ad.,
1986). In terms of basic biology, these differences of
opinion may be more apparent than real since 1) activated T
cells may develop morphologic features of RS cells (Kadin,
1985). 2) RS like LAC in Ly. Pap. type A may express T cell
markers (Wood, et, ad., 1986) . 3) RS cells in Hodgkin's
disease may show weak expression of T cell markers
(Abdulaziz et ad., 1984; Kadin, et ad., 1988). 4) This
case, in which there was divided opinion between Hodgkin's
disease and immunoblastic sarcoma displayed reactivity with
some T cell monoclonals.
The relationship between the neoplastic cells of
Hodgkin's disease and T cells is further strengthened by a)
variants of MF which show morphologic features of Hodgkin's
disease (VanDerPutte, et ad., 1982b), b) the histologic
spectrum of Ly. Pap. with some cases eventuating in MF
(Fine, et. ad., 1974) or Hodgkin's disease (Kadin, 1985) and
c) the simultaneous occurrence of MF and Hodgkin's disease
in the same patient (Hawkins, et ad., 1983). In addition
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(although this does not prove their lineage or origin) cells
with RS morphology have been identified in human thymus
(Thomson, 1955).
It has been suggested previously that Reed Sternberg
cells were derived from follicular dendritic cells (Curran
and Jones, 1978). However, their lack of reactivity with
R423 (Abdulaziz, et al.. 1984), and the negative reaction
obtained with R423 here in RS like cells in Ly. Pap. type A
and one malignancy developing from it fail to support this
contention.
The presence of LeuMl positivity in a small proportion
of infiltrating cells in the malignant lymph node is
consistent with Reed Sternberg cells (Hsu, et ad., 1986) or
a T cell derived tumour (Hanjan, et al., 1982).
The immunologic diversity of the 3 cases of
lymphomatoid papulosis examined is consistent with the
postulate that the histologic diagnosis of lymphomatoid
papulosis encompasses more than one disease (Brehmer-
Andersson, 1981). The disparate histologic diagnoses by
experts in lymph node and skin in case 3 suggests further
immunophenotypic studies are required to more fully
characterize nodal and cutaneous disorders involving Reed
Sternberg or Reed Sternberg-like cells.
3. LYMPHOCYTIC INFILTRATE OF JESSNER
The relationship between LIJ and lymphocytoma has been
debated in the past.
Some authors (Postma and Sluiter, 1958) consider LIJ to
be a variant of lymphocytoma. Whereas, others (Calnan,
1957; Wolf, 1957; Lange, et al., 1982) consider them
distinct clinicopathological entities. The B cell nature of
lymphocytoma has already been discussed. Burg considered
LIJ also to be a B cell pseudolymphoma (Burg, et ad., 1982),
although corroborative immunologic studies were not done.
However, studies utilizing cytochemistry (Konttinen, et. aJL.,
1981) and heteroantisera with immunofluorescence (David, et
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al.. 1980) indicate that the majority of infiltrating cells
in LIJ are in fact T cells.
The results obtained here indicate that the infiltrate
tested consists mainly of T cells. This is in agreement
with 2 other studies (Willemze, et ad., 1984; Ralfkiaer, et
al., 1984b) utilizing McAbs, and as such contrasts with the
findings in lymphocytoma. The H/S ratio in the case tested
is 4:1, similar to those found in the study of Willemze, et
al. (Willemze, et al., 1984) (2:1 to 6:1) whereas suppressor
cells were preponderant (H/S 1:2) in the case reported by
Ralfkiaer (Ralfkiaer, et, ad., 1984b) .
Although a mature T cell infiltrate is identified,
dermal OKT6+ dendritic cells are absent. A similar
phenomenon has been noted by Willemze et al. (Willemze, et
al., 1984) This situation contrasts with the normal Leul+
interspersed OKT6+ pattern found in most T cell infiltrates
(Chapters 4, 5, 6). Analysis of additional cases of LIJ is
required to determine whether this is the usual pattern
observed in this condition.
4-. SARCOIDOSIS
A predominance of esterase positive epithelioid
histiocytes has been shown in one other recent study of
sarcoid (Konttinen, et ad., 1983). Transferrin receptor
expression (OKT9 positivity) has been shown in one other
non-malignant histiocytic disorder, sinus histiocytosis
(Vandenoord, et ad., 1985) and in this respect the sarcoid
histiocyte is similar to the starry sky or tingible body
macrophage of tonsil and lymph node (chapter 4). The latter
cell is also esterase and probably LeuM3 positive (chapter
4) .
A similar T cell pattern with an excess of Leu3A+
helper T cells and peripheral distribution of Leu2A+
suppressor T cells has been observed elsewhere (Modlin, et.
al., 1983) and apparently is typical of sarcoidosis,
tuberculosis and tuberculoid leprosy whereas in lepromatous
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leprosy and rhinoscleroma the Leu2A (0KT8+) mantle is absent
(Modlin, et al., 1983).
Mishra (Mishra, et ad., 1983) using different B cell
(T015) and Langerhans' cell/cortical thymocyte (NA134)
reagents found a similar dearth of B cells and Langerhans'
cells in sarcoidosis.
In keeping with routine histopathology exocytic Leul+
cells are absent in contrast to biopsies of KVEIM and PPD
reactions where 0KT3+, Leul+ T cells may be seen in the
epidermis (Mishra, et al., 1983).
T cells have previously been demonstrated in
sarcoidosis with immunoperoxidase and a heteroantiserum
(anti-HTLA) (Chu, et ad., 1979) . Bronchial washing studies
(Hunninghake and Crystal, 1981) have shown an excess of
helper T cells (without architectural information).
Without the benefit of functional studies, one can only
speculate as to the interactions between the T cells and
epithelioid histiocytes in this disease. Experiments in
thymectomized mice injected by M. Leprae (Tanaka and Emori,
1980) and S. Mansoni (Colley, 1981) indicate that T cells
augment and accelerate the epithelioid granulomatous
response (Rothwell and Spector, 1972).
Although an infectious etiology has never been proven
in sarcoidosis the immunoarchitectural similarity between
this disease and other infectious diseases with active host
response (tuberculosis and tuberculoid leprosy) is striking.
5. HISTIOCYTOSIS X
The OKT6+, HLADR+ phenotype observed confirms recent
observations (Harrist, et al., 1983b) and enhances the
concept that HX cells are of the Langerhans' cell lineage.
Leu3A positivity of HX cells is similar to findings with
OKT4, (Harrist, et. al.. 1983b). Until recently it was
thought that Leu3A resided solely on helper T lymphocytes.
It has since been shown that macrophages and occasional
normal Langerhans' cells can express the Leu3A/OKT4
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determinants (Wood, et ad., 1983a; Moscicki, et al., 1983)
Leu3A reactivity on Langerhans' cells may, therefore, be due
to activation from a variety of causes and not synonymous
with neoplasia.
The OKT4/Leu3A molecules appear to be involved in T
cell recognition of Class II HLA antigens (Meuer, et al.,
1984) promoting cell adhesion between T cells and antigen
presenting cells (APC). The demonstration here and
elsewhere (Harrist, et. ad., 1983b) of Leu3A+/OKT4 +
reactivity in HX cells (normally HLADR+) and of HLADR on
activated T cells (Evans, et al.., 1978) (Leu3A+, 0KT4+ on
the helper subset) suggests these molecules may be involved
in T cell APC interaction and might even be transferred
between the two cell lineages.
The role of Leu3A/OKT4 in T cell proliferation
(Biddison, et ad., 1983) raises the possibility that these
molecules might also be directly involved in an
amplification of Langerhans' cells during delayed type
hypersensitivity reactions. The easier demonstration of
Leu3a/OKT4 in malignant Langerhans' cells compared to normal
Langerhans' cells would then imply that the Leu3A/OKT4
molecules are somehow directly involved in driving the
neoplastic growth of Langerhans' cells observed in HX.
This, of course, is merely supposition and would require
further experimental testing.
The number of histiocytic cells expressing the Leu3A
marker in our cases is smaller than that observed by Harrist
et al. (Harrist, et. al,., 1983b) and may reflect a difference
in sensitivity of laboratory techniques used or a true
heterogeneity among HX cases in the expression of Leu3A.
The reactions with the other monoclonals indicates that
an admixture of T cells is present, a larger number being
found in Case 2 which on routine light microscopy had a more
mixed infiltrate than Case 1. The Myll positivity in Case 2
is probably due to reactivity of this antibody with E
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rosette positive (T) lymphocytes. At least some of the
Leul+, 0KT3+ lymphocytes in Case 2 are phenotypically
suppressor (Leu2A+) cells. The functional role of these and
the HNK1+ cells is open to speculation. It is interesting
that Leu2A+ suppressor cells and HNK1+ (killer/natural
killer) cells are not identified in Case 1 which had a more
aggressive course. Since the study was initiated Case 1 has
died despite Interferon therapy.
The varying numbers of lymphocytes (eg., Leu2A+, HNK1+)
found in the cases examined suggests that future studies
should be performed to assess whether their presence or
absence bears any meaningful relationship to prognosis.
The results in this study and elsewhere suggest that an
0KT6+ phenotype will be characteristic of many cases of HX.
The HX phenotype, therefore, contrasts with that found in
large cell (or "Histiocytic") lymphomas (Chapter 6).
Although 0KT6+ cells may be identified in the cutaneous
infiltrates of many cutaneous diseases including lymphomas
(Chapters 5, 6), the dearth of cutaneous histiocytic
disorders with a preponderantly 0KT6+ phenotype suggests the
0KT6 marker may have potential use as an adjunct diagnostic
aid in HX. However, clinicopathological data would probably
be required in addition as other pediatric disorders may
involve proliferation of Langerhans' cells; eg., Hashimoto-
Pritzker Histiocytosis (Hashimoto and Pritzker, 1973).
The 0KT6+ subpopulation normally forms an insignificant
fraction of circulating mononuclear cells (Kung, et ad.,
1980). Peripheral blood studies were not performed in this
study. The OKT6+ phenotype demonstrated here and elsewhere
suggests that detection and quantification of OKT6+ cells in
peripheral blood in HX would confirm leukaemic dissemination
and could be correlated with multiple organ involvement and
requirement for early chemotherapy.
6. CHRONIC LYMPHOCYTIC LEUKAEMIA
The Leul+ phenotype demonstrated is compatible with B
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or T CLL (Schroff/ et a_l., 1982) . However, the Leu2A and/or
Leu3A positivity seen in the case examined has not been
recorded in B CLL (Schroff et. £d., 1982) the more common
type (normally B1+, B2+/-, Leul+, Leu2A-, Leu3A-)
whereas, T CLL, which commonly involves skin (Sumiya, et
al.. 1973; Lillie, et al,., 1973), is usually positive for
Leu3A, Leu2A or both (B1-, B2-, Leul+, Leu2A+/Leu3A+)
(Schroff, et, al.., 1982) . The reaction with subset
antibodies Leu2A/Leu3A, therefore, suggests this case
belongs to subset 1 of T CLL (Schroff, et al., 1982)
(Leu3A+/Leu2A+).
The lack of 0KT6 reactivity in overlying epidermis is
remarkable as this is the only specimen of the benign and
malignant infiltrates examined in this project with an 0KT6-
epidermis. As other LC markers were not employed and non-
infiltrated skin was not examined in this patient, the
significance of this finding is unknown.
7. MYELOMONOCYTIC LEUKAEMIA (MML)
To date there has been a lack of other studies of MML
using similar McAbs. The LeuMl+, Leul-, Leu2A-, Leu3A-,
0KT6-, Bl- phenotype of the infiltrating cells contrasts
with T cell ALL (Schroff, et al., 1982) (LeuMl-, Leult,
Leu3A+/-, LEU2A+/-) ; pre B/common ALL (Schroff, et. al. ,
1982) (LeuMl-, B1+/-); adult T cell leukaemia (Nakahara, et
al., 1982) (LeuMl-, Leul+. Leu3A+); B CLL (Schroff, et al..
1982) (LeuMl-, B1+, B2+/-, Leul+, Leu2A-, Leu3A-); and T CLL
(Schroff, et, ad., 1982) (LeuMl-. B1-, B2-, Leul + , Leu2A+/-,
Leu3A+/-)The 0KT6- phenotype contrasts with that of
Histiocytosis X.
Although the myeloid McAbs (table 2) were not available
when this case was tested, myeloid/monocyte monoclonals have
been used to further categorize the monocytic and non-
monocytic variants of AML (Sondel, et aj,., 1981; Nakahara,
et al., 1982) .
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The esterase negativity of the MML infiltrate contrasts
with sarcoidosis (NSE+) and also contrasts with pure
monocytic leukaemia (Schilling type) which demonstrates
strong esterase positivity (Shaw and Nordquist, 1975).
Hayhoe emphasises the difficulties in precisely categorizing
monocytic leukaemias according to their presumed cell of
origin (Hayhoe, 1960). In this sense,this case is
interesting as naphthol A.S.D Chloracetate Esterase staining
(granulocytic marker) was also negative.
Schiffer (Schiffer, et ad., 1975) suggested on the
basis of skin window studies that cutaneous monocytic
leukaemia cells may be proliferating in situ as well as
demonstrating the capacity of circulating monocytoid cells
to migrate into tissues. The OKT9 reactivity (proliferation
associated antigen) supports this theory.
The LeuMl antigen is readily demonstrated on
circulating monocytes with relatively few LeuMl+ cells in
non-malignant lymphoid tissue. (Chapter 4) The LeuM3
antigen is readily demonstrated in lymphoid tissue
macrophages (Chapter 4). The finding of LeuM3 positivity in
a proportion of infiltrating leukaemic cells raises further
questions concerning expression of LeuMl/LeuM3 on the normal
monocyte as it circulates and finally emigrates into
tissues.
It is unknown whether the differences observed between
sarcoidosis (NSE+, LeuM3+, LeuMl-, OKT6-), myelomonocytic
leukaemia (NSE-, LeuMl+, LeuM3-, OKT6-) and Histiocytosis X
(NSE+/-, LeuM3-, LeuMl-, OKT6+) likewise reflect origins in
different subsets of the monocyte/macrophage series or
variable expression of markers during the life cycle of the
normal monocyte i.e. LeuM3+ in tissues and LeuMl+ in blood.
This particular case shows no evidence of co-expression
of lymphoid and myeloid markers as described by Scamurra et
al. (Scamurra, et ad., 1983)
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DISCUSSION, SUMMARY. AND CONCLUSIONS
I. DISCUSSION
Prior to 1980 the techniques used to establish the
cellular identity of lymphomas were limited to rosetting
techniques, immunofluorescence or immunoperoxidase in
conjunction with heteroantisera, and enzyme cytochemical
techniques (chapter 2). Application of heteroantisera on
cell suspensions and in situ did permit categorization of
lymphomas into T and B types. T cell lymphomas could also be
roughly categorized into early and late thymic types
(Chapter 2). The limitations of these methods have been
discussed in Chapter 2.
In the introduction an idealized method of tissue
identification of lymphoreticular cells was outlined(Table
1, McMillan, 1985). The advent of monoclonal antibodies
directed against lymphoreticular subpopulations has
permitted us to come closer to this ideal. Despite initial
technical difficulties caused by the effect of fixatives on
the antigens involved (Chapter 3) (McMillan, e£. al..
1981a,b,c; 1982a) in situ studies utilizing McAbs have
proved to be practicable. The technique is simple and
rapid. The expense of some of the early commercially
available reagents should improve as more of these become
available. McAbs directed against differentiation antigens
have been produced and the distribution of the appropriate
235
determinants in non-neoplastic tissue (thymus, tonsil, lymph
node) has been outlined (Chapter 4). However, the studies
of extrathymic lymphoid tissue (Chapter 4) and cutaneous
lymphocytic infiltrates (Chapters 5, 6, 7) indicate that
these antigens of "immaturity" are not confined to
intrathymic cells undergoing normal development. For
instance, OKT9+/OKT10+ cells are readily found in tonsil
(Chapter 4) and 0KT9+ cells are occasionally found in non-
malignant cutaneous lymphocytic infiltrates (Chapter 5).
Although the McAbs provide improved specificity over
heteroantisera, the determinant itself may not be confined
to a particular subtype of cells. This point is exemplified
by the findings of 0KT6 which, when initially used, was
thought to be specific for "common" thymocytes at an
intermediate stage of thymic differentiation, but was
subsequently found to react with a dendritic population in
epidermis (Chapter 4), tonsillar crypt epithelium and lymph
node (Chapter 4), and with cells in a variety of cutaneous
lymphocytic infiltrates (Chapters 4, 5, 6, 7).
Preliminary studies have also been done on paraffin
sections (Andrade, et al.., 1988/ Cerroni, et. ad., 1989) .
These are mainly limited to the broad categorization of
infiltrates into T and B types as the range of antigens
detected by McAbs reacting with paraffin embedded tissue
sections is presently narrow. An additional hindrance is
lack of specificity for distinct cell types eg. sharing of
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the respective antigens by T and B cells. However the use
of formalin fixed paraffin sections often produces
histologic sections with excellent preservation of tissue
architecture.
The technique is also applicable to ultrastructural
studies as shown by several groups (Murphy, et al.. 1981/
Holden <g£ £1., 1982c). The authour's efforts in this
direction (unpublished observations) do, however, indicate
that some of the antigens detected by McAbs (eg., 0KT3) may
be more sensitive to EM processing techniques than antigens
detected by heteroantisera.
The technique provides information on in vivo
relationships as shown in the topographic studies of
tonsillar tissue (Chapter 4) and in the Pautrier
microabscesses in MF (Chapter 5) (Plate 34).
Although most antibodies tested produce interpretable
results on tissue section, the variable strength of staining
within a cell population and day to day variations in the
technique suggest that further improvements in technology
are desirable. One such improvement is the Avidin-Biotin
technique (Hsu, et al., 1981) which appears to produce more
consistent results. Many of the reagents are now widely
available, eg., OKT and Leu series, and this will permit
similar testing in numerous laboratories. In addition,
double labelling may even be done with the immunoperoxidase
technique (Mackie, and Turbitt, 1982; Ralfkiaer, et al.,
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1985a). The variation in intensity of staining throughout
cellular infiltrates and presence of dense populations in
some cases often makes accurate quantification difficult and
the technique is semiquantitative at best. However, the
preponderant phenotype of a cell population can usually be
readily identified and this feature is useful in lymphoma
categorization. In addition, minority markers, eg. HNK1,
can usually be easily identified (Chapters 5, 6). In this
sense the new technology satisfies some of the frustrations
encountered by the author one decade previously and permits
a more revealing dissection of lymphoma into cells of
varying differentiation, and putative immune reactive cells.
One of the histologic criteria for malignancy is
"dedifferentiation". It is uncertain how closely this
resembles the less differentiated state of the maturing
healthy cell.
The differentiation disturbances discussed in Chapter 2
could have immunopathologic corollaries relevant to
diagnosis:
1) Failure or block of differentiation would result in a
phenotype similar to one of the earlier stages of T cell
(Table 5) or B cell (Table 10) ontogeny. This would produce
a) an accumulation of cells expressing immature determinants
(eg. OKT9, OKTIO) or double markers (eg. OKT4/8, Leu3A/2A)
b) a deficiency or "loss" of all mature surface markers
found on peripheral lymphocytes (eg. OKT3, Til, Leul).
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2) A stem cell disorder with clonal expansion and
preponderance of differentiated compartments would be
similar to benign proliferations when examined with mature
markers (mature marker deficiency would not be evident).
Subset markers (eg. Kappa/Lambda, helper/suppressor) might
reveal clonal expansion although clinical utility of this
feature would depend on the degree of overlap with reactive
states. The increased proportion of dividing stem cells
might be evinced by proliferation associated markers eg.
transferrin receptor, (5E9, 0KT9). Again comparison would
have to be made with benign disorders. Degrees of
phenotypic overlap with benign infiltrates would be expected
when the proliferative fraction is relatively low.
Since certain markers may indicate immaturity and/or
proliferation eg. 0KT9 it may be difficult to distinguish
category 1 and 2 unless mature surface marker deficiency is
present.
3) Aberrant differentiation could produce a) selective loss
of markers characteristic of a certain stage of
differentiation with retention of others (eg. 0KT3 and Til)
resulting in a phenotype not recognized during normal
development (aberrant phenotype). When larger batteries of
McAbs are used cases initially grouped as category l)b)
might, however, require recategorization into this group.
This category must remain tentative. It's presence would
imply a more profound qualitative abnormality in malignancy
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than categories 1) and 2) which would present mainly with
quantitative phenotypic abnormalities, eg. increased
fraction of proliferating cells. Tumours expressing
aberrant phenotypes may in fact represent the expansion of
hitherto unrecognized T or B subpopulations. These could be
revealed by more extensive studies of thymus and B cell
zones of non malignant lymphoid tissue. This category is,
therefore fascinating as it touches on possible fundamental
differences between benign and malignant lymphocytes,
b) putative tumour specific markers. This groups unique
feature would be a determinant confined to malignant cells.
This would differ from 3a) where individual markers found on
normal cells are combined in a pattern peculiar to
malignancy.
Although the phenotypic studies permit further
speculation on the pathogenesis of certain disorders, eg.
CTCL (Chapter 5), their practical diagnostic and therapeutic
use also needs consideration. This will now be outlined,
and the results of other laboratories will also be discussed
as a large number of groups have been involved in this area
during the time course of this project. Recent alternative
methods of lymphoma diagnosis will also be discussed.
A. DIAGNOSIS OF LYMPHOMA BY IMMUNOPHENOTYPING
SKIN
Attempts at the diagnosis of CTCL and CBCL using
monoclonal antibodies have concentrated on three areas:
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1) an imbalance in the ratio of markers expressed by normal
lymphocytes; 2) the presence of so-called immature
determinants and 3) the possible existence of antigens
expressed solely by malignant cells.
1) IMBALANCE IN RATIOS OF MARKERS EXPRESSED ON NORMAL
LYMPHOCYTES
a) HELPER/SUPPRESSOR RATIO AND DOUBLE MARKER EXPRESSION IN
CUTANEOUS T CELL LYMPHOMA
McAb studies have demonstrated that CTCL is
phenotypically of the mature helper subset in most cases
(reviewed in Chapter 5). This situation, therefore,
contrasts with T cell ALL (Reinherz, et, ad., 1980) and
lymphoblastic lymphoma where the lymphocytes are
phenotypically "early" or "common" (cortical) thymocytes
(Bernard, et. a!., 1981) indicating a block in
differentiation. (See Thymus, Chapter 4) As discussed in
Chapter 5 this may reflect the presence of a stem cell
disorder in MF with resultant amplification of all
compartments, the more differentiated ones remaining larger
as in benign lymphoid populations. The mature surface
marker profile would then be similar to normal lymphocytes
in the T cell zones of lymphoid tissue (helper T, Chapter 4)
or reactive lymphocytic infiltrates (helper T, Chapters 4
and 5). Phenotypic abnormalities might only then be
detected by examining the cell population in question with
proliferation associated markers (eg. transferrin receptor)
or if other forms of disturbed differentiation are present
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eg. differentiation block or aberrant differentiation (see
below and results in MF, Chapter 5). The demonstration that
a malignant infiltrate is "helper" may, therefore, be useful
confirmatory evidence of a diagnosis of CTCL. There is,
however, considerable variation in the "suppressor" content
in CTCL lesions (Chapter 5) and rare cases may have an 0KT8
positive phenotype. The varying proportions of "helper" and
"suppressor" cells found in CTCL lesions has been reviewed
(Chu, 1983).
Whether McAbs against lymphocyte subsets may be used to
differentiate malignant from benign infiltrates is
uncertain. The overlap between benign and malignant
conditions make this unlikely. A preponderantly "helper" T
cell infiltrate is also present in 1) lichen planus (Bhan,
et al., 1981b; McMillan, et, ad., 1981a; Gomes, et. .al.., 1982;
DePanfilis, et. al., 1983) (Chapter 6), 2) atopic dermatitis
(Zachary, et al., 1984) (Chapter 6), 3) lymphomatoid
papulosis (Burg, et ad., 1981; Harrist, et al., 1981;
Willemze, et_al., 1983 b) (Chapter 8), 4) chronic eczematous
dermatitis of non-specified type (Chapter 6), 5) LPAP
(McMillan, et. al., 1982f; Olsen, et aJL., 1982) (Chapter
6)psoriasis (Baker, et ad., 1984), 7) lymphomatoid
granulomatosis (Harrist, et ad., 1981) and 8) allergic
contact dermatitis (McMillan et ad., 1983c; Scheynius, et
al.. 1983) (Chapter 4). The presence of a helper T cell
infiltrate per se, therefore, is not synonymous with CTCL.
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Clinicopathologic data are mandatory.
Since an OKT8+/Leu2A+ suppressor phenotype is
apparently present in actinic reticuloid (Chu, 1983) McAbs
against mature subset antigens may be of some use in
separating this condition from CTCL.
Monoclonal antibodies against mature T cell markers
have been used in conjunction with immuno-electron
microscopy to analyze more accurately the lymphoid component
of CTCL. (Hashimoto, and Iwahara, 1983) Using this
technique, the nuclear convolutions of accompanying
histiocytes are not included in the overall morphometric
assessment. This approach may yield further useful data
when performed with immature markers.
Double marker expression might also be utilized in
identifying malignant T cell infiltrates and there is
evidence that cells expressing both 0KT4 and 0KT8 are
present in CTCL infiltrates (Chapter 5). Double labelling
of mycosis fungoides infiltrates has been performed using
immunofluorescence (Chu et ad., 1982a) and immunoperoxidase
(Mackie and Turbitt, 1982) methods. Whether these methods
are sufficiently sensitive to identify malignancy in its
early stages remains uncertain. Recently developed
immunogold techniques (Holden, and MacDonald, 1983) applied
to immunoelectron microscopy should permit electron
microscopic double labelling of lymphoid cells and allow for
accurate analysis of such cells in benign and malignant
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infiltrates.
b) LIGHT AND HEAVY CHAIN RESTRICTION IN CUTANEOUS B CELL
LYMPHOMA
Normal and reactive lymphoid tissues contain a
heterogeneous population of B lymphocytes (Curran, and
Jones, 1977). Immunofluorescent or immunoperoxidase
staining shows a mixture of Kappa and Lambda light chain
bearing cells and a similarly heterogeneous reaction with
antibodies to the various heavy-chain determinants. In
contrast, a lymphomatous cell population which represents a
preponderantly monoclonal expansion of one cell (Fialkcw,
1'97 6) exhibits so-called light and heavy chain restriction.
The difference, however, is not absolute (Chapters 6, 7),
and the criteria for diagnosing Kappa or Lambda
monoclonality do not necessarily imply an autonomous
neoplasm, as lymphoproliferative disorders occurring in this
context may disappear on withdrawal of immunosuppressive
therapy, (cyclosporin and corticosteroids) (Starzl, et al..
1984) .
Heteroantisera have been used to demonstrate
monoclonality in CBCL (Barr, et al., 1980) and more recently
McAbs have been used in a similar manner (Wood, et al.,
1983b) (Chapter 6). Further comparative studies of CBCL and
lymphocytoma cutis are required.
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2) MARKERS OF IMMATURITY (0KT6, NAl/34, BL6, OKT9, 5E9,
B3/25, OKTIO)
Monoclonal antibodies OKT6 or NAl/34, BL6, OKT9, and
OKTIO react mainly with immature cortical or subcapsular
thymocytes (Chapter 4). In contrast, medullary thymocytes
show a higher density of mature markers detected by McAbs
such as OKT3/OKT1 and Leu4/Leul (Chapter 4). Studies with
these antibodies indicate certain lymphomas do
preferentially express antigens found on immature thymocytes
during ontogeny. (Chapter 6)
In cutaneous infiltrates the significance of cells
reactive with 0KT6, NAl/34, (McMillan, et ad., 1981b;
McMillan, et. al.. 1982d; Mackie, and Turbitt, 1982; Holden
et al.. 1982a; Chu, et ad., 1982a) BL6 (Schmitt, et. ad.,
1982), 0KT9 (Kunq. et al., 1981; McMillan, et al., 1982e;
Turbitt and Mackie, 1986) and OKTIO (Chu, e£ al., 1983a;
McMillan, et ad., 1983b; McMillan, et ad., 1984; Turbitt and
Mackie 1986) is uncertain since 1) 0KT6 and NAl/34 cross
react with Langerhans' cells (McMillan et. ad., 1981b;
Fithian, et ad., 1981; Chu, et al., 1982b; Dubertret, et
ad., 1982; Schmitt, et ad., 1982; Harrist, gt ad., 1983a)
2) 0KT9 reacts with the transferrin receptor (which is
present on a wide range of replicating cell types) (Goding
and Burns, 1981; Sutherland, et ad., 1981; Trowbridge, et
ad., 1981) and 3) the OKTIO determinant is present on some
activated T cells, bone marrow progenitor cells, (Kung, et
ad., 1980) plasma cells, (Bhan, et ad., 1981a) and K/NK
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cells (Herberman, and Ortaldo, 1981). The significance of
OKT6/9/10 reactivity has been discussed earlier (Chapter 5).
The immunophenotypic profiles of mycosis fungoides (Chapter
5) indicate 0KT9 expression often signifies proliferating
stem cells. However, in a small proportion of cases with
simultaneous deficiency of mature surface markers
(phenotypic profile compatible with a differentiation block)
0KT9 reactivity may be due to the presence of cells similar
to those found in the early stages of thymic differentiation
(Table 5).
The preferential expression of 0KT9 (Chapter 5), 5E9
(another transferrin antibody) and OKTIO reactivity in CTCL
(Chapter 5) is obviously of interest. However, the fact
that these antibodies are not restricted to lymphoma cells
suggests that diagnostic tests using these markers may be
difficult to interpret.
3) LOSS OR DEFICIENCY OF MATURE T CELL MARKERS
Loss of mature T cell markers has also been documented
in several McAb studies of CTCL (Kung, et al., 1981; Chu, et
al.., 1983a; Chu, et al., 1982a; Holden, et. al., 1982b;
McMillan, et. al.. 1982c; Schmitt, et ad., 1982; Wood, et
ad., 1982; Willemze, et al., 1983a) (Chapter 5). This
phenomenon tends to be most apparent in advanced cases. It
is unknown whether this biologic feature can be used
regularly as a diagnostic tool. Its presence in only 3 of
26 cases of CTCL (3 of 23 MF) suggests limited application,
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at least with the reagents used in this study. Abel, et
al., (1985) and Wood et al.. (1986) have suggested more
universal use of Leu 8 and Leu 9 deficiencies in diagnosing
MF. Leu 8/9 deficiency cannot, however, discriminate benign
from malignant erythrodermas (Abel, et al.. 1988) .
4) ABERRANT DIFFERENTIATION
Phenotypes not regarded as part of normal thymic
differentiation (Table 5) may occur in mycosis fungoides
(Chapter 5) and cutaneous lymphomas of non MF/SS types
(Chapter 6). Again these are uncommon in MF (3 of 23 cases)
and it remains to be seen whether these would be helpful in
predicting the outcome of an atypical lymphocytic
infiltrate.
5) "TUMOUR SPECIFIC" MARKERS
The ideal diagnostic McAbs would be specific for
lymphoma or individually for CTCL and CBCL. The McAbs Bel
and Be2, which react with CTCL cells (Berger, et. al.. 1982;
Berger and Edelson, 1983) come closest to this on
preliminary screening studies. The studies done here,
however, show that their expression in malignancy is
preferential rather than specific and considerable overlap
exists between reactive and malignant states. They also
react with normal tissue constituents [Bel, follicular
epithelium; Be2, dermal endothelium and tonsillar
interfollicular area (Chapter 4)]. In addition, not all
lymphomas react with these antibodies. The reactivity of 54
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cutaneous lymphohistiocytic infiltrates and non-neoplastic
lymphoid tissue with McAbs Bel and Be2 is shown in Table 15.
A similar spectrum of reactivity of Be2 with normal skin,
reactive and malignant lymphocytic infiltrates has been
reported by one other group (Ralfkiaer, et. al.. 1986). Bel
was not studied.
The diagnostic usefulness of these reagents in blood is
discussed in the next section.
BLOOD
1) T CELL LYMPHOMA LEUKAEMIA
Problems in the interpretation of McAb studies in blood
have been previously reviewed (McMillan, 1983) .
Studies on circulating peripheral blood lymphocytes
(PBL) have not been performed here. However, for sake of
completion results of recent studies will be mentioned.
Using conventional surface markers (E, EAC rosetting)
the percentage of T cells in peripheral blood may be a
significant prognostic parameter (Van Der Loo, et. al.., 1981)
in CTCL, with less than 55 per cent T cells being an
unfavourable sign. The diagnostic use of T cell and T
subset quantification of PBL in CTCL is unclear.
The phenotype of circulating lymphoid cells in Sezary
syndrome and leukaemic CTCL is OKT3/OKT4 positive (Boumsell,
et al., 1981; Haynes, et ad., 1981; Laroche and Bach, 1981;
Thivolet, et. ad., 1984) but unlike most T cells is 3A1
























































































































































































to malignant expansion of a 3A1 negative subpopulation
within the lymphoma. This possibility has been made more
plausible by the demonstration of a Sezary-like cell having
an 0KT3+, 0KT4+, 3A1- phenotype in normal peripheral blood.
This may be the normal counterpart of the neoplastic Sezary
lymphocyte (Matutes, et. aJL., 1983). Presumably, double
labelling with 0KT4 and 3A1 might identify Sezary cells in
early cases.
Immuno-EM may also be valuable, since the phenotype of
Sezary cells varies with the clinical expression of disease.
For example, an 0KT8 positive phenotype may be observed in
chronic actinic dermatitis (Chu, et al.. 1983b).
Nevertheless, the usefulness of the blood
helper/suppressor ratio in diagnosing CTCL is uncertain.
When erythrodermic patients with and without CTCL were
studied a significant difference in the H/S ratio was
observed in one study (Willemze, et ad., 1983a). In
contrast, another report claimed the helper/suppressor ratio
to be of little help in differentiating CTCL from benign
dermatosis. However, the per cent reactivity of PBL with Bel
and Be2 was claimed to be of diagnostic value (Chu, et al.,
1983c) . In addition, circulating Bel and Be2 reactive cells
have been detected in patients who were not diagnosed as
leukaemic by routine methods. This has been claimed to
indicate that CTCL is a disseminated process at a very early
stage (Berger, and Edelson, 1983) . When one considers the
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migratory capacity of normal lymphocytes this proposition
appears reasonable. However, the Bel/Be2 positivity of
reactive lymphocytes (Chapters 4, 5) indicates that equating
Bel/Be2 positivity with clonal neoplastic cells would be
premature.
2) B CELL LYMPHOMA
Small numbers of circulating monoclonal B lymphocytes
have been described in patients with systemic B cell
lymphomas (Ault, 1979) . This suggests that similar
techniques might be utilized to detect subtle spread in
patients with primary CBCL or atypical B cell infiltrates,
and lymphocytic infiltrates of uncertain prognosis, eg.,
lymphocytoma cutis.
B.. ALTERNATIVE METHODS OF LYMPHOMA DIAGNOSIS AND
CATEGORIZATION
Routine light microscopic diagnosis and categorization
of lymphoma is hampered by the morphologic similarities
between
1) normal transformed lymphocytes and lymphoma cells,
(Chapter 6) and between
2) malignant T and B lymphocytes (Chapter 7).
Electron microscopy (Lutzner, et al., 1971), DNA
cytophotometry (Van Vloten, et al., 1974), morphometry
(Meiier. et ad., 1980), and chromosomal analysis (Whang
Peng, et ad., 1982) are existing ancillary methods of
diagnosis. The first three methods have limitations of
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specificity, the latter, sensitivity. Their application is
mainly in diagnosis rather than categorization and they are
limited to specialized centres.
GENE REARRANGEMENT TECHNIQUES
Recently, the rearrangement of T cell receptor (TCR)
genes and immunoglobulin heavy- and light-chain genes have
been shown to be highly sensitive markers of clonality and
lineage of non-Hodgkin's lymphomas (Arnold, et ad., 1982;
Flug, et. ad., 1985) . The sensitivity of DNA hybridization
permits the detection of clonality in 1% of the total volume
of tissue sampled (Cleary, et al.. 1984). Current areas
requiring clarification with this approach will be outlined.
LINEAGE ASSIGNMENT
Rearrangement of immunoglobulin heavy-chain genes is
not specific for B cell neoplasia and may be seen in myeloid
and T cell leukaemias (Flug, et: ad., 1985; Kitchingman, gt
ad., 1985) . In a similar manner rearrangement of the T cell
receptor gene may be seen in B cell lymphomas and leukaemias
(Pelicci, et ad., 1985) .
Rearrangement of the light-chain immunoglobulin gene is
regarded as much more specific for B cell lineage than
rearrangement of heavy-chain genes. However, rarely, light-
chain rearrangement has been found in lymphomas showing
simultaneous TCR BETA chain gene rearrangement and T cell
immunophenotype (Hakawa, et ad., 1987; Sheibani, et al.,
1987). These discrepancies may be explained by chromosomal
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breakage producing an altered light chain band, or they may
be due to the presence of separate clonal populations of T
and B cells. However, they suggest the desirability of
simultaneous testing by DNA hybridization and McAbs in
future studies of lymphoma categorization.
DIAGNOSIS BY CLONALITY
T cells lack surface markers of clonality similar to
SIg light chains (discussed in Chapter 7). T cell receptor
genes normally undergo rearrangement during intrathymic
development, permitting a wide diversity of idiotypic T cell
receptors necessary for antigen recognition. A clonal
population of T cells will produce a detectable band of
rearranged DNA when labelled with DNA probes. In this
manner, T cell clonality has been identified in skin
affected by mycosis fungoides and in lymph nodes of MF
patients labelled as "dermatopathic" (Weiss, et al., 1985).
Although this is a promising and sensitive technique, the
following areas need to be addressed:
1) The number of other cutaneous disorders studied needs
to be amplified as controls have been extremely limited.
2) The predictive value of the demonstration of clonal T
cell populations in skin is presently uncertain. Clonality
has been demonstrated in 5 of 6 cases of lymphomatoid
papulosis (Weiss, et al., 1986) and 3 of 3 cases of
pityriasis lichenoides et varioliformis acuta (Weiss, et
al., 1987). Examination of the photomicrographic
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illustration of pityriasis lichenoides in the second study
(Weiss, et al., 1987) suggests these cases could be included
under the category of lymphomatoid papulosis type B
(Willemze, et al.. 1982b) or lymphomatoid pityriasis
lichenoides (Black and Wilson Jones, 1972) . Approximately
10% of lymphomatoid papulosis cases develop into lymphoma
(Weinman and Ackerman, 1981) . Development of lymphoma from
classic pityriasis lichenoides is regarded as exceedingly
uncommon even when one includes cases with cytologic atypia
(McMillan and Everett, 1982b). The development of lymphoma
in 3 of 3 randomly selected cases is very unlikely. If the
cases of pityriasis lichenoides described by Weiss et al.
are really lymphomatoid papulosis, this would indicate
clonality in 8 of 9 cases. If one excludes them, clonality
was present in 5 of 6 cases of lymphomatoid papulosis.
Although no follow-up data are available, this small study
group, therefore, suggests that clonality may be more common
than overt malignancy (usually 10%) in these patients. If
this is substantiated, then host immunity (Page 261, Chapter
8) may form part of the equation in determining final
outcome. At any rate these data suggest that clonality like
cytologic atypia is more common than clinical malignancy.
False negative results may also be a problem as certain
peripheral T cell lymphomas (including 1 cutaneous lymphoma)
may lack detectable T cell receptor gene rearrangement
(Weiss, et ad., 1988) .
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Clearly, follow-up data from these interesting studies
are required.
C. THERAPEUTIC APPLICATIONS OF IMMUNOPHENOTYPING
1) CATEGORIZATION OF LYMPHOPROLIFERATIVE DISORDERS
The results here (Chapters 5, 6) and elsewhere have
shown that when the diagnosis of lymphoma is already
established, cutaneous lymphoproliferative disorders may be
classified into various subtypes. This process rests on a
more solid base when multiple markers are used (Chapter 6).
The assortment of phenotypes formed is illustrated in Table
16. The 0KT3+, Leul+, OKT4+, Leu3A+ phenotype of CTCL
(Chapter 5) contrasts with the OKT6+ Leu3A+ phenotype of
Histiocytosis X (Chapter 7) and the variety of phenotypes in
cutaneous lymphomas of non-MF/SS type (described in Chapter
6) .
Improved categorization of lymphomas may eventually
permit more rational therapy. B cell and T cell lymphomas
of similar morphology appear to respond differently to
chemotherapeutic regimens, with T cell lymphomas generally
being less responsive to many of the schedules currently
used for B cell lymphomas (Levine, et al., 1974). The
development of anti-T cell drugs such as Tilorone
hydrochloride (Levine, et al., 1974; Crotty, and Winkelmann,
1982) and deoxyadenosine/deoxycoformycin (Matsumoto, et. al.,
1982) suggests that immunologic typing will be useful in
formulating therapeutic protocols. The results of
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TABLE 16
PHENOTYPIC PATTERN PRESENT IN CUTANEOUS
LYMPHOHISTIOCYTIC INFILTRATES
No. of Cases
. MATURE T HELPER DIAGNOSIS Showing Phenotype
u
jmhofd Ceil





Iflllllllf Large plaque atrophic parapsoriasis 14
|. Benign chronic dermatoses 4
Lichen planus 3
lilllllll Lymphomatoid papulosis type B 1
Allergic Contact Dermatitis 13
terespersed
11
fianriHtfr Chronic lymphocytic leukaemia 1
llllfllfl Lymphocytic infiltrate of Jessner 1




Diffuse large cell lymphoma 2
^ ^y-^Leu1 +
® J—QKT9+ Diffuse large cell lymphoma 1
Leu 1 +
IP J~—Leu3A» Diffuse large cell lymphoma 2
0KT9+ Diffuse large cell lymphoma 1
Leu3A+ ■




Leu 1 + Diffuse small cell well diff. 1
ABERRANT B
Leu 14+









Diffuse large cell lymphoma




















HISTIOCYTE (ABERRANT LANGERHANS' CELL)
r-><-^^-OKT6+




LARGE ATYPICAL CELL (AND REED STERNBERG LIKE CELL)
Leu3A+
Lymphomatoid Papulosis type A 2
HELPER/SUPPRESSOR EQUIVALENCE
OKT3+ OKT3+ f
^Leu 1 + | ^ Leu1 +
Benign chronic dermatosis 1
(©) - (©) Large plaque atrophic
v^ ^ \ parapsoriasis
<L




/^yeu,+ Large plaque atrophic^_-^Leu2A(0KT8)+ Parapsoriasis 1
NOTE:
a) + denotes positive staining of > 50% of lymphoid infiltrate (or of
histiocytic/monocytic component in Histiocytosis X, sarcoidosis,
lymphomatoid papulosis type A, chronic myelomonocytic leukaemia).
b) Phenotype 1 (Mature T Helper) has also been described in
lymphomatoid granulomatosis (Harrist et al., 1981; Harrington, et al., 1983)
and psoriasis (Baker, et al. 1984).
c) Phenotype 10 (Mature T Suppressor) has been described in
pityriasis lichenoides et varioliformis acuta (Wood, et al., 1987), pityriasis
lichenoides chronica (Wood, et al., 1987), erythema multiforme (Margolis, et
al. 1983) and graft versus host disease (Gomes, et al., 1982).
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phenotyping may also have prognostic significance (Yamanaka,
et al., 1981).
2) REDEFINITION OF DISEASES
Mature T cell markers may also be used to redefine
immunologically certain disorders within the CTCL complex.
For instance, cases of pagetoid reticulosis (considered by
many to be a localized variant of mycosis fungoides) can
either demonstrate the 0KT8+ (suppressor) or OKT4+/Leu3A+
(helper) phenotype (Catovsky, et. aJL., 1982/ Mackie and
Turbitt, 1984).
3) PROGNOSIS
Antibodies to the transferrin receptor may also be
useful prognostically as transferrin receptor expression may
correlate with DNA synthesis rates, histologic grading and
survival in non-Hodgkin's lymphoma (Habeshaw, et ad., 1983;
Kvaloy, et al., 1984).
The loss of Leul reactivity may be associated with a
worse prognosis in CTCL.
The expression of lambda light chain in CBCL has been
associated with a poorer response to treatment and the
tendency for a particular tumour to fall into the high grade
category (Lauder, et ad., 1985).
4) INFERENCES FROM DENDRITIC MARKERS AND VIRAL ASSOCIATED
ANTIGENS
The 0KT6 marker may be useful in identifying cutaneous
T cell lymphoma when loss of mature T cell markers has
occurred. 0KT6 reactive cells are present in the dermal
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infiltrates of cutaneous T cell lymphoma and benign T cell
infiltrates (Chapters 4, 5, 6, 7). B cell lymphomas in
contrast are devoid of an 0KT6 positive component (Chu, et
al.. 1982a; Haynes, et al., 1982b) (Chapter 6) but may
contain an R423 positive dendritic component (Table 14).
Further studies are required to determine if this is a
consistent finding.
The presence of the 0KT6 marker on the histiocytic
cells of Histiocytosis X (Chapter 7) suggests 0KT6 labelling
may be a useful adjunct in the diagnosis of that disorder.
Although not covered experimentally in this thesis, it
should be mentioned that T cell McABs have also been used to
evaluate patients with retrovirus - associated adult T cell
leukaemias and lymphomas. The clinicopathologic features of
this group indicate that they are distinct from other
lymphomas (Gallo and Wong-Stall, 1982). Patients with MF
and SS are generally negative for antibodies against the
pathogenetic human T cell leukaemia/lymphoma virus (HTLV).
Monoclonal antibodies against HTLV have been produced and
should be useful for studying the prevalence of HTLV in
various immunoproliferative states. Preliminary monoclonal
typing of adult T cell leukaemia cells has shown an 0KT3+,
0KT4+, Leul+, Leu3A+ phenotype (Hattori, al.. 1981;
Catovsky, et ad., 1982; Nakahara, et. al. ., 1982; Yamada,
1983).
5) MONOCLONAL ANTIBODY THERAPY
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Lymphoma phenotyping should also have application in
therapeutics. For instance, the Leul positivity of CTCL
(Chapter 5), T101 positivity of CLL and J5 positivity of
non-T ALL have been utilized by infusing the respective
antibodies with resultant temporary clinical improvements
(Ritz and Schlossman, 1982). However, phenotypic
heterogenity including the presence of Leul- subtypes of
CTCL (Chapter 5) suggests difficulty in using this single
agent with consistent success. Cross reactivity of Leul and
T101 with normal tissue components has been a problem (Ritz
and Schlossman, 1982) and could be predicted from results in
Chapter 4.
The demonstration of 0KT6, 0KT9 and OKTIO reactivity in
a component of the lymphoid population in CTCL (Chapter 5)
raises the possibility of using these antibodies linked to
chemotherapeutic agents, plant toxins (eg., Ricin), coated
lipid vesicles, and radiopharmaceuticals to reduce various
fractions of the neoplastic population. It should be
emphasized, however, that the number of cells reacting with
these antibodies varies in individual cases and is often
small (Chapter 5).
Of course, researchers with an embryologic point of
view might argue that if these cells are "dedifferentiated"
or "immature", they are the most important ones to
eliminate. Even if 0KT9, 5E9 expression is due to
proliferation rather than a "block" or "reversal" in
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differentiation, it could still be argued that it is crucial
to eliminate this proliferating compartment. Examination of
the normal tissue distribution of these determinants will be
required as a necessary preliminary to such trials. The
extrathymic distribution of the 0KT6, 0KT9, and OKTIO
determinants, for instance, has been demonstrated here
(Chapter 4). Passive therapy with these antibodies might,
therefore, only be appropriate in advanced cases of CTCL in
which normal lymphoid architecture has been largely
destroyed. The results with the myeloid antibodies (Chapter
4) are of interest in this respect as some of them appear to
have a very limited tissue distribution. Other problems
associated with McAb therapy have recently been outlined
(Estabrook, and Patterson, 1983).
6) STIMULATION OF IMMUNE REACTIVE CELLS
The prospect of pharmacologically manipulating the
HNK1+ lymphocytes, T cells, and macrophages present in
lymphoma specimens (Chapter 5, 6) (McMillan and Stoneking,
1987) is intriguing. For instance, interferon, retinoic
acid or interleukin 2 may stimulate K/NK activity
(Pattengale, et al., 1982; Kessler, et al., 1983; Lanier, et
al., 1985) .
The prevalence of HNK1+ lymphocytes in 73 biopsies of
benign and malignant cutaneous lymphohistiocytic infiltrates
(and control scalp skin) is shown in Table 17.






















































































































unknown. Subpopulations of HNK1+ lymphocytes with varying
cytolytic potential may be identified through their
expression of HNK1 (Leu7) and Leull (NK-15) antigens
(Lanier, et, al.. 1983) . The HNK1+ population may also be
subdivided into subsets with positive or negative expression
of T subset markers (0KT4, 0KT8), the various fractions
identified having different tissue distributions (Pizzolo,
et al., 1984). Indirect evidence concerning the cytotoxic
capacity of various tumour immune cells may, therefore, be
obtained by extensive analysis of their antigenic
expression. Similar methods may be applied to macrophages,
as subsets of the mononuclear phagocyte system become better
defined.
Finally, a more pragmatic approach would be to quantify
such cells in tumour specimens and correlate their presence
with clinical response to immunomodulatory therapy.
The conceptual and practical difficulties in
identifying K/NK cells in human tumours and utility of the
data generated has recently been debated (Manara, et al.,
1988; McMillan, 1988).
II. SUMMARY
With reference to the objectives outlined in Chapter 2,
pages 20-23, the results may be summarized as follows:
OBJECTIVE
1 a) Monoclonal determinants expressed on T cells (and T
subsets), B cells of varying maturity, K/NK cells,
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monocytes/macrophages, and D cells are readily demonstrable
in non-malignant lymphoid tissue (tonsil, lymph node,
thymus) and skin (Chapter 4).
The expression of the determinants tested is limited in
skin but they are readily demonstrated in benign and
malignant cutaneous lymphoid infiltrates (Chapters 4-7)
b) The determinants examined have characteristic
topographic distributions (chapter 4).
c) So-called "immature determinants" (0KT6, 0KT9, OKTIO)
are not restricted to thymus and bone marrow, contrary to
the indications from prior studies of these markers.
The OKT6 determinant is present on dendritic cells in
skin, tonsillar crypt epithelium, and in cells occupying the
interfollicular areas of some non-malignant lymph nodes
(chapter 4). The nature of these 0KT6+ cells is discussed in
Chapter 4. The 0KT6 marker is also commonly present on the
dendritic component of benign and malignant cutaneous
lymphoid infiltrates of T cell type (chapter 4-7). (B cell
infiltrates in contrast contain an R423+ dendritic cell,
Chapters 6, 7).
The 0KT9 and OKTIO determinants are present in non-
malignant peripheral lymphoid tissue (tonsil, Chapter 4;
lymph node not tested), and in benign (0KT9) and malignant
(0KT9, OKTIO) cutaneous lymphocytic infiltrates (Chapters 5,
6, 7) .
2) Allergic contact dermatitis, a prototype of reactive
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inflammatory states, exhibits a mature helper T cell
phenotype (Leul+, 0KT3+, Leu3A+, 0KT4+, 0KT9-, OKT10-) with
interspersed 0KT6+ dendritic (Langerhans') cells (Chapter
4). This phenotype is also typical of a variety of
inflammatory disorders (see Discussion section, this
chapter).
3) Concerning Mycosis Fungoides/Sezary Syndrome (CTCL)
a) a mature helper T cell phenotype (Leul+, 0KT3+,
Leu3A+ 0KT4+ (Chapter 5) in CTCL contrasts with acute T cell
lymphoblastic leukaemia and lymphoblastic lymphoma which
usually show immature (early or common thymocyte)
phenotypes.
An admixture of suppressor cells (Leu2A+, 0KT8+) is
also present. The hypothesis that CTCL might be readily
diagnosed through the demonstration of a phenotypically
monomorphous helper infiltrate is, therefore, not
substantiated.
b) cells expressing the immature antigens 0KT9, OKTIO
are present in the cutaneous infiltrates,
and
c) comparison with the prelymphomatous disorder, large
plaque parapsoriasis/poikiloderma vasculare, et atrophicans
(mature T helper) and reactive states, eg., allergic contact
dermatitis, atopic dermatitis (also mature T helper)
indicates preferential expression of the immature
determinants 0KT9 and OKTIO in CTCL and other cutaneous
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lymphomas (Chapters 5 and 6).
0KT9 expression in the parapsoriasis group is
heterogeneous in addition to being less frequently found
than in CTCL (Chapter 5).
The overlap in helper/suppressor ratios in benign
prelymphomatous, and lymphomatous disorders (Chapters 4, 5)
further supports the view that testing of cutaneous
lymphocytic infiltrates with the mature subset markers used
here is of limited diagnostic value.
4) Cutaneous lymphomas of non-MF/SS type
a) may be categorized with McAbs into T or B types
(Chapter 6) .
No true histiocytic lymphoma is identified here.
Unclassifiable (U cell) types occur as with previous
methods. The inclusion of multiple markers decreases the
number of unclassifiable cases (Chapter 6).
b) show evidence of aberrant differentiation with the
presence of phenotypes not found during normal T cell or B
cell ontogeny.
5) Characteristic antigenic patterns are found in other
cutaneous disorders involving mononuclear-phagocytic cells,
eg., sarcoidosis, histiocytosis-X, myelo-monocytic leukaemia
(Chapter 7). The histiocyte of histiocytosis X, in common
with the normal Langerhans' cell, expresses the OKT6
determinant, but in addition reacts with the Leu3A (helper T
cell) antibody.
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The immuno-architectural pattern of the dermal
infiltrate of lymphocytoma cutis taken in conjunction with
overlying epidermis (Chapter 7) is remarkably similar to
tonsillar lymphoid tissue with its adjacent crypt epithelium
(Chapter 4) or B and T cell zones of human lymph node.
Lymphomatoid papulosis demonstrates phenotypic
diversity which may be useful prognostically.
6) Putative immune cells, i.e., HNK1+ lymphocytes
(probably K/NK cells), macrophages, and non-neoplastic T
cells are present in cutaneous lymphomas (Chapters 5, 6),
prelymphomas (Chapter 5), pseudolymphomas (Chapter 7) and
inflammatory states (Chapters 4, 5, 6). The prevalence of
HNK1+ lymphocytes in benign and malignant cutaneous
lymphohistocytic infiltrates is summarized in Table 17.
Their presence in lymphoma may be of prognostic or
therapeutic import.
7) The Bel/Be2 antigens purported to be specific for
lymphomas are present in
a) non-malignant lymphoid tissue (Be2 in tonsil,
Chapter 4),
b) skin (Bel in follicular epithelium, Be2 in
endothelial cells, Chapter 4),
c) benign lymphocytic infiltrates (Chapter 5),
d) pseudolymphomas (Chapter 7), as well as cutaneous
lymphomas of MF/SS (Chapter 5)and non MF/SS (Chapter 6)
types.
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They are preferentially expressed in lymphomas (in
terms of numbers of cases showing Bel and/or Be2
positivity). Overlap with benign disorders (in terms of
percentages of positively staining cells and frequency of
positively reacting cases) makes their present application
in tissue section diagnosis impractical. The reactivity of
Bel and Be2 with a variety of non-malignant and lymphomatous
cell populations is summarized in Table 15.
Within the limits of sensitivity of the indirect
immunoperoxidase method used, non-malignant lymphoid tissue
(tonsil) is non-reactive with the J5 (CALLA) marker. Rare
cases of cutaneous lymphoma are J5 positive (Chapters 5).
No comparison with benign lymphocytic infiltrates is
presently available.
III. CONCLUSION
One decade ago, it was possible to extract lymphocytes
from tissues and make a gross assessment of T or B content
by rosetting assays. The development of McAbs has permitted
a more accurate dissection of a wide range of normal and
malignant lymphoid populations (Chapters 4-7). The studies
described here with McAbs on tissue sections indicate that
lymphomas are often more complex than the simple expansion
of a clone of cells. The inter-relationships of the
constituent cell types is wide open to speculation and
further investigations. These reagents provide the framework
for more creative diagnostic, prognostic and therapeutic
269
approaches to cutaneous lymphoma. They offer the exciting
possibility of being able to treat lymphoma patients more
effectively. The studies here, however, demonstrate
conclusively that any new marker must be extensively tested
in non-malignant lymphoid tissue, reactive and malignant
states prior to its clinical application.
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TABLE 2
SPECIFICITIES AND SOURCES OF MONOCLONAL ANTIBODIES
AlxU tlS/.Ynt tYIUtntllDIKK
ANTIBODIES SPECIFICITY
T Cell and Subsets
0KT3 (CD3) Pan T (Kung, et al, 1979).
0KT4 (CD4) HelperT (Ledbetter, et al,1981).
0KT8 (CD8) SuppressorT (Kung, et al, 1979).
Leu 1 (CD5) Pan T (Ledbetter, et al, 198 1).
Leu2A (CD8) SuppressorT (Ledbetter, et al, 1 98 1).
Leu3A (CD4) HelperT (Ledbetter, et al, 198 1).
1
Leu4 (CD3) Pan T (Ledbetter, et al, 198 1).
Leu5 (CD2) E receptor (Ledbetter, et al, 1 98 1).
T11 (CD2) E receptor (Ip, et al, 1982; Greaves, et al, 1981).
OKT11 A (CD2) E receptor (Greaves, et al, 198 1).
T 1 0 1 (CD5) Pan T, some B cell neoplasia (Royston, et al, 1980).
3A1 (CD7)
SuppressorT cells, subset of helperT cells (Cossman,
et al, 1983), K cells (Herberman and Ortaldo, 1981).
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Immature (common) thymocytes (Kung, et al, 1980),
epidermal dendritic cells (Chapter 4).
0KT9
Immature thymocytes, T cell ALL (Kung, et al, 1980),
wide range of proliferating cell types in culture
(Greaves,et al, 1981), eg., mammary carcinoma,
teratocarcinoma. Transferrin receptor.
OKT10 (CD38)
Immature thymocytes (Kung, et al, 1980), bone
marrow progenitor cells some activated T cells (Kung,




Granular lymphocytes with K/NK function (Abo ana
Balch, 1981),fetal hamster olfactory epithelium,
(Ward, 1986) human neuroectodermal tumours,
(Cailland,et al, 1984) neural and neuroectodermal
cells of several species (Lipinski, et al, 1 983;
Schuller-Petrovic, et al, 1983).
B Cell
B1 (CD20) B cells, B cell lymphomas (Nadler, et al, 1981a).
B2 (CD21)
Subset of B cells and B cell lymphomas (Nadler, et al,
1981b).
Leu 14 (CD22) B cells, weakly with monocytes, but not macrophages.
Kappa Anti-kappa light chains.
Lambda Anti-lambda light chains
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HLADR Monocytes, macrophages, Langerhans' cells,
activated T cells, B cells (Warnke and Levy, 1980).
Monocyte/Macrophage/D Cell
OKM1 (CD11) Monocytes, macrophages, myeloid series (Breard,
et al, 1980).
M02 (CD14W) Monocytes, macrophages (Todd, et al,1981).
LeuM1 (CD15)
Monocytes, macrophages, myeloid series (Hanjan,
et al, 1982) adenocarcinomas, (Sheibani, et al, 1986),
interdigitating reticulum cells, (Hofman, et al, 1984),
Reed-Sternberg cells, (Pinkus, et al, 1985; Hsu, et al
1986).
LeuM3 (CD14) Monocytes, macrophages (Dimitriu-Bona, et al, 1983).




Macrophages ("Histiocytes") (Yam and Li, 1971)
R423
Dendritic reticulum (follicular dendritic) cells
(Naiem, et al, 1983).
OKT6 (CD 1a) Epithelial dendritic cells (Chapter 4) ■
Non Lineage Restricted
2D1 (CD45) T200 Leukocyte common antigen (Pizzolo et al 1980).
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Common acute lymphoblastic leukaemia antigen, (Ritz,
et al, 1980), adult and fetal nonhaematopoietic tissue
(Metzgar, et al, 1981) , immature T cells (Hsu, et al,
1985), neutrophils (Cossman, et al, 1983), germinal
centre B cells, (Hsu, et al, 1984), B cell lymphomas
and leukaemias (Hsu, et al, 1984; Cossman, et al, 1984).
Myeloblasts Leukaemia cell lines
My 10 (CD34)
Kg-1, Kg-1 a cell lines, some ALL and ANL, myeloid
progenitor cells (Civin, et al, 1983, 1984).
My 11 (CD45R)
Kg— 1, Kg-1 a cell lines, monoblastic, B-lympho-
blastoid lines, E rosette+ and E rosette- PBL,
monocytes, some ALL, ANL, CLL, CFU-C but not
CFU-E or 8FU-E (Civin, et al, 1983, 1984).
My 12 Kg- 1, Kg- 1 a, U-937, K-562, HEL cell lines, some ANL,CML, ALL (Civin, et al, 1983, 1984).
My 1 3 Kg-1, Kg-1 a cell lines blast cells from less than
10% of ANL or ALL, CLL. (Civin, 1983)
Leukaemia/Lymphoma
Bel
Leukaemic CTCL lymphocytes, lymph nodes infiltrated
by CTCL, Epstein Barr virus transformed cell lines
and some long term T cell lines.
Be2
Peripheral blood lymphocytes from 75% of CTCL
patients, Epstein Barr virus cell lines, some T cell
lines and a subpopulation of lymphocytes from 5 of 8









M0PC21 No known specificity.
Mouse Ascites No known specificity.
NOTES OF EXPLANATION:
1. KG-1 is a myeloblastic leukaemia cell line derived from a patient with nonlymphocytic
leukaemia (Koeffler, and Golde, 1978). The KG-1a cell line arose from it as a spontaneous tissue
culture variant (Koeffler, et al., 1980). KG-la cells are phenotypical 1 y less differentiated than
KG-1 cells, and have the morphological and cytochemical features of primitive haematopoietic
blast cells. (Koeffler, et al., 1980).
2. The McAbs MY 1 0-13 have been raised against determinants on KG-la cells. None of these
antibodies react with blood granulocytes, red blood cells, or platelets from normal donors. Large
subsets of peripheral blood lymphocytes and monocytes express the My 11 antigen. My 10, 12, 13
antigens are not expressed on significant numbers of blood lymphocytes or monocytes. My 1 1 is found
in 25% of bone marrowcells of normal donors. MylO, 12, 13 bind only subpopulations of normal
marrow cells.
3. Sources of McAbs:
A. Orthoimmunobiology. Raritan, New Jersey, USA: 0KT3, 4, 6, 8, 9, 10, 1 1 a, and OKM 1.
B. Becton Dickinson Facs Systems Ltd., Sunnyvale, California, USA: Leu1, 2A, 3A, HLADR,
LeuMI, LeuM3, Leul4, Anti-Kappa, and Anti-Lambda.
C. Coulter Ltd., Bethesda, Maryland, USA: B1, B2,T1 1, M02, and J5.
D. Hybritech, Inc., T 101.
E. Barton Haynes, M.D., Dept. of Medicine, Duke University, North Carolina, USA: 3A1.
F. Toru Abo, Ph.D./Charles Balch, M.D. Departments of Microbiology and Surgery, University
of Alabama, Birmingham, Alabama, USA: HNK1
G. David Mason, M.D., Department of Haematology, John Radcliffe Infirmary, Oxford, England: R423.
H. Curt Civin, M.D., Department of Paediatric Oncology, The John Hopkins Oncology Center,
Baltimore, Maryland, USA: MY3, MY10-13, M.O.P.C. 21.
I. Carole Berger, Ph.D., Department of Dermatology, Columbia College of Physicians, New York,
New York, Be 1 and Be2.
J. American type Tissue Collection, Rockville, Maryland: M.O.P.C. 21. Mouse myeloma protein
(culture supernatant with no known specificity, IgGI Kappa produced by the P3 x63 AG B cell line.
4. ABBREVIATIONS
ALL: acute lymphoblastic leukaemia; CLL: chronic lymphocytic leukaemia; PBL: peripheral blood
lymphocytes; BFU-E: burst forming units - erythroid; CFU-E: colony-forming units erythroid;
CFU-C colony forming units - culture; ANL, acute nonlymphocytic leukaemia.
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